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Abstract 
 
The prevalence of Type 2 diabetes mellitus (T2DM) has increased dramatically 
over the past 10 years in Malaysia due to the modernisation of the country. The 
most recent national health survey revealed that more than 15.2% of Malaysian 
adults are suffering from the diseases. 
 
Insulin treatment has been demonstrated to play a clinically significant role to 
improve glycaemic control among selected Type 2 diabetes mellitus (T2DM) 
patients. However, studies from several local hospitals showed that more than 
half of T2DM patients are reluctant to initiate insulin treatment. There is an 
increasing trend for the Malaysian healthcare sector to invest in understanding 
patientsÕ health experiences. This qualitative study focused on T2DM patientsÕ 
insights about their lived-experience of using insulin treatment as part of their 
diabetes management. This study aimed to understand the facilitators, which 
encourage patients to accept insulin treatment and also the psychological, 
social and behavioural barriers to effective diabetes management.  
 
Drawing on interview data with 37 participants, the three main barriers to 
initiate insulin treatment were worries about inability to handle using insulin, a 
sense of personal failure and negative perceptions of injections due to past 
experiences. The facilitators that encourage patients to accept insulin treatment 
were prior exposure to insulin injections, better side effect profile and wanting 
a better quality of life. However, there were many obstacles faced by T2DM 
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patients when coping with insulin treatment such as the restriction of lifestyle 
and concerns about social acceptance.  
 
In general, knowledge of T2DM and insulin treatment are still lacking among 
the Malaysians interviewed in this study. There are still many distorted beliefs 
and misconceptions about insulin among T2DM patients. At the same time, 
patientsÕ concerns and beliefs regarding insulin use are greatly influenced by 
their experience and support from others. Many participants felt embarrassed 
and self-conscious when self-injecting insulin in public places. They felt that 
the Malaysian public often associate the use of injections to drug abuse. Social 
stigma is one key point, which leads to poor adherence to insulin treatment. 
Thus it is crucial to increase public awareness about insulin treatment in order 
to help these patients to be more comfortable about injecting, and also to 
encourage other people to be more open minded towards insulin treatment. 
Apart from raising public awareness, there is a need to empower T2DM 
patients with adequate knowledge through early, simplified, tailored education 
focusing on the disease nature and the role of insulin. Making them more 
aware of their health condition and the uses of modern insulin devices at an 
early stage will better prepare them mentally for insulin therapy. 
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CHAPTER 1  
INTRODUCTION 
 
1.1 Background 
Diabetes mellitus is an ancient disease yet remains today a worldwide threat 
with an alarming rise of prevalence and is creating a massive health burden.  
The term diabetes mellitus describes a chronic, persistent hyperglycaemia 
disorder, accompanied by other metabolic abnormalities. WHO classified 
Diabetes Mellitus according to their aetiologies namely Type 1, Type 2, 
gestational diabetes and other specific types (Alberti & Zimmet 1998). Type 2 
diabetes mellitus (T2DM) includes the common major form of diabetes and it 
is characterised by dysfunction action of insulin at peripheral tissue, or 
impaired insulin secretion from pancreatic beta cell or both. There is also an 
unusual increase of hepatic glucose output and abnormal metabolism of 
carbohydrate, fat and protein, thus leading to a marked raised level of blood 
glucose (Ministry of Health Malaysia 2009; Alberti & Zimmet 1998; 
International Diabetes Fedaration 2013). T2DM is traditionally found in the 
older population, but recently it has been increasingly seen in younger adults 
and even children.  
 
T2DM is a chronic and progressive disease, there is no known cure for the 
disease but medication is used to maintain a near normal blood glucose level. 
T2DM is a progressive disease, which characterised by worsening glycaemia. 
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At diagnosis, most patients were found to have only approximately 50% of 
normal pancreatic beta cell function. It is estimated that the diagnosed patientÕs 
pancreatic beta cell function will further decline at a rate of approximately 5% 
per year (Turner & Holman 1995).  
 
Uncontrolled T2DM can lead to long-term permanent damage, dysfunction and 
failure of various organs. Macrovascular and microvascular complications are 
the major consequences of poor glycaemic control, which contribute to a 
significant rate of mortality and morbidity. Micro-vascular complications 
refers to damages on smaller blood vessel causing nephropathy, neuropathy 
and retinopathy which lead to the need of dialysis, amputation and loss of 
vision; on the other hand, macro-vascular complications increase risk of 
cardiovascular and cerebro-vascular events causing damages to other 
peripheral vascular systems. As a result of these complications, T2DM poses 
an enormous health and economic burden from repetitive hospitalisation, 
pharmaceutical costs and loss of productivity due to various disabilities. 
Furthermore, it causes a substantial impact to the patientsÕ longevity and 
quality of life and indirectly affects their family members. 
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1.2 Literature Review 
1.2.1 Epidemiology of Type 2 Diabetes in Malaysia  
In a recent International Diabetes Federation (IDF) report, it was estimated that 
the current population of diabetes is already at the bar of 382 million and this 
number will continue to increase to 592 million by 2035. The report 
highlighted that 80% of the diabetes population lives in low and middle 
income countries such as Malaysia (International Diabetes Fedaration 2013).  
 
The prevalence of Type 2 diabetes mellitus (T2DM) in Malaysia has increased 
dramatically over the past 10 years due to the modernisation of the country. 
The 2006 National Health Morbidity Survey (NHMS III) reported as many as 
1 in 7 Malaysian adults over age of 30 years are suffering from diabetes. 
Despite the less stringent criteria for diagnosing diabetes in 2006 NHMS III 
survey compared to 1996 NHMS II survey, the prevalence of diabetic patients 
≥30 year old had increased from 8.3% in the 1996 survey to 11.6% in 2006 
(Letchuman et al. 2010; Zaini 2000).  
 
The most recent National Health Morbidity Survey (NHMS 2011) reported the 
prevalence of diabetic patients has increased to 15.2% (Kaur et al. 2011). 
Among the diabetes population in Malaysia, the Indians had the highest 
prevalence at 24.9%, this was followed by the Malays at 16.9% and lastly, the 
Chinese diabetes population was sitting at 13.8% (refer Figure 1).  
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The figures shown that the in the space of 5 years, the prevalence of diabetes in 
Malaysia has increased by 31.0%, from 11.6% in 2006 to 15.2% in 2011 (refer 
Figure 2). NHMS 2011 concluded that this dramatic increase was due the 
result of the increased proportion of "undiagnosed diabetes". This current 
figure placed Malaysia in sixth place in the world for the highest prevalence of 
T2DM in the age group 20-79 years (International Diabetes Fedaration 2013). 
Judging from the trend, the prevalence of diabetes in Malaysia will also exceed 
the projected prevalence by International Diabetes Federation for all regions in 
the world for year 2025 (Wild et al. 2004).  
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Figure 1 Percentage of diabetes patients among main ethnic groups.  
 
 
Figure 2 Status of Diabetes Mellitus in Malaysia in the past 20 years 
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1.2.2 Economic Burden 
The dramatic rising prevalence of T2DM has mainly occurred in developing 
countries where there has been rapid urbanisation causing major lifestyle 
changes. In Malaysia a developing country, modernisation has rapidly 
transformed the country and also modified the lifestyle of the population. 
Furthermore, the Malaysian diet is high in carbohydrates and fat, but lacking in 
vegetable and fruits intake; synergising that with the urbanising lifestyle, lack 
of physical activity; the rise of diabetes prevalence is indeed very alarming 
(Kaur et al. 2011). This growing population of diabetes patients has not only 
put an enormous economic burden on individuals, but also the countryÕs health 
system and economy. In 2010, International Diabetes Federation (IDF) 
estimated that US Dollar (USD) 376 billion was spent on treating and 
preventing diabetes, which translated to 11.6% of the total healthcare 
expenditure worldwide (Whiting et al. 2011). Three years later, IDF (2013) 
reported this figure has increased to USD 548 billion. 
 
Poor glycaemic control leads to long term complication and contribute to a 
significant rate of mortality and morbidity. The NHMS III survey revealed that 
as high as 4.3% of diabetic patients had have lower limb amputations, 3.4% 
suffered strokes and 1.6% were on dialysis or had kidney transplants due to 
micro-vascular complications (Letchuman et al. 2010). These complications 
resulted in repetitive hospitalisation, pharmaceutical cost and loss of 
productivity and causing an immensely burden to Malaysia. 
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Therefore, good glycaemic control is very critical to prevent the development 
of diabetic complications. Due to the progressive nature of diabetes, most 
T2DM patients eventually will require exogenous insulin to control their blood 
glucose levels. Most patients with T2DM only retain 50% of pancreatic beta 
cell function at diagnosis, and the function of these cells is declining at 5% 
each year. By the 6
th
 year of treatment with oral hypoglycaemic medication, 
over 50% of the patients will eventually require insulin intervention to 
maintain a healthy blood glucose level (Turner & Holman 1995).  
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1.2.3 Development of Insulin Products 
Since the discovery of insulin by Frederick Banting and his student Charles 
Best back in 1921, insulin has been widely used for treatment of diabetes. Oral 
hypoglycaemic agents were later introduced in the 1950s, transforming the 
treatment of diabetes mellitus (Watkins et al. 2003). The initial production of 
insulin contained significant amount of impurities but manufacturing technique 
was rapidly improved to allow the manufacturing of higher quality insulin 
formulation (Hirsch 2005). By early 1980s, a new technology, recombinant 
human insulin technology, was developed to replace bovine and porcine 
sources in the manufacturing process. This technology improves the side effect 
profiles of insulin particularly insulin allergy and immune-mediated 
lipoatrophy. 
 
The first long-acting preparation, protamine zinc insulin, was developed in the 
1930Õ. The development of this long-acting insulin preparation reduced the 
frequency of injection required in a day. In 2001, insulin glargine, the first of 
the long-acting insulin analogues, was introduced which is widely used today 
as basal insulin injection (Hirsch 2005). This is followed by the development 
of insulin detemir, another long-acting analogue that only required to be 
injected once daily offering additional benefits of lifestyle flexibility and 
improved glycaemic control.  
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1.2.4 Improvement of Insulin Delivery Devices 
Over the years, there have been many significant developments to improve the 
efficacy and safety profiles of insulin; the mechanical devices used to deliver 
insulin have also been improved. Insulin product was originally available in 
glass vials and to be administered with glass syringe and large, long needles. 
The glass syringes and the needles were reusable and had to be sterilised by 
boiling, furthermore the reusable needles needed to be sharpened with a 
pumice stone (Bohannon 1999).  Insulin syringes still to play an important role 
in diabetic care today, they are now available as a single-use, disposable plastic 
syringe and used with much shorter and finer attachable needles.  
 
After years of using glass vial together with syringes and needles, drug 
companies that manufacture insulin product have developed a more ÔpersonalÕ 
version of the mechanical devices to encourage of self-administering of insulin 
at home (Griffin & Hieronymus 2002; Selam & Charles 1990; Bohannon 
1999). The developments of insulin pen devices make the process of injecting 
insulin much more pleasant compared to the traditional insulin syringes and 
needles. These injecting devices consist of a reusable injecting device and a 
replaceable insulin vial that comes in 3mL cartilage. This device is to be used 
with a new and improved needle, a single-used, disposable needle. These 
disposable needles are much finer and smaller in size compared to the 
traditional insulin needles and therefore causing less pain and more acceptable 
to patients.  
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The latest development is the new fully disposable modern insulin pen devices. 
The principle of the devices is similar to its predecessor, instead of having to 
change the cartilage; these new disposable pen devices has the cartilage Ôbuilt-
inÕ. This development has further increased flexibility and acceptability by 
patients (Griffin & Hieronymus 2002; Bohannon 1999). Other insulin delivery 
systems such as insulin pumps and jet injectors are available overseas but not 
popular in Malaysia (Griffin & Hieronymus 2002). 
 
Since the first introduction of insulin in 1921 by Frederick Banting and his 
student Charles Best, insulin has been administered as an injection and this 
delivery method had no major breakthrough until 2006, when Pfizer drug 
company launched the first ever inhaled insulin, Exubera¨ (US food and Drug 
Administration 2006). However, it was not well received by the public and any 
health authorities. Therefore Pfizer, the manufacturer has ceased its production 
in 2008, only 2 years after it first launched. The National Institute for Health 
and Clinical Excellence (NICE) concluded that using this new treatment option 
is not more clinically and cost effective than the current available injectable 
insulin and had since withdrawn the product from British National Formulary 
(National Institute for Health and Clinical Excelence 2006).  
 
Over the years, many researchers have spent an immense effort in the 
development of an alternate delivery method for insulin such as transdermal 
and oral-buccal route, unfortunately face with many challenges (Carino & 
Mathiowitz 1999; National Institute for Health and Clinical Excellence 2009). 
Thus, until today injectable insulin treatment remains the only effective 
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delivery method to control and maintain healthy blood glucose level for many 
diabetic patients.  
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1.2.5 Treatment Aim 
The aim of diabetes management has remained the same throughout the 
century: to maintain a satisfactory glycaemic control and subsequently 
reducing both micro-vascular and macro-vascular complications. The short 
term goal is to achieve appropriate glycaemic control to avoid any hyper or 
hypoglycaemia, the long term aim is to reduce the concurrent risk factors such 
as cardiovascular risks, identification of complications and management of any 
existing complications (Ministry of Health Malaysia 2009). 
 
Diabetes management involves lifestyle adjustment, medication and in the 
more recent years, focus has been shifted to incorporate patient education and 
to encourage self-care. Malaysian healthcare has been advancing in diabetes 
treatment. Diabetic medications are wildly available in Malaysia, from the 
traditional oral hypoglycaemic agents such as biguanides and insulin 
secretagogues, to the newer generation of insulin sensitizers and dipeptidyl 
peptidase-4 inhibitors (Ministry of Health Malaysia 2009). Injectable 
medication also evolved from the well-established different classes of insulin 
to the later class of glucagon-like-peptide such as liraglutide and exenatide. 
 
The Ministry of Health, Malaysia has been making the public aware that the 
epidemic of T2DM has been rising dramatically and affecting the nation. The 
ministry constantly updates treatment guidelines to provide healthcare 
providers the best available evidence on the current concepts in management of 
T2DM. The two recent publications, Management of Type 2 Diabetes Mellitus 
and Practical Guide to Insulin Therapy in Type 2 Diabetes Mellitus, solely 
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focus on T2DM management with an extensive updates on the treatment 
guidelines (Ministry of Health Malaysia 2009; Ministry of Health Malaysia 
2010). Because beta-cell failure is progressive in T2DM, most patients can be 
expected to require insulin therapy to maintain glycaemic control. As a result, 
increased emphasis has been placed on the earlier use of insulin therapy in 
patients with Type 2 diabetes. NHMS 2011 estimated 79.9% of the known 
diabetic patients were on oral anti-diabetic (OAM) drugs and 19.3% were on 
insulin treatment.  
 
Among these diabetic patients, majority (80.6%) sought treatment from MOH 
facilities. NHMS 2011 estimated that 56% sought treatment at MOH health 
clinics, followed by 24.6% at MOH hospitals. The rest of diabetic patients 
referred to private clinics (15.0%) and private hospitals (2.5%). Around 1.6% 
of diabetic patients self-medicated by purchasing medications directly from 
retail pharmacies and 0.2% opted for traditional and complementary medicine 
(Kaur et al. 2011). 
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1.3 Research Interest  
Due to the progressive nature of Type 2 diabetes mellitus (T2DM), insulin 
therapy can significantly reduce morbidity and mortality if introduced to 
suitable patients at an early stage, or aggressively enough to achieve their 
glycaemic control. However only 7.2% of diabetes patients are on or are 
willing to use insulin treatment. Furthermore, many T2DM patients who could 
potentially benefit from insulin therapy do not receive the treatment or do not 
have treatment initiated in a timely manner (Ministry of Health Malaysia 2009; 
Ministry of Health Malaysia 2010). The Malaysian Ministry of Health has 
issued a guideline to advice T2DM patients to maintain HbA1c of less than 
6.5%. However, due to multiple factors and barriers, only 22.5% of the 
patients are able to achieve this target (Abdul Rahman 2012). This 
phenomenon is partly attributed to the patientsÕ reluctance to initiate insulin 
therapy. This reluctance arises from many factors such as patientsÕ cultural 
health beliefs, knowledge of diabetes disease, perception of insulin therapy and 
other social and economic barriers. The reluctance towards initiating insulin 
treatment might also reflect that there is unsatisfactory quality of care and poor 
relationship between patients and their healthcare providers, which may result 
in poor adherence. 
 
Medicines adherence or compliance is a major health issue in chronic diseases 
such as diabetes. Non-adherence significantly impact on our healthcare system. 
Like many other countries, MalaysiaÕs healthcare policies are largely driven by 
cost containment strategies.  With the exponentially increasing healthcare cost, 
health policy makers are focusing on reducing wastage and inappropriate 
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expenditure (Pollock 2005). The large number of diabetes patients failing to 
take medication as prescribed deems to be both inexplicable and intolerable.  
Poor adherence not only leads to a tremendous wastage of expensive resources 
but also heavy burden on the country health system as a result of diabetes 
complications. In 1997, The Royal Pharmaceutical Society of Great Britain 
developed a concept of concordance from concern about patient non-
compliance. The aim was to refocus from a preoccupation with non-
compliance as a technical issue to an increase in understanding of patientÕs 
experience of illness as well as the values and aspirations underpinning his or 
her preferences for treatment.  
 
Much quantitative research conducted in the pharmacy field focuses on 
improving adherence of insulin treatment among T2DM patients (Lindenmeyer 
et al. 2006; Drab 2009; Krass et al. 2007; Nur Azmiah et al. 2011). While 
quantitative research reveals theories on why it is important to initiate insulin 
to control HbA1c, and how crucial is the input from pharmacists to achieve 
better compliance; qualitative research is needed to explore and capture the 
complexity of patientsÕ perspectives on their diabetes. A detailed qualitative 
study will lead to an in-depth understanding of patientsÕ lived experiences of 
diabetes and their social-psychological aspects which underpinning their 
preferences for insulin treatment.  
 
In recent years, more emphasis has been put on the social-psychological 
aspects of patients with T2DM. There are numerous studies overseas using 
both quantitative and qualitative methodologies, conducted by different 
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disciplines focusing on patientsÕ perspectives on insulin therapy. However, 
little is known about Malaysian patientsÕ lived-experience with insulin 
treatment.  
 
The qualitative research approach has gained the popularity in Malaysia due to 
its strengths. There are a few qualitative studies conducted in Malaysia looking 
at the barriers and factors influencing insulin acceptance among T2DM 
patients (Hassali et al. 2013; Lee et al. 2012; Abu Hassan et al. 2013; Ng et al. 
2013). Lee et al. (2012) and Ng et al. (2013) used the strength of qualitative 
study to explore healthcare providers' perceived barriers to insulin initiation. 
Their findings are important, as they have identified substantial barriers to 
optimising insulin treatment. On the other hand, Hassali et al. (2013) and Abu 
Hassan et al. (2013) conducted qualitative studies on the patientsÕ perspective 
of insulin treatment; both published their studies recently. Abu Hassan et al. 
(2013) focused on finding the initial reasons for accepting insulin treatment 
and their barriers of using insulin. Whereby Hassali et al (2013) employed a 
phenomenological approach to explore barriers to initiation of insulin and to 
evaluate the impact of a short educational intervention regarding patientsÕ 
resistance to using insulin injections. Both studies which were conducted while 
I was undertaking my research yielded positive results, which corresponded to 
some of my findings, and they are used in the discussion in my study. 
 
An important quantitative study was published in 2011, looking at the 
psychological insulin resistance (PIR) among T2DM patients in two public 
hospitals (Nur Azmiah et al. 2011). Nur Azmiah and her colleagues used a 
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self-administered questionnaire for a cross-sectional study to determine the 
magnitude of insulin refusal or PIR. The questionnaire utilised a five-point 
Likert scale on eighteen attitudinal items, measuring the perception of fifteen 
negative attitudes and three positive attitudes about insulin treatment.  These 
attitudinal items were adapted from three different studies conducted in United 
State of America and Germany. Nur AzmiahÕs research highlighted that T2DM 
patients in Malaysia do develop similar misconceptions regarding insulin 
treatment. These misconceptions were pre-determined by questionnaire, which 
mainly based on studies done in western countries. Therefore, they might not 
be able to reflect Malaysian T2DM patientsÕ perspective. However, some of 
these misconceptions were similar to the findings of this study.  
 
Malaysia being a multi-ethnic country populated by Malay, Chinese, Indian 
and other indigenous ethnicities; the socio-cultural dimension underlying a 
Malaysian patientÕs health values, beliefs and behaviours is very unique when 
compared with other countries particularly the west. For example, some 
Malaysians believe that long-term medication will ÔweakenÕ the body systems 
and once started, it has to be taken for life; and diabetes is represented by 
Ôsweet urineÕ and is not associated with high blood glucose (Ariff & Beng 
2006). Scottish research on the lay perceptions of T2DM in Scotland however, 
yielded a different perception of the disease. For example, Scottish patients 
have a notion that hospital referral signified worsening of their T2DM; they 
interpret non-referral to hospital as meaning that their T2DM is ÔmildÕ and 
cannot be serious (Lawton et al. 2005). However, the vast majority of 
Malaysian patients will go to hospital to receive their regular and follow up 
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appointments due to the different structure of healthcare system. As reported in 
NHMS 2011, 24.6% of diabetes patients sought treatment at MOH hospitals 
2.5% at private hospitals. For The notion of hospital referral is different from 
countries-to-countries and culture-to-culture. Therefore, understanding the 
underlying socio-cultural dimension of Malaysian diabetes patients is crucial 
towards a successful outcome of a clinical encounter.  
 
As a result, I have decided to utilise the strength of qualitative research 
methodology to enable a detailed exploration of the lived-experience of Type 2 
diabetes patients who are using insulin treatment for their glycaemic control in 
Malaysia. Qualitative methodology using an interpretative phenomenological 
approach is employed to develop theory to explain these phenomena. The 
methodology and methods are discussed in CHAPTER 2. The findings of this 
study are discussed in chapters 3 to 7, following patientsÕ lived-experience of 
being diagnosed with T2DM (see CHAPTER 3), followed by their initial 
reactions to insulin treatment (see CHAPTER 4: facilitators, CHAPTER 5: 
barriers). In CHAPTER 6, I discuss patientsÕ coping strategies and lifestyle 
adaptation. In CHAPTER 7, I focus on the social factors that influence 
patientsÕ experiences of using insulin injection to manage their diabetes.  
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CHAPTER 2  
METHODOLOGY AND METHODS 
 
2.1 Introduction  
In this chapter the methodology and methods used in this study are discussed. 
This begins in section 2.2 with the rationale of choosing qualitative 
methodology instead of quantitative methodology for this study. This is 
followed by a discussion on qualitative methodology and the use of the 
interpretative phenomenological approach. This leads to a discussion on the 
modified grounded theory principles as tool to analyse the qualitative data in 
this study. This is followed by a discussion on the use of semi-structured 
interview as the qualitative interview research method. 
 
In section 2.4 the methods used in this study are discussed in detail, starting 
with a discussion of the aims of the study. This is followed by a discussion of 
the research questions. This leads to discussions about the study site, the 
process of gaining research and ethical approval, field activities, patient 
recruitment, data collection, data analysis and confidentiality.  
 
Section 2.3 focuses on the concerns regarding quality in qualitative research 
and this is followed by a discussion on reflexivity.  
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2.2 Part One: Methodology 
2.2.1 Choosing the Research Methodology and Rationale  
Healthcare is a knowledge-based system (Ziebland et al. 2013), research into 
health and medicines seeks to improve health, health outcomes and improve 
health services (Bowling 2002). Quantitative biomedical research has a long 
tradition to demonstrate the knowledge in the healthcare system. Quantitative 
methodologies are used to gather and demonstrate scientific knowledge, 
epidemiological knowledge, and clinical knowledge on diseases and treatment 
interventions. But research in healthcare has often overlooked knowledge 
about how people experience health, illness, treatment and delivery of 
healthcare (Ziebland et al. 2013).  
 
Quantitative research often employs experimental designs such as randomised 
controlled trials usually to test hypotheses. Quantitative orientated research 
using randomised controlled trials is only able to assess whether complex 
interventions have the desired outcomes; however it cannot provide an 
explanation for either the outcomes nor can it include evidence on how people 
experience the intervention or how it fits with their lifestyle or matches with 
their preferred choices or expectations. (Pope & Mays 1995; Britten 2010; 
Bowling 2002; Noyes 2010). Randomised controlled trials are able to 
demonstrate result with statistical analysis but do not provide any answer about 
how people experience the complexity of health issue (Jones 2003). As a 
result, a randomised controlled trial has a limited role when trying to explain a 
social phenomenon such as why patients do not adhere to their medication.  
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This is especially important when a piece of research is trying to draw the 
attention of policy makers and commissioners of health services, who are 
looking for other types of evidence such as patientsÕ views and context in order 
to make decisions to improve health services and health outcomes (Noyes 
2010).  
 
Similarly, a quantitative questionnaire or a cross-sectional survey can generate 
numerical data, which can be analysed statistically and used to demonstrate 
what the majorityÕs view on a health subject or compare results from a sample 
population (Ziebland et al. 2013).  However it does not give the insight of 
peoplesÕ experience, which is more meaningful (Brikci & Green 2007). 
Questionnaire questions are usually ÔclosedÕ and offer only a specific set of 
pre-coded response options (Ziebland et al. 2013), therefore they do not offer 
any room for answers that fall between the grey areas, for example answers 
such as Ôit dependsÕ or ÔmaybeÕ. It often based upon pre-coded or pre-
determined assumptions built into the researchersÕ question (Jones 2003).  
 
Furthermore, Malaysian patientsÕ experience has seldom been investigated in 
the past, so using a questionnaire for this would not be a good idea as there is 
no firm foundation to build upon and too much would be based on the 
researcherÕs assumptions. Pre-determined assumptions therefore would be 
based on questionnaires that were conducted in other countries with different 
cultures; as a result they might not be able to explain the complexity of health 
issues faced by Malaysian patients.  
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Due to the advancement in medical treatment, increased specialisation and 
exposure of the public to modern technology, patient expectations of treatment 
and health outcomes are rising. As a result, healthcare professionals are 
working in an increasingly complex arena (Pope & Mays 1995). This rising 
complexity and expectation from patients has generated a gap in healthcare 
provision, in which traditional quantitative research such as randomised 
controlled trials are inadequate and difficult to apply in the current clinical 
practice. This gap is related to the knowledge of how people experience health, 
illness, treatment and the delivery of care (Ziebland et al. 2013).  
 
In order to cater for the rising complexity of patientsÕ experiences with 
different health issues, a different approach in conducting research is required 
to gain deeper understanding of these phenomena (Pope & Mays 1995). There 
is a paradigm shift in research approach, we are exploring improving patientsÕ 
health outcomes; we are interested to know more about how patients feel about 
a particular subject. Research into the complexity of patient health experiences 
requires researchers to explore and reveal what is going on and not just attempt 
to measure how often an issue or event occurs (Black 1994). In short, 
researchers are more concerned with answering the "what" question, not the 
"how often" question (Table 1). 
 
Not everything that can be counted counts, and not everything that 
counts can be counted     (Albert Einstein) 
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Qualitative methodology does not simplify the views of the subject in order to 
measure and count the occurrences of an issue or events (Table 1), however it 
takes on a more holistic perspective which preserves the complexities of 
human behaviour (Black 1994). It places emphasises on the meanings, 
experiences, and views of people and it is particularly suited for understanding 
subjects such as why do patients worry about using insulin treatment and how 
do patients adapt to insulin treatment in their everyday lives (Pope & Mays 
1995).  It helps us to understand the nature, strengths, and interactions of 
variables. This approach is particularly useful in complex situations such as 
patientsÕ health behaviours or where the relevant variables associated with an 
outcome are not apparent (Black 1994). As a result qualitative research is 
notably a more useful tool for policy makers and healthcare professionals 
because it allows a clear understanding of descriptive information and the 
context in which policies are implemented (Murphy et al. 1998). 
 
Table 1 The overstated dichotomy between quantitative and qualitative social 
science (Pope & Mays 1995) 
Quantitative Qualitative 
Testing hypothesis/theories Generating hypothesis/theories 
Demonstrate Exploratory 
Experiment, survey Interview, observation 
Numbers (How many Xs) Words (What is X) 
Statistical sampling Theoretical sampling 
Reliability: Representative, 
generalizability 
Validity: Rich, detailed, trustworthiness  
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2.2.2 The Qualitative Methods  
I have established in section 2.2.1 that qualitative research takes a holistic 
perspective, which preserves the complexities of human behaviour, and places 
emphasis on the meanings, experiences, and views of people. Research 
question on Ôwhat?Õ is best answered with qualitative research, Ôwhat?Õ 
research question do not require a hypothesis (Pope & Mays 1995) but  
generate hypotheses or themes; this is discussed in the previous section. By 
asking the Ôwhat?Õ question, we are able to seek the deeper truth through 
exploring knowledge in a natural setting, and it also attempts to understand the 
participants and what it means to them to live with a particular condition or in 
a particular situation (Murphy et al. 1998; Greenhalgh & Taylor 1997). 
Therefore it is an appropriate tool to facilitate an understanding of the 
complexity of a phenomenon and offer possibilities of interventions to policy 
makers and healthcare professionals (Biggerstaff & Thompson 2008). In this 
study, I am interested to find out ÔwhatÕ is the experience of using insulin 
treatment by T2DM patients, an area that has not previously been researched in 
Malaysia. In addition, I want to explore patientsÕ perspectives and their 
experiences of insulin treatment; therefore qualitative methodology and 
methods were selected to design this health experience research.   
 
To design this study, different research strategies within the qualitative 
methodology were examined and carefully considered. The choice of research 
strategy is influenced by factors such as the researcherÕs preference of certain 
ontological and epistemological assumptions; his or her perceived link 
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between preferred research methods and research strategies; and also 
pragmatic factors such as time and funding (Blaikie 2010).  
 
Ontology is the starting point of all research, it is about what we may know; 
epistemology is one of the core branches of philosophy and is about how we 
come to know what we know (Grix 2002). For this study with the research 
question focusing on the lived-experience of using insulin treatment to control 
T2DM, an interpretivism epistemology was considered as the most appropriate 
approach. Qualitative researchers situating on interpretivism epistemology put 
emphasis and value on the human, interpretative aspects of knowing about the 
social world and the significance of the researcherÕs own interpretations and 
understanding of the phenomenon being studied (Ritchie & Lewis 2003). I 
have landed myself with interpretivism epistemological assumption when 
designing this study. It is the most appropriate epistemological way to explore 
the lived-experience of T2DM patients in order to link their experience with 
the social, cultural and health aspects of their lives, and to understand the 
meanings and interpretations that the patients have and consider these in the 
network of their own statement and beliefs. 
 
Interpretivism epistemology adheres more closely to an idealism ontology 
standpoint; this standpoint assumes that reality is only knowable through the 
human mind and socially constructed meanings. Therefore we have no way of 
understanding the reality other than through the lens of our own beliefs and 
understanding (Ritchie & Lewis 2003). 
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2.2.3 Interpretative Phenomenological Analysis 
Social research using qualitative methodology has been conducted against a 
background of some traditions of theoretical and methodological ideas (Blaikie 
2010). Blaikie refers these traditions as research paradigms, other qualitative 
researchers might refer them as ÔapproachesÕ, which I adopted in this chapter 
(Bryman 2006). Qualitative research has developed and evolved over the 
course of the twenty first century and a number of different schools of thought 
have emerged (Ritchie & Lewis 2003; Blaikie 2010).  
 
There are several research approaches within qualitative research and they 
differ radically in their assumptions and implications (Maxwell 2008; Blaikie 
2010). It is important to shape the conceptual framework for qualitative 
research; therefore it is crucial to choose the best-fit approach to match oneÕs 
assumptions and methodological preferences. Blaikie stated that it is possible 
to choose a research approach, however Maxwell argued that selection of the 
research approach is not a matter of free choice (Blaikie 2010; Maxwell 2008). 
As I have mentioned in section 2.2.2 that I have selected idealism as my 
ontological position and selected interpretivism epistemology, I have already 
made assumptions about the reality and how I understand the world, and my 
assumptions and knowledge of my research topic. As a result of my pre-
conceived assumptions, they have guided me to adapt the principle of 
interpretative phenomenological analysis approach (IPA) and modified 
grounded theory (MGT) to design this study. The principle of grounded theory 
is discussed in section 2.2.4.  
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Figure 3 The interrelationship between the building blocks of research 
 
Interpretative Phenomenological Analysis (IPA) is a newly developed 
qualitative research approach. IPA was introduced in 1996 in a seminal paper 
by a psychologist, Jonathan Smith (Smith 1996). Since then, it has spread from 
the psychology field and gained recognition from other research disciplines 
particularly in applied areas such as clinical, health and counselling 
psychology.  
 
Interpretative phenomenological analysis (IPA) is concerned with trying to 
understand peoplesÕ lived-experience and how people make sense of their 
experiences. Therefore it is particularly suited in this study concerned with 
patientsÕ experiences of using insulin treatment and how it holds for them. IPA 
is theoretically underpinned by the traditional of phenomenology and 
interpretation. This approach is phenomenological because it is used to explore 
an individualÕs personal perception or account of an event or state (Smith & 
Osborn 2008). Thus, one important theoretical touchstone for IPA is 
Ontology Epistemology Methodology Method 
Idealism Interpretivism Interpretative 
Phenomenological 
and Modified 
Grounded Theory 
Semi-
structured 
Interview 
What is out 
there to know? 
What and how can 
we know about it?  
How can we go about 
acquiring that knowledge? 
Which precise procedures 
can we use to acquire it?  
Figure adapted from Hay, 
2002 and Grix, 2002 
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phenomenology, which originated with Husserl's attempts to construct a 
philosophical science of consciousness with hermeneutics and with symbolic-
interactionism. It attempts to explore personal experience through an 
interpretative process (Biggerstaff & Thompson 2008).  
 
IPA also considers that one cannot get close to the participantÕs personal world 
directly or completely. This hermeneutics interpretative process must also 
depend on the researcherÕs own conceptions which are required to understand 
the participantÕs world through another level of interpretative activity. 
Therefore the second important theoretical current for IPA is that it is a two-
stage interpretation process, or a double hermeneutic (Smith & Osborn 2008).   
 
The participants are trying to make sense of their world; the 
researcher is trying to make sense of the participants trying to 
make sense of their world.  
 
IPA is a suitable approach in the research as the T2DM patients are trying to 
understand how they perceive insulin therapy and find out how the 
introduction of insulin therapy is affecting their personal and social world. 
Using semi-structured interview, the participants were asked to tell their story 
through their own interpretation of the experience; I would listen to their story 
and try to interpret what they said and how they interpreted their experience. 
 
The aim of any qualitative research is to explore, flexibly and in detail, an area 
of concern. With an IPA approach, qualitative researchers are allowed to have 
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their own conceptions when conducting interviews to explore a phenomenon 
or an area of concern, but researchers should not make any attempt to test a 
predetermined hypothesis. (Smith & Osborn 2008). Therefore, the principles of 
grounded theory approach were employed in designing this research in 
particular the iterative process of collecting and analysing data (refer Figure 4).  
 
Figure 4 Process of data in qualitative research. 
 
Data 
Collection 
Data 
Reduction 
Conclusions: 
Drawing/verifying 
Data 
Display 
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2.2.4 Modified Grounded Theory and Thematic Analysis  
2.2.4.1 Grounded Theory  
Grounded theory (GT) was originally developed by Barney Glaser and Anselm 
Strauss in 1967 and it is one of the major philosophical approaches widely 
used in qualitative research. The approach of GT has evolved and diversified 
over the years and both Glaser and Strauss have also shifted their perspective 
(Charmaz 2008; Heath & Cowley 2004). In general, GT offers a systematic 
methodology to obtain data and emphasises the development of theory from 
data in the process of conducting research (Boeije 2009; Glaser & Strauss 
2009). Glaser and Strauss stressed that the data is the centre stage in reaching a 
theoretical description of a phenomenon and explaining peopleÕs actions. GT 
emphasises developing theory through an iterative process of collecting and 
analysing data which is different from other branches of qualitative research 
approaches (Boeije 2009; Glaser & Strauss 2009; Murphy et al. 1998). 
 
In the initial part of grounded theory research, researchers are required to go 
through a series of cycles in which they move back and forth among the data 
collection and the analysis, hence the iterative process (Smith & Osborn 2008). 
The data are analysed with a technique called ÔcodingÕ, in which relevant parts 
of the data, for example a section from an interview transcripts, are highlighted 
and labelled. Coding process in GT is a very detailed approach as data is said 
to be at the center of the stage during GT research. During the coding process, 
researchers have to go through the interview transcripts, line by line to 
highlight and label the relevant parts. This initial coding process is referred as 
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Ôopen codingÕ; researchers have to pay attention to every sentence to avoid 
missing out any important information. 
 
This initial part is explorative, but as the research progresses and starts to 
generate more data, the researcher will focus on verifying results or theories 
found earlier on in the initial research process (Boeije 2009). The researchers 
have to compare data to data, codes with codes throughout the whole research 
project. This process is referred as constant comparison, in which each item is 
checked, compared and verified with the rest of the data (Pope et al. 2000). 
This process of constant movement between theory and data is an important 
feature of GT proposed by Glaser and Strauss (Murphy et al. 1998). Constant 
comparison of theory generation and refinement process is sought to expand, 
confirm or deepen the newly found theory.  
 
The analysing process gradually advances from simply coding the data, to 
conceptual categories, and then to develop theory to explain the studied 
phenomenon (Boeije 2009). The later process of conceptualised categories and 
developing new theory is important in influencing the recruitment of further 
participants; it is another important feature of GT. This recruitment or 
sampling technique is referred as theoretical sampling. This principle of 
sampling technique is adopted in this study and is discussed in section 2.2.5. 
 
Researchers using grounded theory approach only develop theoretical 
categories during the analytic process; they do not know in advance what they 
will be sampling. Thus theoretical sampling is a unique feature of GT and it is 
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different from other selective sampling which most qualitative researchers 
employ as they set criteria for their research problem (Murphy et al. 1998). In 
comparison, interpretative phenomenological analysis  (IPA), which is 
associated with phenomenological approach, uses another technique, purposive 
sampling. IPA researchers usually select a defined group of homogenous 
sample be relevant to the research question (Chapman & Smith 2002). IPA 
researchers usually focus on small sample sizes ranging from six to ten 
participants, IPA focuses on gathering the detail of the perceptions and 
understandings of a particular phenomenon. Therefore a pure IPA uses case-
by-case analysis of individual transcripts and it takes a long time to complete 
an IPA study (Smith & Osborn 2008).  
 
 
 
 33 
2.2.4.2 Modified Grounded Theory 
Since its original development back in the 1960Õs, grounded theory  GT! 
has been modified by different qualitative researchers during the years 
(Murphy et al. 1998; Charmaz 2008). Charmaz describes GT as an analytic 
method of producing qualitative research, it is a set of methods that are 
systematic, but there are flexible guidelines for collecting and analysing 
qualitative data to construct theories which are ÔgroundedÕ in the data 
(Charmaz 2008; Guest et al. 1971).  
 
The original Ôpure grounded theoryÕ suggests that researcher should only look 
at the data from an absolute neutral point of view without any preconception. 
However, it is impossible in real practise for any researcher to conduct 
research without any prior knowledge. Even before data collection, a 
researcher will have ideas about what to be found in the data, drawn from his 
or her own experience, discipline, reading or awareness of theory (Ziebland & 
McPherson 2006; Charmaz 2008). Charmaz has recognised that researchersÕ 
pre-existing knowledge can affect a pure grounded theory analysis process; in 
her study she modified the ÔpureÕ grounded theory approach, and allow more 
flexibility in generating theories from analysing her data (Charmaz 2008). 
Charmaz modified the Ôpure grounded theoryÕ approach to suit her 
constructivist grounded theory and it is suggested to other researchers that they 
can also use the principle of GT and modified it when they are coding 
qualitative data. In real practice, most researchers have adapted the modified 
grounded theory approach. Since most researchers have preconception or 
theories in mind when they look at their data, by modifying ground theory, 
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they can combine their pre-defined categories and new founded ones which 
emerge out of the data (Charmaz 2008; Braun & Clarke 2006).  
 
In this qualitative study, I have modified the pure approach to grounded theory 
and used some of the principle features of grounded theory. Particularly in the 
process of theory generation, theoretical sampling, and constant comparative 
method of data analysis. Thematic analysis is used during write up where the 
results section contains emergent themes with a separate discussion linking the 
analysis to literature review (Smith & Osborn 2008).  
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2.2.4.3 Thematic Analysis 
Thematic analysis (TA) evolved from grounded theory but it has been poorly 
branded. TA is similar to interpretative phenomenology analysis and grounded 
theory (GT), they all seek patterns in the data however TA is not theoretically 
bounded and therefore has more flexibility compared to the ÔpureÕ grounded 
theory approach (Braun & Clarke 2006). It is more accessible to researchers 
who have less experience or a limited time frame to conduct their studies, 
especially when working with large data sets, as pure GT can be very time 
consuming.   
 
Researchers using the thematic analysis approach need not subscribe to the 
implicit theoretical commitments of ÔpureÕ grounded theory which they will 
have to produce a fully worked-up grounded-theory analysis (Guest et al. 
1971; Braun & Clarke 2006). Through its theoretical freedom, TA provides a 
more accessible and flexible research tool that provide a rich and detailed, yet 
complex, account of data. It is well suitable for large data sets with variation 
samples and relatively large studied population, which can be more than 40 or 
more interviews. The other advantage of using thematic analysis is that it is not 
wedded to any pre-existing theoretical framework, and therefore it can be used 
within different theoretical frameworks (Braun & Clarke 2006).  
 
Ziebland and McPherson suggested that thematic analysis works well in 
studies with a relatively narrow research question and potentially dominated by 
anticipated themes. TA focuses more on interpreting anticipated and emergent 
themes in interview data. Although there are anticipated themes, it is vital to 
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explore all the relevant data thoroughly and ensure that the explanation is 
robust (Ziebland & McPherson 2006). The aim of this study is relative focus 
and narrow: to find out the barriers and facilitators to either hinder T2DM 
patients or encourage them to use insulin and adhere to the treatment. I was 
aiming to be more explorative in studying this phenomenon and therefore 
bracketing technique is used. While conducting the interviews and reading the 
interview transcripts, I have made several attempts to suspend pre-existing 
knowledge and judgments. Bracketing involves suspension of critical 
judgment and a temporary refusal of critical engagement, which would bring in 
the researcherÕs own assumptions and experience. It is a self-reflective process 
whereby the researchers acknowledge but set aside their priori knowledge and 
assumptions to allow the analytic goal of attending to the participantsÕÕ 
accounts with an open mind (Biggerstaff & Thompson 2008; Starks & 
Trinidad 2007). I tried to hide behind my pharmacist role and using a different 
lens when interviewing the participants. During interviews, I had to temporary 
suspended my pharmacist knowledge and identified myself as a PhD student. 
This helped me to position myself as researcher and built a better rapport with 
the participants. 
 
 In this study, the initial part of the data collection employed interpretative 
phenomenological analysis approach and the principle of grounded theory; 
later data analysis leaned towards thematic analysis which sit within the 
modified GT and IPA frameworks. Similar to grounded theory, thematic 
analysis is used in identifying, analysing and reporting patterns or themes 
within data (Braun & Clarke 2006). TA looks across all the data to identify and 
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describe both implicit and explicit ideas within the data referred to as a 
ÔthemeÕ. A common theme summarises all the views that are identified within 
the data (Brikci & Green 2007; Guest 2006). It captures something important 
about the data in relation to the research question, and represents some level of 
patterned response or meaning within the data set. Themes sometimes come 
from the researcherÕs prior knowledge or understanding of the phenomenon 
being studied, it is referred as priori approach or Strauss calls it ÔData in the 
headÕ (Ryan & Bernard 2003; Charmaz 2008). Priori themes are discussed in 
section 2.2.4.1, these Ôdata in the headÕ arise from the background of the 
phenomenon being studied; from prior study of the phenomenon found in 
literature reviews; from local, common-sense constructs; or from researchersÕ 
awareness of the theory, or sometimes it can simply be part of the researcherÕs 
personal experiences (Ryan & Bernard 2003; Ziebland & McPherson 2006). 
As data collection progresses it is useful to record the ideas or Ôdata in the 
headÕ, as it could possibly be some initial analytic interests or thoughts which 
can develop into themes later (Braun & Clarke 2006; Ziebland & McPherson 
2006). 
 
It is important to point out that the stages of data collection and data analysis 
are closely related and they are not independent processes. Data collection and 
analysis do not occur in a linear sequence, they are cyclic in nature and the 
analysis process is part of an iterative process (Miles & Huberman 1984). But 
for the purpose of this report, the steps involved in this study are discussed in 
sequence and the collected qualitative data is presented as interview 
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transcripts. The steps involved in data collection and data analyses are 
discussed in detail in section 2.4.8 and section 2.4.9 respectively.  
 
In these recent sections, I have described my ontological, epistemological and 
methodological positions that underpinning this research. In the following 
section, I will discuss the utilisation of these approaches in conducting the 
qualitative interviews. 
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2.2.4.4 Qualitative Interviews  
The methods used in qualitative research depend partly on a researcherÕs own 
epistemological and ontological positions (Ritchie & Lewis 2003; Carter & 
Little 2007). Ontology influences a researcherÕs epistemological position, 
which in turn influences the methodology adopted and the way data are 
collected. The main methods used in ethnographic studies involving naturally 
occurring data are observation, documentary analysis, conversation; the main 
types of generated data in qualitative research such as phenomenological 
studies are interviews and focus group discussion (Ritchie & Lewis 2003). In 
other words, an interview is used to find out from the interviewee things that 
we cannot directly observe.  
 
As my epistemological stance for this study is interpretivism epistemology, 
using interviews to collect data deems to be appropriate in learning about 
patientsÕ lived-experience of using insulin treatment as part of their diabetes 
management. Focus group discussions were considered for this study, they are 
useful for studies focusing on attitudes or for difficult and technical issues 
which involvement of many participants will facilitate the understanding of the 
research topic (Ritchie & Lewis 2003). However, as this study focuses on 
patientsÕ own lived-experience of using insulin treatment, one to one 
interviews were deemed to be more suitable, given the consideration of 
patientÕs privacy. Furthermore, this study is bounded by the ethics committee 
approval from Ministry of Health Malaysia and must be carried out within the 
hospital compound (see section 2.4.3); it was impractical to set up focus group 
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meetings in the hospital compound due to space constraints and also 
difficulties in arranging group meetings with selected participants. 
 
Apart from focus group discussions, there are three main types of interviews: 
structured, semi-structured, and in depth (Britten 1995). Structured interviews 
involve the administering of structured questionnaires, which are often used in 
quantitative research. In depth interviews allow in depth understanding of the 
personal context within which the research topic is located, and provide a 
detailed investigation of each person's personal perspective (Ritchie & Lewis 
2003). Semi-structured interviews use open ended questions that define the 
area to be explored initially, and then may diverge in order to pursue an idea in 
more detail (Britten 1995). After serious consideration of the practicality and 
cultural sensitivity, I decided to use semi-structured interview for data 
collection.  
 
Semi-structured interviews are more appropriate to illuminate this research 
topic as it offers patients the opportunity to express their own definitions of 
their experiences, it allows them to tell their story like it is and interpret what 
they feel personally. At the same time, the interviewer may diverge in order to 
pursue an idea in more detail (Britten 1995). Therefore semi-structured 
interview offers more dynamic and more flexibility compared to a structured 
questionnaire. In real practice, any interview may diverge from what was 
originally planned; therefore semi-structured interviews provide the 
interviewer with the assistance of an interview topic guide to steer the topic 
back to the area of interest. The interview is therefore Ôsemi-structuredÕ with a 
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guide but not restricted to it. It is vital to decide the right questions to ask 
during interviews and participants being interviewed might not share the same 
perspective on the world as researcher, therefore a list of pre-defined questions 
would be helpful in this instance (Brikci & Green 2007). An interview topic 
guide is a set of key issues, themes, possible probes or pre-defined key 
questions to cover during an interview, it is designed to encourage the 
interviewee to talk about specific issues or when the interviewee is stuck at a 
particular question or when topic has been diverge considerably from what was 
originally envisaged. 
 
There are different models of semi-structured interviewing, and definition of 
'semi-structured' interviews may be termed differently by different researchers 
(Ritchie & Lewis 2003). A semi-structured interview might be described as 
unstructured or in-depth or even open-ended survey interviews. In this IPA 
study which focuses on patientsÕ lived-experience of using insulin treatment, 
semi-structured interview allowed me to steer the conversation from one topic 
to another, creating transitions with a semi-structured questions to ask.  The 
flow of the interview followed the sequence of when the patients diagnosed 
with T2DM, followed by their experience of using oral medication to control 
their T2DM, and then went into how they were being prescribed insulin 
followed by their experience of using insulin treatment.  As each interview is 
different from another, sometimes I altered the sequence of questions or the 
way in which they are phrased; sometimes there were fixed structure with 
some probing. 
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2.2.5 Purposive Sampling and Theoretical Saturation 
Sampling strategies are determined by the purpose of the research project, 
probability sampling is often used in quantitative research for statistical 
purpose and to sought statistical representativeness but it is not suitable in 
qualitative research (Ritchie & Lewis 2003; Britten 1995). Quantitative 
research uses probability sampling to choose participants from a population 
randomly to represent in the sample in their true proportions. On the other 
hand, qualitative research uses non-probability samples to select participants. 
Participants are deliberately selected to reflect particular features of the 
sampled population. It is not intended to be statistically representative but 
participants are selected according to pre-determined criteria for the purpose of 
the research objective hence purposive sampling (Ritchie & Lewis 2003).  
 
Participants are chosen with two 'purposes' in mind: firstly they are likely to 
generate useful data for the research topic and secondly to ensure that this 
sample is credible. The second purpose is to ensure that some diversity is 
included especially in this study of Malaysian T2DM patients. Malaysia is a 
multicultural country and the prevalence of T2DM is higher in the minority 
ethnic group (Kaur et al. 2011). According to the National Health and 
Morbidity Survey 2011 (NHMS 2011), the minority ethnic group, Indian, had 
the highest prevalence at 24.9%, followed by the Malays at 16.9% and lastly, 
the Chinese at 13.8%. Therefore the participants in this study were selected not 
only for the relevance to the research topic, but also to cover the main ethnicity 
groups for maximum variation, which are likely to have an impact on 
participantsÕ view of the research topic. 
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Sampling for participants was inductive and continued until theoretical 
saturation, which follows the principle of grounded theory (see 2.2.4.1). With 
this sampling technique, the researcher would not be able to estimate upfront 
the number of participants required for the study. It often posses as an obstacle 
for the qualitative researcher when compiling a research proposal or applying 
for ethics committee approval (Guest 2006). Guest has summarised guidelines 
for determining the sample size in qualitative research (refer Table 2). 
 
 
Table 2 Summary of estimated sample size for qualitative study approaches 
 
 
Theoretical sampling is a particular kind of purposive sampling and is 
associated with grounded theory as mentioned earlier (Ritchie & Lewis 2003). 
Theoretical sampling guides the researcher to recruit participants that aim 
toward the development of the emerging theory which is grounded in the data 
(Glaser & Strauss 2009; Murphy et al. 1998). The sampling process is 
iterative: the researcher starts with the initial data collection, analyses the data 
for emerging theories, and then uses the emerging theories to focus on 
Study Approaches Estimated Sample Size 
Ethnographic studies 30-60 (Bernard) 
>15 (Bertaux) 
30-50 (Morse) 
Phenomenological studies >6 (Morse) 
5-25 (Creswell) 
Grounded theory 30-50 (Morse) 
20-30 (Creswell) 
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subsequent data collection until Ôdata saturationÕ or when there is no more new 
theory emerging, thus referred as theoretical saturation.  
 
This study used Interpretative Phenomenological Analysis and modified 
grounded theory approach; the sampling technique was purposive and the 
stopping point for recruitment was until theoretical saturation. 
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2.3 Quality in Qualitative Research 
The strength of the quantitative research lies in its reliability or repeatability; 
on the other hand, the strength of qualitative research lies in validity: closeness 
to the truth (Greenhalgh & Taylor 1997). It is impossible to judge the quality 
of a qualitative research using the traditional framework such as that of 
quantitative research. However it is still vital to review the validity and quality 
of qualitative research by specific criteria that are appropriate to it.  
 
There are no mechanical or ÒeasyÓ solutions to exclude the likelihood of errors 
in qualitative research but there are several ways of improving validity and 
ensuring rigour in quantitative research (Mays & Pope 2000).  
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2.3.1 Validity, Reliability and Generalisability 
Thematic analysis is the most commonly used method of analysis in qualitative 
research (Guest et al. 1971). Guest states that a thematic analysis is most useful 
in capturing the complexities of meaning within a textual data set. Reliability 
is greater with thematic analysis compared with other word-based analyses 
such as content analysis because more interpretation goes into defining the 
codes as well as applying the codes to chunks of text.  
 
This issue is even more pronounced when working in teams. In this study, all 
the transcripts were shared with supervisors and emerging themes were 
discussed regularly during data collection and data analysis. Data analysis is a 
part of an iterative process, this involved reading and re-reading for any 
possible missing data and identify emerging themes in the constant search for 
understanding and the meaning of the data. Collected data was repeatedly read 
and discussed to ensure that detailed, high quality codes and subsequent 
themes were identified. The principle of constant comparison also being 
employed throughout the analysis process to improve the validity of the study. 
 
During the data analysis process, especially when searching for themes from 
the initial coding process, any presentation of cases that are inconsistent with 
the emerging analysis were discussed with supervisors. Mays and Pope 
suggested to search for, and discuss any Ôdeviant caseÕ for improving the 
quality of explanations in qualitative research (Mays & Pope 2000). Such 
Òdeviant case analysisÓ helps refine the analysis until it can explain all or the 
vast majority of the cases under scrutiny. This study used theoretical sampling 
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technique which also facilitated the search for negative cases. Theoretical 
sampling encourages researchers to establish the limits of their findings 
through systematic search for disconfirming cases (Murphy et al. 1998).  
 
The findings from qualitative research are not meant to be generalisable or 
transferable; generalisations of the rationalistic variety are not possible because 
phenomena are intimately tied to the times and contexts in which they are 
found (Murphy et al. 1998). ÔGeneralisabilityÕ in qualitative research uses the 
theory developed within one particular study and extends it to provide 
explanatory theory for the experiences of another individuals who are in 
comparable situations. Participants in this study were purposively chosen 
based on their intended ability to generate relevant data for the research topic; 
this is to ensure at the data generated is credible. Furthermore, a purposive 
sampling technique was employed to include the main ethnicity groups for 
maximum variation, this is to ensure that the findings were sufficiently detailed 
to be relevant for the healthcare providers or policy makers. According to 
Mays and Pope, another important dimension of relevance is the extent to 
which findings can be generalised beyond the setting in which they were 
generated (Mays & Pope 2000). 
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2.3.2 Reflexivity 
Reflexivity means sensitivity to the ways in which the researcher and the 
research process have shaped the collected data, taking account of the 
researcherÕs own personal experiences, theoretical biases, recognising the role 
of values and a priori assumptions in shaping any research account (Murphy et 
al. 1998; Mays & Pope 2000)  
 
The bracketing technique was employed during data analysis. As I had been 
working as a clinical pharmacist in a public hospital overseas and locally in 
Malaysia, the perception I have towards diabetic patients overseas and in 
Malaysia might interfere with the research process. Other factors that might 
interfere with the research process including interpretation of findings were 
acknowledged and I remain aware of it and do constantly reflect upon (see 
section 8.2 Reflexivity: Practical Application in the Study). 
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2.4 Part Two: Methods  
2.4.1 Study Objectives 
This is an exploratory study; the aim is to explore the lived-experience of 
Malaysian patients with Type 2 diabetes mellitus who are using insulin as part 
of their glycaemic control. The objectives are to explore how these participants 
experienced using insulin, in order to understand what are the barriers 
perceived by a lay person regarding insulin treatment, at the same time to learn 
from these participants what facilitate or motivate the adherence to treatment.  
 
Specifically this involved: 
¥ Obtaining approval at the study site to conduct the study (section2.4.3). 
¥ Obtaining National Research Ethics Committee approval to conduct the 
study (section 2.4.4). 
¥ Screening patients list for suitable participants (section 2.4.5 and 2.4.6). 
¥ Obtaining formal written consent from all participants in the study 
(section 2.4.6 and 2.4.7). 
¥ Conducting initial semi-structured qualitative interviews (section 
2.4.8). 
¥ Refining interview technique.  
¥ Analysing data along with interviewing patient (section 2.4.9). 
¥ Continuing to recruit and interview patients until theoretical saturation 
had been reached. 
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A qualitative study is not a linear process; it is iterative and constantly reflects 
onto the research question. Therefore the analytical process was started whilst 
the interviewing was being carried on. This allowed constant comparison and 
reflecting on the interview questions, the participantsÕ experiences and the 
technique.  
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2.4.2 Research Questions  
The main objective of this study was to explore the patientsÕ lived-experience 
of using insulin to manage T2DM. The research questions linked between the 
interpretive paradigm and the phenomenological approach for data collection. 
 
The following research questions, using ÔwhatÕ and ÔhowÕ were employed 
during the semi-structured interview to obtain rich details of peoplesÕ lived-
experience. They reflect on the aim of this qualitative study more appropriately 
and shaped the direction of the research methodology as discussed in section 
2.2.1: 
 
¥ What is your experience of using insulin to control diabetes? 
¥ What influences these experiences? 
¥ How do your perspectives of insulin treatment change overtime? 
 
The First Research Question 
What is the experience of using insulin to control diabetes? 
The main research question was to develop an understanding of how patients 
experience diabetes disease and the initiation of insulin. A phenomenological 
approach was used to discover and understand the lived experience.  
 
Guiding Questions 
¥ How did you find out about having diabetes? 
¥ How was insulin introduced? 
¥ How do you find using insulin injections? 
 52 
The Second Research Question 
What influences these experiences? 
The second research question focused on the influences of people around the 
patients. These people could be any healthcare professionals, their family 
members, colleagues, or friends from their social circle. This was set to 
explore how social issues and culture influences the experiences of being 
diabetic and using insulin as part of the treatment.  
 
Guiding Questions 
¥ How did you react when insulin was mentioned as part of your 
treatment plan? 
¥ How did you inform your family and friends about insulin therapy? 
 
The Third Research Question 
How do patientsÕ perspectives of insulin treatment change overtime? 
The third research question aimed to explore how patientsÕ attitudes toward 
insulin treatment changed with their experience. This study is an exploratory 
study to find out the contributing factors which change patientsÕ behaviour 
towards insulin and to develop new theory on the topic. 
 
Guiding Questions 
¥ How have you adapted to insulin treatment? 
¥ What has changed in your life since insulin was introduced? 
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These are the guiding question which underpin the study aim of this research, 
the interview topic guide which was used in the semi-structured interview are 
summarised in appendix 3. The process of semi-structured is discussed in 
section 2.4.8. 
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2.4.3 Study Site and Local Research Approval  
A public hospital (PH) was selected as the research study site. PH is located at 
the government administrative town of Malaysia peninsular, around 35km 
from Kuala Lumpur city centre with easy access by public transport via train or 
buses. This hospital is a 341 bedded hospital providing both primary and 
secondary level care and specialised in endocrinology, rheumatology and 
general medicine. The National Health and Morbidity Survey 2011 stated that 
24.6% of known diabetics patients sought treatment from public hospital such 
as PH. Most patients can get free treatment including doctor consultations and 
medication. Malaysians who are over 60 years old, under schooling or working 
at any government department are entitled to free treatment at PH. For others 
patients they have to pay a very minimal fee of around RM1 for each 
registration and also RM1 for each prescription.  
 
 This hospitalÕs administration and data storage system is run on an electronic 
system called Total Hospital Information System; this has added advantage to 
the patient recruitment process. The process was much easier and faster with 
this electronic system as it provided faster access to patientsÕ medical profiles, 
which facilitate the recruitment of T2DM patients who have been prescribed 
any insulin product (see section 2.4.5 and 2.4.6).  
 
PH has been classified by the Ministry of Health, Malaysia (MOHM) as a 
model hospital in the country. The other reasons to select PH as my study site 
was because it has a well-established Diabetes Resource Centre (DRC), which 
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caters for a large number of diabetes patients and also recently set up a Clinical 
Research Centre (CRC) in 2010 one of the first in Malaysia. 
 
The Diabetes Resource Centre (DRC) was set up in September 2002 in line 
with MOHM initiatives to strengthen diabetes education and services. DRC 
provides counselling and support to diabetes patients especially those initiated 
on insulin treatment. Recruitment of patients participating in this study was 
conducted at DRC using their Total Hospital Information System; field 
activities at DRC are discussed is section 2.4.5. Clinical Research Centre 
(CRC) was established in 2010 and it was chosen as a Centre of Excellence. It 
aims to facilitate MOHM to achieve the goal set by the National Key 
Economic Area, which encourages industry-sponsored research. The other 
function of CRC is to facilitate and monitor research done in PH, either 
conducted by staff in PH, other health services or students from other 
institutions. An application to conduct this study at PH was submitted to CRC 
to gain local approval in early August 2011. The head of endocrinology, Dr 
Zanariah Hussien who also agreed to be the field supervisor and the hospital 
director, Dr NoraÕI Binti Mohomad Said, approved this initial application; 
permission to conduct this proposed study at PH was granted at the end of 
August 2011. Second stage of the approval was subsequently sought from 
MOHM, which will be discussed in the next section. 
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2.4.4 Research and Ethics Committee approval  
All research conducted at MOHM facilities in Malaysia must be registered 
with National Medical Research Registry (NMRR). It is a web-based service to 
support the implementation of the National Institute of Health (NIH) guideline 
on the conduct of research (https://www.nmrr.gov.my). NMRR streamlines all 
research application and submit relevant documents to respective authorities 
such as the Medical Research and Ethics Committee (MREC).  
 
Application for this study was lodged at the end of August 2011 after gaining 
local approval from PH. The application was submitted with the study proposal 
which included a Patient Information Sheet, consent form, the interview guide 
and other relevant supporting documentation. The Patient Information Sheet 
and consent form were printed in both Bahasa Malaysia (the national language 
of Malaysia) and English language and are included in appendix one and two. 
The interview topic guide used is included in appendix three.  
 
The application was first reviewed by the Institute for Health Behavioural 
Research (IHBR) under NIH, which acts as the gate keeper. The application 
was then reviewed by MREC and subsequently approved by NMRR on 23th 
December 2011. The approval letter was received in early January 2012 which 
was in time to start patient recruitment in February as planned (appendix four).  
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2.4.5 Study Process and Field Activities 
Initial observations were conducted to familiarise myself with the outpatient 
diabetes clinic setting within PH. These included outpatient diabetes clinic 
working environment, events and people, work patterns, patientsÕ appointment 
system, consultations, referral process, and all activities relating to operation of 
diabetes clinic.  
 
At PH, different specialists run their outpatients clinic on a particular day of 
the week. Diabetes clinic is scheduled to run every Thursday within the 
endocrine clinic. Endocrinologists or medical doctors review T2DM patients at 
the endocrine outpatient clinic together with other Type 1 diabetes patients, 
and patients with hyper- or hypothyroidism, Cushing syndrome or any other 
endocrinology related diseases. 
 
Patients with T2DM are given an appointment slot on this day for their regular 
check-up, medical review and refill of medication. T2DM patients are 
normally given a four monthly outpatient follow-up appointment. Patients with 
uncontrolled T2DM are given more frequent follow-up and might be referred 
to the Diabetes Resource Centre (DRC). The appointment list for Thursday 
diabetes clinic is usually managed by a staff nurse and usually finalised one 
week before the diabetes clinic day.  T2DM patients who are referred to DRC 
will have a separate appointment list which is kept by the diabetes nurse in 
DRC.  
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Patients with an appointment on the day will register at the front hospital 
counter and then leave their appointment books for re-registering at the 
endocrine clinic counter. The staff nurses will then call up the patients for 
measurement of weight, blood pressure and waist circumference. Subsequently 
patients wait at the waiting area for a medical consultation. The waiting period 
can be up to a few hours and it gave me the opportunity to approach the pre-
selected T2DM patients for interview (see section 2.4.5).  After the medical 
consultation, patients may be referred to diabetes pharmacists or diabetes 
nurses for extra counselling. Otherwise patients may collect their medication 
from the outpatient pharmacy and leave the hospital. 
 
Endocrinologists and the medical team usually start seeing patients from 8AM 
until 1 or 2PM. On average around 200 endocrine outpatients are seen in a day. 
Recruitment for this study involved filtering these patients and targeting 
T2DM patients who were currently using insulin treatment, the details of the 
recruitment is discussed in the next section below. 
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2.4.6 Recruitment of Participants  
Purposive sampling technique (as described in section 2.2.5) was employed to 
select T2DM patients who were using any insulin treatment. Patients were 
selected with the purpose that they are likely to generate useful data for 
answering the research question.  
 
Inclusion criteria for this study were: 
¥ Malaysian male and female patients with Type 2 diabetes who are 
using insulin treatment to control T2DM, 
¥ Aged over 18 years, 
¥ Patients who initiated insulin treatment at diabetes clinic or other health 
facilities as a result of consultation between prescribers and patients, 
¥ Patients with no known serious medical conditions, which may affect 
their experience of insulin initiation. 
Patients with serious medical conditions such as having an emergency cardiac 
bypass surgery followed by the initiation of insulin treatment were excluded 
from this study. The reason being that the traumatic event from the immediate 
medical condition may greatly influence their experience of insulin initiation.  
 
Exclusion criteria were: 
¥ Patients who had gestation diabetes and had used insulin, 
¥ Patients with mental health issues, 
¥ Patients who started insulin treatment as an emergency procedure, 
¥ Patients who have been residing overseas for a long period of time. 
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Patients were excluded based on the above criteria because they were often not 
given an option for their initiation of insulin treatment. Patients who have been 
residing overseas for a long period of time or their insulin treatment was 
initiated by overseas doctors were excluded. This group of patients may 
encounter different experiences from Malaysian patients because of the 
differences approach in healthcare systems and expectations.  
 
PatientsÕ medical information is stored electronically and accessible by using a 
computing system called Total Hospital Information System. I was assisted by 
the diabetes nurses at DRC to access patientsÕ medical information. Based on 
the diabetes clinic appointment list which I usually obtained early in the week, 
I was able to screen through the appointment list and identify T2DM patients 
who were coming for the Thursday endocrine clinic. T2DM patients who were 
on insulin treatment were then identified and pre-selected for participating in 
the semi-structured interview.  
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2.4.7 Confidentiality  
All participated patients were informed about the confidentiality arrangements. 
All field notes, transcriptions and recorded audiotapes were secured in a 
lockable cabinet at the researcherÕs office and will be stored thereafter for six 
years. All attempts were made to protect the identity of patients by the usage of 
pseudonyms, and places or persons mentioned in the interviews. This applied 
to all the interview transcripts, and any articles related to the interviewee. All 
the information which might lead to the linkage to the interviewee were 
disguised. However, some of these linkages remain such as their ethnicity as I 
felt that it is an important piece of information which could give the context 
more meaning and also enrich the data.  
 
The location and name of the participating hospital (PH) is made anonymous, 
however this information is available to the MOHM and it might be used for 
auditing and reporting purpose. All participated patients were made aware that 
their interview transcripts would be used for publication and education 
purposes.    
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2.4.8 Qualitative Data Collection: Semi-structured Interviews  
Semi-structured interviews were conducted for data collection. The 
participants in this study were mainly T2DM patients recruited from the 
diabetic clinic on a Thursday. A small proportion of participants were patients 
recruited from the DRC appointment list. As mentioned in section 2.4.6, pre-
selected T2DM patients were approached after they left their appointment card 
to be re-registered at the endocrine clinic counter (see section 2.4.5). During 
the initial observations, I had noticed that all hospital personnel wore uniforms, 
including pharmacists and doctors who are required to wear a clinical lab coat. 
It might not be appropriate for the interviewer to wear uniform lab coat as this 
might mislead the participants into thinking that the interviews were a proper 
clinical consultation. As a result the interviews might not be as relaxing and 
the explorative nature be inhibited. In the first few interviews, I introduced 
myself as a pharmacist to the participating patients; I had noticed it was harder 
to build a good rapport with the patients and I was asked clinical questions by 
interviewee. I did not want the participants perceiving my role as such, as this 
could lead to interviewee giving responses he or she thinks a health 
professional wants (Britten 1995).  
 
After fine-tuning my interview skills, I introduced myself as a PhD student 
from The University of Nottingham and explained briefly about the purpose of 
my research at PH. The patient information sheet was given to the patients to 
read. For those patients who agreed to take part in the interview, I then 
explained further about the study aims and at that point a consent form was 
given to them.  I then explained to them about the confidentiality arrangements 
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and informed them that the interview would be audio-recorded. A signature on 
each of the consent forms was obtained from patients who agreed to 
participate. A copy of the consent form and patient information sheet was 
given to participating patients.  
 
Before I started recording the interview, I would ease the interviewee into the 
interview by reassuring them that the interview questions were designed to 
explore their lived-experience, therefore there were no right and wrong 
answers. And also letting them know they could stop the audio-recording at 
any time if they felt uncomfortable. I had taken into account that it might take 
the interviewee some time to speak comfortably and freely in front of the 
audio-recorder; I often started with an open-ended question or simple question. 
As suggested by Britten, I minimised note taking activities during interviewing 
and retained more eye contact with interviewees which encourage them to talk 
more openly and comfortably (Britten 1995). After each interview, I would 
write down some field note to highlight the interesting points regarding the 
interview. The field notes were useful as a reminder regarding each of 
interviews conducted and were used to generate the topic guide and also were 
used to support data analysis (refer to section 2.4.9.2). 
 
When I approached the participants, I used the English language to introduce 
myself. If the participants responded in Bahasa Malaysia, then I would start to 
converse in Bahasa Malaysia. I would use languages which the participants 
were comfortable converse in to build a good rapport. This was done before I 
actual carried out the interviews and I would spend around ten minutes to 
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introduce myself, my research project and explained to them how they could 
help. Majority of the interviews were conducted in English with a mixture of 
Bahasa Malaysia. Some Chinese participants were using terms or phases in 
Cantonese and Mandarin during the interviews. Similarly, a few Indian 
participants used some Tamil terminologies during the interviews, which they 
had to translate into English. I have reflected on these language and cultural 
issues in section 8.2; it would be beneficial to conduct separate studies 
focusing on each ethnic groups in Malaysia and their perception of using 
insulin treatment.  
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2.4.8.1 Transcribing and Translating of Interview Data 
Majority of the interviews were conducted in English language with Malaysian 
accents and slang. When transcribing these interviews, I had made some 
adjustments to the sentence structure and translations. For interviews 
conducted in English language with minor translations, the translated 
terminologies were transcribed into English with parentheses. For example: 
 
ZA: I would think insulin when teruk (terrible), I mean [when] the 
diabetes is very, very bad then  [only] you should take insulin.  
 
ÒTerukÓ in Bahasa Malaysia means bad, or terrible; the translated meaning was 
put in parenthesis. Malaysian English has a unique local style, often the past 
tense was replaced with the use of ÔalreadyÕ which signified that an action has 
been taken or done; or very often relative pronouns are skipped in a sentence. 
Square brackets were used in these situations to give a better meaning of the 
transcription.   
 
Six interviews were conducted in Bahasa Malaysia and these interview 
transcriptions were translated into the English language. The initial translated 
transcription would have the English version next to the sentence for cross 
checking (see example below). The English version was then imported into 
Nvivo¨ software for analysis process.  
 
AM: Tak teruk la dan dia kasi makan pills sahaja. (Not in critical 
stage, he just gave me the pills) 
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2.4.8.2 Interview Topic Guide  
Although the interview was semi-structured with guiding questions (see 
appendix three), the interview itself was conducted in a conversion like manner 
to encourage patients to open up and express more freely about their lived 
experience and also to build rapport. The interview topic guide for this study 
was developed to provide a direction to explore patientsÕ lived-experiences of 
using insulin treatment as part of their diabetes management. The topics guide 
was a set of key issues, themes and possible probes; it contained questions in 
which I was interested and intended to cover during the interview. The topics 
of interest were formulated as: experience of being diagnoses with diabetes; 
experience of using insulin treatment; influences of these experiences; 
perspective of insulin treatment overtime. The initial questions covered in the 
topic guide were developed based on my own experience with diabetes 
patients. They were questions I was interested to learn from T2DM patients, 
especially about how they experienced their diagnosis, their story of being 
introduced to insulin treatment and how they managed insulin injections. 
When developing these questions, I had kept in mind of my original research 
questions which are: 
 
¥ What is your experience of using insulin to control diabetes? 
¥ What influences these experiences? 
¥ How do your perspectives of insulin treatment change overtime? 
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Often questions were asked in a different way from the interview topic guide, 
sometime questions were asked but were not specifically in the interview topic 
guide. This was to encourage patients to talk about their experiences and 
express their perspectives in their own words. Questions were asked at points 
that flowed from what patients said, generally to clarify or explore the 
responses given, rather than sticking rigidly to the order in the guide. Guiding 
questions were useful when patients got side-tracked and ramble or became 
repetitive. As Ritchie and Lewis warned:  
 
Every interview situation is unique, and every interview a step into 
unknown territory. What is important is to be alert to changes in the 
dynamic of the interview and in the participant's demeanour, to 
ponder what might be bringing about this change, and to shape the 
response accordingly (Ritchie & Lewis 2003).  
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2.4.8.3 Interview Venue 
Semi-structured interviews generally last for a considerable amount of time 
compared to structured questionnaires (Smith & Osborn 2008). Sometimes the 
interview can become intense and involved, therefore choosing the venue for 
the interview must take into account of such situations.  
 
This study was approved by the PH and bounded by the term set by the Ethics 
Committee of the Ministry of Health Malaysia, that is all interviews must be 
carried out within the hospital compound. After the initial observations at the 
studied site, I identified a few potential areas for conducting interviews. These 
included the waiting area at diabetes clinic and the diabetes resource centre 
(DRC), which had sofas and counselling desks. The waiting area at the 
diabetes clinic has a corner with chairs but it can be noisy and sometimes 
during the peak hours other patients might occupy the seats nearby. It might 
hinder patientsÕ freedom of speech when their privacy is compromised.  
However the area was an open-planned floor, the interviews itself would not 
feel like a consultation and patients could relax and feel more at ease and 
comfortable during the interview. In contrast, the diabetic resource centre was 
just around the corner from the waiting area, had a coffee table and sofas; it 
looked comfortable. However the diabetic educator and nurses were often in 
the room. Occasionally I used the desk for interviewing patients, which felt 
like a counselling session.  
 
The participants for this study were approached at the diabetes clinic waiting 
area, after I introduced myself and explaining the purpose of this study, they 
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were requested to be interviewed either at the corner of the waiting area or to 
go to the diabetic resource centre.  
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2.4.9 Qualitative Data Analysis 
This study used semi-structured interviews to collect data from patients with 
T2DM. Interviews were recorded and transcribed verbatim. Transcripts from 
interviews are the raw data which are descriptive record of the research, but 
they cannot provide explanations without analysing the data (Pope et al. 2000). 
The researcher has to make sense of the data by closely examining and 
interpreting them. The process for data analysis used thematic analysis 
approach. The following table (see Table 3) summarises the steps involved in 
thematic analysis which I adapted for the data analysis in this study (Ziebland 
& McPherson 2006; Burnard et al. 2008; Brikci & Green 2007; Braun & 
Clarke 2006) 
 
The steps involved for data analysis are described in stages (refer Table 3). 
However, in practice they are not independent processes but cyclic in nature. It 
is important to execute the principle of constant comparison in this study. 
Therefore, both data collection and analysis processes were cyclic in nature, 
iterative process and not a linear process (Miles & Huberman 1984). The data 
analysis is discussed as a linear step for the purpose of this report. 
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Table 3 Steps of thematic analysis  
Phase Description of the process 
Familiarising    with 
collected data 
Transcribing data, reading and re-reading the 
data, immersing oneself in the data, start thinking 
of the themes. 
Generating initial codes 
(open codes) 
Noting down ideas (codes) to summarise what is 
being said in each of the transcripts.  
Searching for themes Collecting together all of the initial codes from all 
of the interviews and collates codes into potential 
themes, gathering all data relevant to each 
potential theme. 
Reviewing themes 
(Constant comparison) 
Checking if the themes work in relation to the 
coded extracts and the entire data set, generating 
a thematic ÔmapÕ of the analysis. 
Defining and naming 
themes 
On going analysis to refine the specifics of each 
theme, and the overall story the analysis tells, 
generating clear definitions and names for each 
theme 
Producing the report The final opportunity for analysis. Selection of 
vivid, compelling extract examples, final analysis 
of selected extracts, relating back of the analysis 
to the research question and literature, producing 
a scholarly report of the analysis 
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2.4.9.1 Computer Software for Data Analysis 
During data analysis process, coding technique was used. Coding can be done 
manually which involve the use of coloured pens or highlighters, scissors and 
glue to literally cut and paste sections of text onto cards or piece of poster that 
could later be examined together in a bigger picture (Ziebland & McPherson 
2006). In this study, both manual cut and paste as well as a computer-assisted 
qualitative data analysis (CAQDA) software Nvivo¨ software were used.   
 
Nvivo¨ software is a sophisticated software tool to store and manage the data, 
however it does not provide analysing function. It facilitates accurate and 
transparent data analysis process whilst also providing a quick and simple way 
of counting who said what and when (Welsh 2002). It can display and assist in 
categorising themes and making links between sections of the data for easy 
retrieval later. Thus software package such as Nvivo¨ software enables the 
researcher to look across all the data easily and effectively to label codes and 
identify themes. Especially during the thematic analysis process, the transcript 
is read and re-read several times and sections of the text are highlighted under 
different headings, which might be merged or subdivided or changed through 
the analysis process. 
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2.4.9.2 Familiarisation with Data 
The first step of analysing using thematic analysis is to get familiar with the 
collected data and start thinking about the data collected (Braun & Clarke 
2006; Ziebland & McPherson 2006). After transcribing the interview data, I 
checked through the transcripts together with the audio files. At this stage, the 
field notes were used to further conceptualise the conversation. It is crucial to 
get familiar and immerse oneself into all aspects of the collected data so that 
the researcher can get familiar with the depth and breadth of the content. The 
process of familiarisation with the data is to build a strong foundation of 
structure for data analysis later (Ritchie & Lewis 2003). If this foundation is 
weak or incomplete, it could jeopardise the integrity of the research.  
 
The method to get familiar and immerse oneself into the collected data 
involved Ôrepeated readingÕ of the data and searching for meanings and 
patterns. Due to the intense repeated reading process, qualitative research tends 
to use smaller samples compared to quantitative research as it can potentially 
generate huge amount of data (Braun & Clarke 2006). After reading the 
transcripts a few times, I made a preliminary observation of my data and 
started to develop a few general ideas which were noted down to be used in the 
following analysis process: coding. It is an important step to get familiarised 
with the first few transcripts first to generate an overall feel of the data. 
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2.4.9.3 Initial Coding 
Before any theme is identified, a coding technique is used to mark and identify 
themes and subsequently applied or linked to the collected interview data, as a 
way of organising data into manageable units and as summary markers for 
later analysis (Guest et al. 1971).  After re-reading a transcript a few times, I 
noted down short phrases (initial codes) that sum up what was being said in 
that transcript. The aim of initial coding is to offer a summary statement or 
word for each element that is discussed in the transcript (Burnard et al. 2008). 
They refer to the most basic segment, or element, of the raw data or 
information that can be assessed in a meaningful way regarding the 
phenomenon (Braun & Clarke 2006).  
 
After re-reading the first few transcripts and reviewing the range and depth of 
the data, I generated a list of initial codes to categorise or index the data. Some 
researchers note down such concepts as they emerge during reading or 
listening to a piece of paper (Ziebland & McPherson 2006; Ritchie & Lewis 
2003). I used similar method but creating nodes (codes) in Nvivo¨ software 
during the reading or listening of the transcripts. Table 4 is an example of the 
initial coding framework used in the data generated from one of the interview: 
 
Table 4 An example of an initial coding framework 
Interview transcript Initial coding framework 
BK: At where I stay, the clinic there 
provides health-checking service like 
for diabetes; I regular go there for 
checking. During one time, the doctor 
said my blood sugar is high, but it is 
ok.  
Diagnosis  
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I created several codes to organising the data into meaningful groups such as 
diagnosis, symptoms, diabetes complication, initial oral treatment, healthcare 
services and other descriptions of the transcripts data. These are referred as 
initial coding or open coding which describes the raw data and provides a 
summary statement for each element that is discussed in the transcripts but 
they are not the units of analysis or the themes yet (Braun & Clarke 2006; 
Burnard et al. 2008). Themes are often broader and are only developed in the 
following steps (see next section 2.4.9.4) where the interpretative analysis of 
the data occurred, and in relation to which theories about the phenomenon 
being examined are made (Braun & Clarke 2006).  
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2.4.9.4 Searching for Themes 
Next step in data analysing started after all the raw data were initially coded 
and collated.  I have now created a long list of the different nodes or codes that 
were identified across all the transcripts. This is followed by the next step, that 
is to sort the different nodes into potential themes, and collating all the relevant 
coded data extracts within the identified themes (Braun & Clarke 2006). 
Essentially, it is a process to re-focus the created codes at the broader level and 
consider how different codes may combine to form an overarching theme.  
 
Some researchers use tables, or mind-maps, or write a name for each code with 
a brief description to create a thematic map to search for the overarching theme 
(Braun & Clarke 2006). I adapted the Ôone sheet of paperÕ (OSOP) method as 
described by Ziebland and McPherson to search for potential themes. Nvivo¨ 
software allows exporting the list of initial codes together with the coded 
section of the transcripts. Using the printout, I switched to manual method: cut 
and paste on a sheet of paper. OSOP involves reading through each section of 
data in turn and noting on a single sheet of paper all the different issues raised 
by the coded extracts (Ziebland & McPherson 2006). From Ôone sheet of 
paperÕ (OSOP) it was easy to observe that some potential themes were not 
really themes as there were not enough data from transcripts to support them. 
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Using the OSOP method, I have developed a set of overarching themes, and 
then I created them as new nodes in Nvivo¨ software to categorise the initial 
codes. Example of the categories are shown below: 
¥ Positive effect of insulin 
¥ Side effect of insulin 
¥ Peer influence on diet 
¥ Availability of healthy food 
¥ Restriction on travelling  
¥ Effect on social activities 
¥ Restriction on food choices 
 
 
 78 
2.4.9.5 Reviewing Themes 
After I started to develop a set of overarching themes, at this point it is 
important to review and refine these themes. During this step, I also merged 
two apparently separate themes to form one overall theme and some themes 
were split into separate themes. Data within themes should cohere together 
meaningfully, while there should be clear and identifiable distinctions between 
themes (Braun & Clarke 2006). There were constant reflections throughout 
this process as well as discussion with supervisors to enrich the analysis. 
Discussing the findings with colleagues from another disciplinary background 
can provide new insights and interpretations (Ziebland & McPherson 2006). 
During this analysis process, themes were reported and discussions with the 
endocrinologist at the data collection site.  
 
These potential themes were then created in Nvivo¨ software and linked to all 
previously created nodes (codes). A screenshot of an overarching theme 
created for this study is displayed as follow: 
Figure 5 Screenshot of Nvivo¨ software showing a theme and the nodes 
associated to it. 
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Nvivo¨ software not only stores qualitative data for easy referencing but also 
efficient in retrieving the transcripts data. The newly created themes linked 
across the transcripts and encoded the part of the transcripts that converse to 
that particular theme. It is an essential function in Nvivo¨ software, which 
facilitated constant comparison between themes and also between transcripts. 
The next step was to define and name the themes and this process was easily 
managed in Nvivo¨ software. 
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2.4.9.6 Defining and Naming Themes 
At this step, researcher is required to define and further refine the themes and 
analyse the data within them (Braun & Clarke 2006). The identified themes 
should capture the ÔessenceÕ of what each theme is about, it needs to fit overall 
ÔstoryÕ. I have identified the overarching themes and linked them to the 
individual ÔstoriesÕ told by the participants. In Nvivo¨ software, I can easily 
retrieve the identified themes and the individual stories that linked to that 
particular theme. Then I refined and renamed these themes to create a stronger 
connection to the stories being told and capture the essence from the stories. 
 
During the process of refining and renaming of themes, reviewing literature 
was again being carried out. Ziebland and McPherson suggested going back to 
the literature as the most common method to seek depth in qualitative data 
analysis (Ziebland & McPherson 2006). Apart from the constant reflection, 
this analysis process is also enriched by going back to the literature to explore 
how other theoretical literature fitted and how it could further support the 
analysis.  
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2.4.9.7 Producing the Report 
Quantitative studies are often designed to answer one or more main research 
questions; in contrast qualitative interview studies explore the experiences and 
meanings (Ziebland & McPherson 2006). The resulting data are rich and have 
the potential for many different analyses. It is necessary to identify the story 
that can be told with the qualitative data to produce new and useful theories.  
 
It is important that the analysis, and the resulting report, provides a concise, 
coherent, logical, non-repetitive and interesting account of the story the data 
describe (Braun & Clarke 2006). During the study, findings were constantly 
discussed with supervisors. Interesting and potentially useful theories were 
presented and discussed in this report.  
 
The findings are presented in the order of patientsÕ lived-experience of using 
insulin treatment to manage their T2DM. This report begins with exploring 
participantsÕ reactions to T2DM diagnosis, and then followed by their 
reactions to initiation of insulin treatment, and lastly looking at how the 
participants coping insulin injection in their day-to-day life.  
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2.5 Chapter Summary 
In CHAPTER 2, a detailed description of the methodology and methods used 
in this study has been discussed. The following chapters will present the 
findings of this study. Demographic information of the interviewees is 
presented in appendix 5. 
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CHAPTER 3  
REACTION TO DIAGNOSIS 
 
3.1 Introduction 
This aim of this chapter is to discuss the analysis of the data from the 
interviews that concerns these thirty-seven patientsÕ perspectives on reaction to 
the diagnosis and initiation of insulin treatment. Key points are summarised in 
the final section of the chapter. 
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3.2 Information-Knowledge of Diabetes  
At the beginning of the interview, patients were asked about their experience 
during diagnosis with T2DM and how much they knew about the diseases. 
And how they perceive T2DM. From the discussion with the patients during 
interview about their knowledge prior to diagnosis, most patients had little 
knowledge of diabetes diseases. The average patients were diagnosed with 
T2DM 13.5 years ago; they had been given limited information about their 
condition. Internet and computers were not readily available as SA explained 
below. Patients obtained their limited knowledge of T2DM mainly from 
friends or family such as KK explained how the Ôold peopleÕ referred diabetes 
as a disease with sugar in the urine.  
 
SA: So at that time, when the doctor told me I got diabetes, I did a 
lot of research: what is diabetes? You donÕtÕ know what is 
Diabetes at that age, a disease called diabetes. And those days, you 
donÕt have Internet you can look up thing quite easily.  
 
CH: Very little at that time. At that time very [little knowledge]É I 
know that it is the diabetes, but I am not really sure what is the 
actual diabetes, the disease and all theseÉ It is something like you 
donÕt know moreÉ how to say itÉ we donÕt understand actually 
how is this diabetes É and how it affects our future and all these. 
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KK: Just that, sugar in the urine, that was what the old people used 
to say. I donÕt have a very clear idea of it. 
 
Patients such as SA explained that when he was diagnosed with T2DM, he had 
no knowledge of the diabetes. With no Internet at the time, he went the extra 
mile to read up about information of diabetes.  
 
Most patients had limited knowledge of T2DM when they were diagnosed, 
especially in the 90Õs when prevalence of T2DM started to increase at an 
alarming rate. In 1986, the prevalence of T2DM In Malaysia was reported at 
6.3%; ten years later this figure had increased by one third to 8.3% 
(Letchuman et al. 2010). This dramatic rise spurred the initiation of numerous 
national healthy lifestyle campaigns by the Ministry of Health Malaysia. As a 
result, the ministry has set up a national committee to improve the screening 
and management of diabetes in primary and secondary care clinics. Non-
government organisation Malaysian Endocrine and Metabolic Society 
(MEMS), National Diabetes Institute (NADI) were also set up and focusing on 
screening, counselling and educate public, and also running exhibitions 
targeting to raise awareness of T2DM. With this greater attention paid to 
diabetes education, it has created more awareness of T2DM and better 
accessibility to diabetes screening and detection. However, a number of 
participants in this study concerned that these diabetes campaigns were only 
seen in urban areas and sometimes confined to health facilities only.  
 
LM: I would say that the younger generation should be aware of 
and take careÉ But people should be aware and help them what I 
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would say. More awareness... more talk, to the rural area, not to 
town areaÉ To the uneducated. 
 
LT: All because of lack of awareness... The only awareness is only 
[seen] in hospitals. So it is not out there. Is not out there, it is not. 
Heart attack is out there, cancer is out thereÉ But you can put 
your advertisement on midnightÉ but this is an awareness needed. 
... Because this is not a problem in hospital. You can promote in 
hundred of hospitals, but you will get the same thing.  
 
Overall, the level of awareness and knowledge of T2DM among Malaysians 
remains low and there is a greater need to improve the design of T2DM 
educational campaign as supported by the findings of other recent studies (Yun 
et al. 2007; Al-Qazaz et al. 2011; Tan 2004; Rampal et al. 2010; Ali 2009). As 
the participants suggested, these diabetes campaigns should be spread to a 
wider community especially in rural areas and also promoted in the media to a 
wider audience. The focus should be targeted at younger Malaysians in raising 
the awareness of healthy lifestyle and diabetes preventative measure.  
 
Rampal and et al reported that less than 4 out of 10 diabetics are aware of their 
problem and seek treatment (Rampal et al. 2010).  Yun et al revealed up to 
85% of diabetes patients have good to very good degree of knowledge of the 
diseases; whereas only 55.8% of the healthy population has the same degree of 
knowledge (Yun et al. 2007). It highlighted that in general, the Malaysian 
public does not have the adequate knowledge of diabetes and its preventative 
measures such as healthy lifestyle.  Because of the unhealthy lifestyle which 
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has led to an increase in obesity rates, Malaysians are at greater risk of 
developing T2DM (Pank 2012). Awareness and education about healthy 
lifestyle among the Malaysians, particularly the younger population who are at 
risk, needs urgent attention.  
 
YunÕs suggestion to design two separate education programs: a prevention 
program which targeted healthy individuals at risk, and diabeticÕs program for 
secondary and tertiary prevention for patients with diabetes (Yun et al. 2007). 
It is important to design a separate educational campaign from those focusing 
on diabetes patients. This would aim at improving the health literacy of the 
general public; in particular knowledge and awareness on healthy lifestyle, 
which includes information about risk factors of diabetes, diet, exercise, and 
screening. This can be promoted at many levels, including schools, work 
places, and community events across the country.  Printed materials such as 
posters were criticised by participants in this study, as they Òdo not speak to 
peopleÓ and therefore do not have much impact and get the message across 
especially to those with a lower education level. Campaign activities should be 
interactive and involve the target audience. In addition, education campaigns 
need to be well structured to address the population who live in the rural and 
remotes of Malaysia. It should be tailored to meet the culture needs and 
lifestyle, and delivered through series of talks or screening activities at 
community halls, clinics and religious venues.  
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3.3 Health Screening and Diagnosis  
Participants in this study appeared to have an adequate knowledge and 
awareness of diabetes symptoms. Some of the participants took immediate 
action to seek medical attention when they experienced the signs and 
symptoms. The other participants were diagnosed during diabetes screening 
services either provided by the public hospital or privately. As reported by 
many participants, the availability of diabetes screening at various healthcare 
facilities provided an approachable channel for self-diagnoses.  
 
AM: There was thisÉ blood screening here, at the diabetes center. 
They offer people to check their blood.   After checking, he said my 
blood sugar level reached 13 and then he asked me to come back 
here for two to three times more to follow-up.  
 
ZZ: I did a test, a random test in a [private hospital], they had this 
diabetes week. ItÕs just a campaign. I realised that my sugar was 
very high.  
 
BK: At where I stay, the clinic there provides health-checking 
service like for diabetes; I regular go there for checking. During 
one time, the doctor said my sugar is raised, but it was ok. So after 
a long while, there isnÕt any symptom. But in 2004, my sugar level 
is over the borderline. 
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With the greater awareness and easy accessibility to public health services, 
many participants attended their medical check up at a public health clinic or 
hospital, and therefore were diagnosed with T2DM in the public system. 
Participants such as MY attended a public health clinic for a body check-up 
and was diagnosed with T2DM and high blood pressure; MJ on the other hand 
was diagnosed with hypertension and attended the regular follow up at which 
he subsequently discovered that he is also diabetic.  
 
MY: Went for check-up. Clinic at a [government health clinic] É 
Just went [for check-up] since our age 50 overÉ time for check-up. 
So we check-up, we found out I am diabetes then high blood 
pressure, all these things. 
 
MJ: During the blood test. I was having the hypertension at first... 
For every four months, I got to take the blood test. From the blood 
test, they discovered that my blood sugar is high. 
 
 
Apart from the diabetes screening service provided by the public health 
system, some privately owned companies also provide annual health check-ups 
and have been shown to encourage employees to discuss their health issues 
with the healthcare provider. Two of the participants were diagnosed with 
T2DM through their companiesÕ routine body check up.  
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SR: When I was working there, they will have a periodic check... So 
that makes me to go to see the doctor to get consultation. 
 
SA: That time I was with a company called [private company]. A 
company doctor, a panel doctor said that I have diabetes. But we 
didnÕt believe it, so he said come back in two or three days, and 
then [confirmed] it is diabetes. 
 
 
In general participants were satisfied with the healthcare service and the 
support that they received from either a private hospital or the public health 
system. However, none of the participants mentioned the health screening and 
diagnostic services provided by the pharmacy sector. This could be due to the 
lack of recognition of the role of pharmacists by the Malaysian public; and also 
the lack of confidence, time and funding for the pharmacists to run such 
activities as reported in a number of studies (Hassali et al. 2009; Eades et al. 
2011; Sarriff et al. 2010).  
 
An exploratory study to ascertain the publicÕs awareness of Malaysian 
community pharmacy and pharmacists was conducted in 1997, it was reported 
that Malaysian public has a very low knowledge of the community pharmacists 
and their role (Hashim et al. 2001). Hashim et al reported that less than 12% of 
respondents will choose to go to community pharmacy for screening purposes 
and less than 50% will ask community pharmacists for advice on medication. 
This could be due to the lack of recognition of the pharmacist role and lack of 
confidence in community pharmacists. It was reported in Malaysia that the 
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community pharmacists showed a lower perception of the importance of and 
competence for the current pharmacy practice activities including public health 
promotion compared to the pharmacists in the hospital setting (Sarriff et al. 
2010). There are also insufficient supporting materials and training for 
community pharmacists for providing health promotion activities. In addition, 
there is no standard guidelines for offering health education and insufficient 
management support which has hindered community pharmacists from 
involving themselves in health promotion activities (Hassali et al. 2009).  
 
Community pharmacists are keen to expand their role as public healthcare 
provider and become involved in health promotion activities. Sarrift et al also 
concluded that the majority of general medical practitioners in Malaysia are in 
favour of community pharmacistsÕ involvement in providing public health 
activities (Sarriff et al. 2012). With increasing attention in the mass media on 
the issue of dispensing separation and the role of the community pharmacists, 
the publicÕs perception towards the pharmacists has since improved.  
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3.4 Reaction to Diagnosis and Link to Family 
History 
 
At the beginning of the interview, patients were asked what was their reaction 
when doctors diagnosed them with T2DM. Patients with close family members 
who were also diagnosed with T2DM did not have such a big reaction to the 
news as compared to the others. As indicated by Al-QazazÕs study on 
perception of diabetes among T2DM patients in Malaysia, genetic factors or 
family history were perceived as the main cause of T2DM by the participants 
(Al-Qazaz et al. 2011). This group of patients expected to have T2DM at some 
point of their life, therefore their reactions to the diagnosis were somewhat 
expected. In fact, family history is one of the prompts to encourage participants 
to seek medical attention when they experienced the signs and symptoms of 
diabetes. 
 
YP also expected to have T2DM because of his family history; therefore he did 
not react emotionally to the news: 
 
YP: Because it's geneticÉ No reaction because I expected it. 
Because we know that it is genetic, it is Type 2 thing and it will 
come. The chance of getting it is about 90%. It is nothing to be a 
shocked.  
YP represents an example of preparedness for diagnosis connected to an 
absence of negative emotion. However, he was not alone in this respect.  
Participants HT and AZ also have similar expression: 
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HT: My reaction wasÉ. was normal because my family is diabetic, 
[and] my mother, [and] my motherÕs father. 
 
AZ: I didnÕt, I didnÕt think of anything because my dad was 
diabetes.  
 
ZZ was diagnosed during a random blood glucose test at a diabetes campaign. 
He was surprised to find out that he has T2DM but was not unexpected 
because his father is diabetic.  
 
ZZ: Of course I was surprised also but it wasnÕt really unexpected. 
I think the family there was a history. My father he is a diabetic 
patient and also that I know I was a little bit of overweight. I 
presumed that it contributes a lot to it.  
 
 
LV is 35 year old Indian lady with a strong family history of T2DM, both LVÕs 
parents and one of her aunty are diabetic. When she was diagnosed with 
T2DM at the age of 33, she reacted differently: 
 
INTERVIEWER: So, when they tell you that you have diabetes, 
what was your reaction? 
LV: I said, Òha? Ai-yah!Ó you knowÉ Yeah, genetic. 
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LR had a very strong diabetes background, she explained that she is a ÔcarrierÕ 
for the gene and therefore during the interview, she had no strong reaction 
towards the diagnosis process: 
 
LR: I didnÕt take any junk food or soft drinks or whatever and I 
donÕt have that kind of habit of drinking soft drinks. But I think my 
father, my mother, my grandmother, both side my grandparents; 
have a very strong gene for diabetic, I am the eldest of the family 
and I was the carrierÉ 
 
In both LV and LRÕs response to the diagnosis, there was no strong emotional 
reaction to the bad news. However, there was an attendant sense that they felt 
ÔunfairnessÕ. LV said she felt ÒunluckyÓ and she expressed it in a local slang 
ÒAi-yahÓ, it is a common expression in response to unlucky event. LR 
emphasised in the interview that she was trying to stay healthy by refraining 
from junk food and bad eating habits, but in the end she was still diagnosed 
with T2DM. She felt that being the Ôeldest of the familyÕ would have to carry 
the ÔgeneÕ. It is common in South Asian culture that eldest female sibling 
carries extra responsibility (Waxler-Morrison et al. 1990). 
 
In contrast, patients without a family history of diabetes received the news 
differently and mostly reacted in shock and were unable to accept the news. 
For example, ET did not know much about diabetes and with no family 
history; when he was diagnosed with T2DM, he was very upset and worried 
because he thought that T2DM is a serious disease. LT got a shock when 
receiving the news, and he was worried how to cope with living with diabetes.   
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ET: Upset and very worry. I lost a little bit of weight too. 
 
LT: Got a shock, I mean nobody will want it, that is the only thing. 
Then [I started] thinking of how to go on with my life. 
 
 
From the interview, it is found that participants who have family member 
living with T2DM reacted less emotionally when diagnosed with T2DM. Peel 
et al described this as Ôsuspected diabetesÕ route to diagnosis, this sense of 
preparedness was evident in the emotional reactions described experiencing 
when their diagnosis was given (Peel et al. 2004). With prior awareness of 
T2DM, these participants group emphasised that they had not experienced 
ÔshockÕ when diagnosed. In contrast, participants without any prior awareness 
of T2DM was emotionally affected by the receipt of bad news as they often 
expressed in ÔshockÕ and upset by the news.  
 
Prior awareness of T2DM and family history has an impact on patientsÕ 
emotional reactions at the time of their diagnosis. This finding coincides with 
Peel et al finding as the commonly cited ÔshockÕ reaction to diagnosis does not 
feature prominently in T2DM.  
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3.5 Chapter Summary 
 
The average period patients were diagnosed with T2DM is 13.6 years; 
information technology was not as advance and accessible as today. Patients 
were less aware of T2DM and its complications except those who have had 
family members who also diagnosed with T2DM. Patients with family history 
have neutral reaction when diagnosed with T2DM, they were ÔexpectingÕ it at 
some point of their life and were not surprised.  
 
However, the other group of patients without a family history were shocked 
and mostly sad when diagnosed with the disease. Some participants felt that it 
was ÔunfairÕ and that they were unlucky to ÔgetÕ diabetes. When they learned 
more about T2DM being a chronic illness and with no cure, they felt worried 
and ÔhopelessÕ. They understand that they wonÕt be able to cure the disease and 
for life will have to live with diabetes. Delivering the ÔbadÕ news to patients is 
challenging and needed to be handled with patience and care, patientsÕ 
emotional reactions to the news can be complex and diverse. At the same time, 
health care providers need to provide sufficient information at the point of 
diagnosis. Therefore, simple but detailed and specific information forms an 
important part of initial counselling for patients newly diagnosed with T2DM. 
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CHAPTER 4  
FACILITATORS TO INSULIN INITIATION 
 
4.1 Introduction 
During the interview, one of the objectives was to explore patientsÕ reactions 
toward initiation of insulin treatment. Patients were asked to describe their 
reactions and thoughts when their doctors suggested adding an insulin injection 
to their diabetes treatments. In the following sections, I will be discussing the 
facilitators toward initiating insulin treatment, which were expressed by 
participants in the interview. The barriers toward insulin treatment will be 
discussed in the next chapter (see CHAPTER 5). 
 
During the interviews, participants were asked about their reaction about 
initiation of insulin treatment, one prominent theme is the association with 
prior experience or prior exposure to insulin injection and the acceptability of 
insulin treatment. This phenomenon of preparedness is also seen during 
diagnosis, when participants who have family history of T2DM often have less 
emotional reaction to the news. 
 
The second facilitator discussed in this chapter is the patientsÕ health beliefs 
especially about the mechanism of action and side effect profiles of both oral 
anti-diabetic medication (OAM) and insulin. The third facilitator that 
encourages participants to take up insulin treatment is to have T2DM under 
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control. The motivators that prompt the participants to control their blood 
glucose level are to prevent diabetes complications and thinking about the 
future with a better quality of life.  
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4.2 Prior Exposure to Insulin Injection 
Similar to the reactions reported by participants who have family history of 
T2DM, participants who have close family members using insulin injection 
have more awareness of insulin; they did not have such a large reaction 
towards the suggestion of using insulin. In fact it was more acceptable for them 
to make the transition from oral therapy to insulin treatment when suggested 
by their healthcare providers. AZ, HH and SL reported that because of their 
prior exposure to insulin injection, they felt it's just a ÔnormalÕ treatment that is 
no different from taking tablet and they were not feeling ÔstrangeÕ about 
insulin.    
 
AZ: I said insulin was ok because my dad is diabetic. I was 
injecting him while he was sick. So, is like a normal thing for meÉ 
I donÕt have any fear [towards injecting insulin]. 
 
HH: I think I am the same. Before I started using insulin, I saw my 
parent using insulin; so when it is my turn, I donÕt feel any big 
reaction. Because I was prescribed the same thing. Same as what 
my parent used to use, so I donÕt feel strange to insulin.  
 
SL: Yup, my mother. My mother got diabetes. We used to [inject 
insulin] for her...I got the experience, so I not scared...So, I know 
how to useÉ I am ok because I know what is insulin, how to put in 
insulin because my mother is on insulin. 
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One participant, YP, requested to be on insulin treatment because a few of his 
close family members are on insulin treatment. As a result, he could see the 
positive effects of insulin treatment and that it facilitates improved glycaemic 
control: 
 
YP: No fear, no fear, because I requested for it. Because I mean, 
you see I come from a family of diabetics, from both side of them, 
father side and mother side. So, we have a lot of experience with 
those older than us. It is nothing for me to be shocked about or 
even insulin, I was the one who actually requested for it.  
 
 
Participants who have had prior exposure to insulin treatment were very 
positive towards adding insulin to their T2DM management. Participants 
usually encountered insulin treatment because of close family members with 
T2DM who were using insulin. As a result these participants had a better 
awareness of the positive effect of insulin treatment and also the side effects 
involved. Because they have been exposed to insulin devices, they are more 
familiar with the modern insulin pen devices and also the techniques required. 
This prior experience of insulin treatment has eased them into taking up insulin 
treatment as compared to those who have less awareness of the insulin devices.  
In a recently study conducted in Malaysia, participants agreed to initiation of 
insulin through learning about benefits of insulin from other peopleÕs 
experience. They affirmed that their acceptance became stronger as they 
personally experienced the benefits of insulin in terms of improved general 
health, well-being (Abu Hassan et al. 2013). These findings were supported by 
overseas research conducted by Hunt (Hunt et al. 1997). They showed that 
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previous personal experience, observations and interactions with others 
influence peopleÕs attitudes towards insulin, they concluded that T2DM 
patients are involved in an active process of assessing the expected benefits 
and costs of using insulin based on what they have seen and felt, as well as 
what they have heard from friends, family, and health professional.  
 
Prior exposure to insulin injection is a facilitator in my study to encourage 
insulin initiation, participants who had the opportunity to observe others using 
insulin appeared to manage T2DM accepting insulin with ease and this 
experience also helps them to alleviate their negative concerns and 
misconceptions about insulin injections. Support from relatives and friends 
who used insulin also promoted their insulin acceptance. PGÕs willingness to 
initiate insulin treatment was a result of support from patients who used 
insulin:  
 
PG: I wanted to go on insulin. I heard from other people that 
insulin would be a good solution for my problem and it actually 
turn out quite well. After trying it for the first three, four months I 
found [that] itÕs very good, the insulin is very good. Overall sugar 
comes down very fast. 
 
In addition, many participants also expressed their willingness to promote 
insulin treatment to others T2DM patients who are not able to control their 
blood sugar level. Four participants from the interviews were willing to use 
their own experience of using insulin treatment to encourage other T2DM to 
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use insulin for a better glycaemic control. BK and YF explained the positive 
effect of insulin treatment and used their own personal experience to promote 
and support their friends and family into accepting insulin treatment: 
 
BK: The advantage of using insulin, they [can] see it from me. This 
is something obvious, so all my sisters now are on insulin injection. 
 
YF: I am insulin user so you can take my advice. If I am not using 
insulin but I am telling you the good thing about insulin, then you 
can the doubt about my story.  
 
 
 
Experiential learning through observing T2DM patients coping well with 
insulin treatment and having positive effect of insulin can help other diabetes 
patients to alleviate their negative altitudes and misconceptions about insulin. 
Apart from the support and counselling by the healthcare providers, support 
from relatives and friends who use insulin also plays an important role in 
promoting insulin acceptance among T2DM patients.  
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4.3 Side Effect Profile 
In the interviews, many participants talked about the side effects of ÔwesternÕ 
medicines. In general Malaysian patients have the notion that ÔWesternÕ 
medicines can harm the body because they are synthetic and made from 
chemical substances (Jose et al. 2011; Babar et al. 2012). In this study, one of 
the facilitators for insulin acceptance is that many participants worried about 
the side effect of oral anti-diabetic medication (OAM).  They think that oral 
tablets would cause undesired effect to the body organs if they take them for a 
long period of time. Especially medication for chronic illnesses that patients 
have to take on a long-term basis, they are said to ÔweakenÕ the body system 
(Ariff & Beng 2006): 
 
SR: [Oral] medication I came to know that there are a lot of side 
effects. So, I think insulin is much better compared to [oral]É So 
when I came in to see the doctor, they [also advised me that] the 
medication doesnÕt help for long term, it got side effects and all 
that. When I heard that, I decided to take up insulin. 
 
 
YF: Yes, I have asked around. I have considered that taking all the 
medication is not good for my body so I had been thinking of using 
injection.  
 
 
This negative perception of ÔwesternÕ medicine was also reported by diabetes 
patients in a study conducted in Taiwan (Lai et al. 2005) as well as  in western 
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countries. A meta-ethnographic study among English speaking countries 
highlighted that non-adherence to medication could be due to negative 
concerns of the potential harm from taking medicines on a long-term basis 
(Pound et al. 2005). This notion that western medication for chronic diseases 
would cause organ damage is universal rather than culturally specific. In my 
interviews, participants showed worries taking oral tablets because they 
believed that oral medication could cause undesired effects to body organs 
such as liver, kidney and pancreas: 
 
ET: Insulin is better. Actually with tablets I donÕt think it is good. It 
will affect our liver, affect our body organsÉ With modern 
medicine nowadays, it will affect your body parts; I know that most 
of the medicine will.  
 
LV: Because tablet I heard it will it can spoil your pancreas, I 
heard but not sure if it is true [or not]. 
 
WM: if I were taking the medicine... the pills, I was more worried 
then! So much of this pills then the cholesterol pill and then they 
wanted to put me on high blood pressure pill, but I told them I 
didnÕt want to add that one on. Because I saw all these things that 
will damage my kidney, I was more worried about the pills. 
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With the notion that oral medication could ÔdepositÕ in the body organs causing 
unwanted side effect, most of patients find that insulin is more straightforward 
and therefore it is more acceptable to initiate insulin treatment. Participants not 
only worried that oral medication could ÔdepositÕ in the body and cause organs 
failure, they also fed up with taking too many oral medications throughout the 
day: 
 
 
HH: I think if insulin is prescribed earlier to me, then I would end 
up with less medication to take. If I have started insulin first then I 
donÕt have to take so many medication 
 
BK: Insulin is better compared to tablet, do you know why? 
Because with insulin, I only have to inject it in the morning, and 
then once at nighttime. But with pills, I have [taken] the diabetes 
pills a few times a day and I already on so many other pills for my 
heart and others problems. I counted I need like 10 medication! 
Sometimes I am felt very angry because I have so many tablets to 
take.  
 
LT: You see, everyday I have to take 17 tablets! I need to count this 
numberÉ morning one session, afternoon one session then night 
one session. So nevertheless it is crazy, because I also have 
hypertension. So everything all add up about 17 to 20 tablets per 
day. My box is almost full, cannot fit anymore already. I was 
thinking that I might as well go for insulin.  
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NA: I feel it is better to use insulin than tablet. I was taking too 
many types of tablets. I have tablets for cholesterol and high blood 
pressure. So, I am taking many tablets... Maybe the tablets É  have 
effect on stomach, uncomfortable. 
 
T2DM often presented in patients with multiple health conditions such as 
hypertension and dyslipidaemia.  Hypertension is a common comorbidity of 
diabetes and the prevalence of hypertension is reported near 80% among 
diabetes patients in Malaysia (Ministry of Health Malaysia 2009; Blonde 
2005). Because the notion that oral medication will go through the body 
systems therefore causing harm to the organs, taking multiple medications will 
furthermore multiply their fears of taking medication. As a result, many 
participants in this study preferred to use injection as they think that injection 
Ôgoes directlyÕ into their body system. Participants believed that insulin is 
injected directly into the blood stream and exerts its effect by lowering the 
blood sugar. Therefore insulin injection would not Ôgo throughÕ or ÔdepositÕ in 
other body organs, as a result it is perceived to have has fewer side effects 
compared to oral medication and it could ÔpreserveÕ kidneys and other vital 
organs.  
 
MM: Because for long run of taking tablet, got side effects. But 
with this insulin, it goes direct... For long run, [oral tablet can 
cause] side effect. Because this insulin, it goes direct, so it doesnÕt 
[go around your body organ]. 
 
 107 
 
RK: Because the tablet doesnÕt work. So they want to use the 
insulin to fast into the blood stream and control [diabetes]. 
Tablets, I think will take certain hours to go inside the blood 
stream, insulin goes straight into your blood. Once insulin goes in, 
I can feel the effect. É It is better than tablet. Because insulin goes 
direct, and we can feel the effect.  
 
YP also explained in the interview that oral medication would go through 
kidneys and would subsequently be excreted through urine, therefore he 
believed that the drugs would ÔdepositÕ in the kidneys, which could lead to 
kidney failure. Whereas insulin is injected directly into the blood stream and 
directly lower blood sugar level, therefore it would not harm the kidney. This 
notion may also be accentuated by the metaphor of the kidney in Chinese 
culture (Lai et al. 2007). The kidney is seen as a vital organ containing the 
inherited Ôvital essenceÕ and sperm. Medication, which goes through kidney, is 
therefore causing loss of vital essence, and leads to a shortened lifespan. 
 
YP: Plus also too much drugs goes through the kidneys and all 
that. Maybe it is a concluded fact or not I donÕt know but to me 
anything that goes through the kidney gets deposited there, is not 
as good as something that goes right through to the bloodstream. 
So in a way I think why not, I was prepared and asking the doctor 
to give insulin to meÉ If it works and it doesnÕt go through the 
kidney, it just goes directly into the bloodstream and does its works 
there, that's all that matters to me. 
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Healthcare providers have a great influence on patients understanding of how 
insulin works. Using simplified explanation of how insulin is delivered into the 
body, healthcare providers can alleviate many of the participantsÕ concerns 
about insulin. In addition, good healthcare provider-patient relationships will 
contribute to achieving long term treatment targets for both the patient and 
healthcare provider (Abu Hassan et al. 2013). As non-adherent patients 
frequently felt their healthcare provider had not adequately explained the risks 
and benefits of insulin. Good interactions and interpersonal relationships 
between patients and their healthcare providers had been found to be the main 
promoters for insulin initiation (Abu Hassan et al. 2013; Hunt et al. 1997; Nair 
et al. 2007). The importance of good doctor-patient communication is 
underscored by the association between insulin initiation and health literacy 
(Karter et al. 2010).  
 
The initial patient education program should be simplified and tailored to the 
individual patient. As reported by many participants a simplified explanation 
of how insulin works promotes the acceptance of insulin treatment. The 
guidelines for insulin initiation should be simplified and delivered together 
with tailored, individualised counselling. Studies show that initiating insulin 
may be successful when appropriate glycaemic targets are chosen and a 
systematic titration of insulin dosage is agreed on by both the healthcare 
provider and patient (Meece 2006). There should not be a mandate to 
aggressively titrate insulin therapy as this might create a barrier with the 
patients. As reported by MZ in the interview that she felt that the pharmacist-
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lead diabetic counselling program at the public hospital was too strict with her 
glycaemic target which put her off: 
 
MZ: They (pharmacists) really control stringently! Sometimes it 
put me off. They are even worst than the doctor, when come to 
think of it. Even my doctor, my specialists donÕt do in that manner.  
 
 
LR, LV and LT had sought opinion from healthcare provider on insulin 
treatment, the information on insulin were explained in a simple term, which 
tailored to their understanding. After they learned that exogenous insulin is 
replacing the ÔlostÕ endogenous insulin, which their body could no longer 
produce; their negative concerns on insulin dismissed:  
 
LR: And I asked the doctor, when I go visit my normal GP in my 
housing area, I asked her what happens if we take insulin. She 
said, ÒVery good, it goes directly into the bloodstream and control 
your blood sugarÓ! 
 
 
LV: And then the doctor explained to me about the insulin. She 
said, ÒItÕs not bad, itÕs like replacing your insulin in your body, 
because your body not producing enough insulin.Ó So I said ok. 
 
 
 
LT: So I went to consult my panel clinic and asked Òhow about 
insulin? Is it a very bad thing or what?Ó He said ÒDonÕt think 
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about that, insulin is just a step ahead. If you are taking dosage 
tablets, is a one step behindÓÉ He said, ÒWhen you taking insulin, 
which is lost in your body, so you [are replacing] back directly, so 
itÕs one step aheadÓ. 
 
 
 
As reported by these participants, their explanations about how insulin works 
are comparatively simple and easy to comprehend; the explanation given is 
neither pharmacologically accurate nor scientific but it has been tailored to the 
understanding of the general public and is therefore more acceptable.  
 
It is highlighted by many studies that good interactions and interpersonal 
relationships between patients and their healthcare providers are vital for 
building trust and effective communication, which will promote better health 
outcome by increase medication adherence and better disease control (Abu 
Hassan et al. 2013; Hunt et al. 1997; Nair et al. 2007; Karter et al. 2010; 
Adolfsson et al. 2008). Apart from building a good interaction and 
interpersonal relationship with patients, health professionals must also take 
into account the cultural influences in medicine. Peyrot (2012) suggested that 
country differences reflect the interplay of cultural beliefs, healthcare provider 
training and health system characteristics. Ethnic and cultural considerations 
should be highlighted and to be integrated into the health delivery system in 
Malaysia to further improve care and health outcomes (Ariff & Beng 2006).  
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4.4 Quality of Life: Thinking of Future 
Another prominent facilitator that encourages participants to accept insulin 
treatment is to achieve optimal control of T2DM. The motivators behind this 
facilitator are to prevent diabetes complications and thinking about the future 
and well-being. Many participants mentioned in the interviews that they agreed 
to initiate insulin because they want to live a healthier, longer life: 
 
CH: Because you know about in the future you will get something 
probably affect other organs and all theseÉ Whatever 
[complication] in the future, anything that will be affected. 
 
LM: Get a better health. Like your eyes, kidney, and all that. 
Depending on [insulin], if you want a good health...  I have to live 
for the rest of the life well.  
 
LV: If I take insulin now, and then I will be ok in the future. I am 
talking about like 10 years... You need to see for the future... We 
have to look for the future, diabetics and this and that. 
 
 
There is a strong association between well being and diabetes complications. 
Diabetes complications are one of the predictors for T2DM patients to seek 
insulin treatment, as they want a better quality of life. A few participants in the 
interview understand that insulin treatment is effective to improve glycaemic 
control and to diminish future diabetes complications and therefore agreed to 
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initiate insulin treatment. They were not scared about insulin injections; in fact, 
they were more scared to suffer from diabetes complication and symptoms:   
 
AZ: And then I started feeling numbness on my feet. That is the 
reason why I said ok, why not take insulinÉ Because I could not 
feel my feet, I was numbÉ the medication, because I need this. 
 
NR: To prevent more complicationÉ  I was very worry that sooner 
or later my kidney will die off. So I have to accept the treatment. 
 
MY: I am worry only about kidney. I am not worry about the 
insulin. Doctor said your kidney a little bit affected.  
 
However, some patients who accepted insulin treatment to prevent diabetes 
complications had a negative attitude as they often felt that they had no choice 
but to use insulin. This negative attitude is also reflected by other participants 
who had close relatives suffered T2DM complication, which resulted 
unpleasant experiences:   
 
YLC: Maybe my brother case, because his legs are all blacken, he 
had trimmed off one of his toe. The doctor did say that he wanted 
to trim [the leg]. É That maybe triggers me, before that also 
trigger me that I feel like I do not want to suffer like himÉ  
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LR: Because I have a family member, my uncle recently passed 
away. His eye was completely blind, kidney damaged, heart was 
swollen, he canÕt walk and he was bedridden.  
 
 
These participants understand that diabetes complications could affect their 
quality of life and therefore they had to accept insulin treatment in turn for 
better glycaemic control. As mentioned by Peyrot (2005) in a multinational 
study, as patientsÕ diabetes controls worsen, they may become more receptive 
to a treatment strategy they have previously avoided. In this instance, 
participants became more receptive to insulin treatment that they would have 
previously avoided. At least six patients expressed that they had no choice but 
to start on insulin treatment: 
 
CH: We have no choice you have consider that, we get the sickness 
already then we have to [take] medicationÉ We have to put 
[insulin], no choice, we have no choiceÉ. Because when the time 
tablet cannot control, you have to go to insulinÉ Of course we 
donÕt like to put a needle. But the thing is I want it to be better, I 
have no choice. 
 
HT: Because, because I got no choice already. Because I have 
come to a stage that the tablet doesnÕt work, is either you have to 
use it by all mean because the tablet had been changing from 
dosage, had been changing from brand, still noÉno effectiveness. 
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If I got the choice, but I got no choice, is either you like it or you 
donÕt like it, you have to use [insulin]. 
 
ZT: What can I do? I have no choice; since the tablet is not 
effective the only way is to use insulin. What else can I do? If the 
tablet canÕt control our blood sugar well, and [if] I donÕt want to 
use insulin, I will die faster!  
 
The participants explained that if they had a choice they would not use insulin. 
They felt that they had no other alternatives and were forced into accepting 
insulin treatment. Lai et al. (2007) reported in their qualitative research that 
many patients wrongly assumed that the T2DM progressed in a step-by-step, 
uni-dimensional manner. Therefore, insulin to many patients would mean the 
last resort when other agents failed to control their T2DM. Similarly in this 
study, the participants knew that insulin would be their last resort when tablets 
failed to control their blood glucose level. As mentioned by ZT, Òif I don't 
want to use insulin, I will die faster!Ó  This shows again the importance of 
good healthcare provider-patient communication. When discussing the 
initiation of insulin treatment, it is essential to ask patients about their thoughts 
or feelings about insulin. Many studies have reported that starting insulin 
treatment is often perceived as a personal failure; patients often felt a strong 
sense of failure when it was suggested for them to go on insulin treatment 
(Polonsky et al. 2005; Brod et al. 2009; Korytkowski 2002; Neumiller et al. 
2009; Morris et al. 2005). It is essential to understand patientsÕ thoughts or 
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feelings about insulin to ensure that counselling about insulin is supportive, 
tailored for each individual patient, and effective (Funnell 2007).  
 
 
One of the powerful motivators to prompt participants into accepting insulin 
treatment is their bonding with their family and their wanting a better quality 
of life for the future. LR said that her reason to accept insulin treatment was 
due to the fact that she wanted to start building a family. She was certain that 
insulin treatment would improve her glycaemic control thus providing her a 
better quality of life:  
 
LR: Then they asked then Òwhy do you want to go for insulin?Ó I 
said because I wanted to get pregnant, I want to have a good 
lifestyleÉ  
 
 
Some older participants accepted insulin treatment because they want to 
improve their physical well-being. They were not only wanting a better quality 
of life but also not to burden their family members. As described by the 
participants below, they have a strong connection with their family members 
and that is their motivators to stay healthy. They mentioned about Ôgreat 
grandchildrenÕ, Ôlonger lifeÕ, Ôuntil end of the dayÕ which suggested that they 
are thinking about their future with their families in long run.  
 
 
S: And I got great grandchildren. I feel that I should take care of 
myself. 
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YLC: I should follow this way, I should monitor. At least I have aÉ 
longer lifeÉ something that you can take care of your own self. 
 
LR: I definitely donÕt want to be like this. I donÕt want to torture 
anybody else; I want to be on my own self until the end of the day.  
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4.5 Chapter Summary 
 
Healthcare providers affirmed that an early intervention of insulin treatment 
could prevent or delay complications for most patients, however some still are 
reluctant to prescribe insulin because of worries about the risks of 
hypoglycaemia and weight gain (Hayes et al. 2008). In addition, delays in 
initiating insulin for T2DM might be due to uncertainty for healthcare 
providers about how best to make the transition from oral therapy to insulin 
treatment (Meece 2006). Therefore, by exploring patientsÕ experiences of using 
insulin they could review their concerns and beliefs about diabetes and insulin. 
The findings, especially the facilitators could be beneficial to assist healthcare 
providers in the diabetes field in delivering patient-centered care. As reported 
by the participants in this study and also in Abu Hassan and colleaguesÕ study, 
one of the facilitators for T2DM patients to accept insulin treatment is their 
concern about complications of poorly controlled diabetes and the side effects 
of other treatment regimes (Abu Hassan et al. 2013). These findings could be 
used in educating T2DM patients and raising their awareness of disease 
prevention, and also best used as a facilitator to initiate insulin treatment for 
those insulin-nave patients.  
 
In some instances, T2DM patients think that diabetes in a uni-dimensional 
manner; they considered the disease as progressing uni-dimensionally and that 
the perceived severity could be measured on a uni-dimensional scale. 
Therefore this poses as an obstacle when discussing initiation of insulin 
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treatment to T2DM patients. As reported by many studies, many T2DM 
patients think that insulin is for severe diabetes or used as a last resort and even 
worse is thinking that the need for insulin reflects a personal failure (Polonsky 
et al. 2005; Neumiller et al. 2009; Abu Hassan et al. 2013; Brod et al. 2009). 
As a result, initiating insulin would signify that they do not have any other 
option but to accept insulin treatment. This negative perception obviously will 
cause resistance to insulin treatment and often will have a negative impact on a 
patientsÕ emotional well-being. Meece (2006) suggested that healthcare 
providers need to reveal this particular reason for insulin resistance by having 
appropriate conversations with the patients. Healthcare providers need to be 
aware of culturally sensitive issues and to be aware of the patientÕs perspective, 
and use every opportunity for education and clarification.  In addition to early 
education on T2DM, which should be tailored and individualised; continuous 
educations as well as practical and emotional support from others are valuable 
for insulin acceptance (Abu Hassan et al. 2013).  
 
For some patients, their first exposure to insulin was via a relative who used 
insulin as part of their T2DM management. It is shown in this study that this 
might be a positive facilitator for insulin acceptance. Experiential learning 
through observing their relative coping well with insulin treatment can help the 
patients to alleviate their negative altitudes and misconceptions about insulin. 
Practical as well as emotional support is not only confined to healthcare 
providers, support from relatives and friends who used insulin also play a 
crucial role in promoting insulin acceptance among T2DM patients.  
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CHAPTER 5  
BARRIERS TO INSULIN INJECTION 
 
5.1 Introduction 
During the interviews, one of the objectives was to explore patientsÕ reactions 
toward initiation of insulin treatment. Semi-structured interview questions 
were used to explore patientsÕ perspectives of insulin treatment. In the 
following sections, I will be discussing the negative perspectives of insulin 
treatment, which acted as a barrier and resulted in low acceptance of and non-
adherence to insulin treatment.  
 
Reluctance to accept insulin treatment in T2DM patients has been examined in 
several studies, the term psychological insulin resistant (PIR) is used to define 
this psychological opposition towards insulin injection (Brod et al. 2009; 
Polonsky et al. 2005; Korytkowski 2002; Peyrot et al. 2005; Snoek 2001). 
Many participants reported that their negative perspectives of insulin treatment 
are due to their lack of knowledge of modern insulin pen devices and also 
miss-information on the availability of modern insulin pen devices and 
injection process involved.  
 
In the following sections, I will be discussing the influences of Malaysian 
society on the use of insulin injection, and how the participants anticipate it. 
This is followed by the discussion about how lack of awareness and knowledge 
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of modern insulin pen devices resulted in needle phobia, and how past 
experiences with injections influence peopleÕs knowledge of insulin injection, 
and the fears faced by participants when handling insulin injections. 
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5.2 Personal Failure 
 
In this study, thirteen participants had commented that their first impression of 
insulin injections was that injections are meant for severe, uncontrolled 
disease. In addition, many T2DM patients have the notion that T2DM 
progressed in a step-by-step, uni-dimensional manner as mentioned in section 
4.4. When discussed switching from oral anti-diabetic medication to insulin 
injection, patients often felt reluctance because of the use of an injection.  
Patients felt that tablets are generally used for Ònon-acute conditionsÓ while 
injections are reserved for Òserious conditionsÓ (Brod et al. 2009; Polonsky et 
al. 2005; Korytkowski 2002; Peyrot et al. 2005; Snoek 2001). As a result, 
many T2DM patients think that initiating insulin treatment signified that they 
have failed to control their health and have reached a critical state and this 
created a strong sense of personal failure (Polonsky et al. 2005; Brod et al. 
2009; Korytkowski 2002; Neumiller et al. 2009; Morris et al. 2005).  
 
In the interview with participant ZA, her impression of insulin injections was 
that insulin is indicated for severe cases. She used the word ÔterukÕ in local 
language to emphasise that insulin is indicated for those T2DM patients in a 
severe, terrible state of uncontrolled diabetes.  
 
ZA: I would think insulin when teruk (terrible), I mean [when] the 
diabetes is very, very bad then  [only] you should take insulin.  
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Many participants think that T2DM progressed in a uni-dimensional manner; 
therefore they think that insulin injections are only used in the last resort. In 
the interview with CH, he mentioned that to use insulin injections signified the 
Ôfinal stageÕ of diabetes; ÔnormalÕ people or patients with well-controlled 
T2DM will not require insulin injections: 
 
CH: I know that patient [who] is serious, and then only you need to 
use insulin. Normal people they donÕt need insulin... That is the 
final stage already; you have no other way, to do anything already. 
 
 
CH expressed that he has failed to control his diabetes and he has no other 
option but to use insulin injections. He illustrated that initiating insulin 
treatment was like a personal failure. It is a common finding which is also 
reported by other studies that patients often perceive insulin to be the last 
option of treatment, or a form of punishment, or a failure of their own doing 
(Polonsky et al. 2005; Brod et al. 2009; Korytkowski 2002; Neumiller et al. 
2009; Morris et al. 2005).  Personal failure is one negative perception often 
reported by studies as a common barrier to initiating insulin treatment. Nur 
Azmiah et al. (2011) reported that the most frequently expressed negative 
attitudes by Malaysian T2DM patients were personal failure (59.2%). In my 
study, participants expressed that this negative perception is often inflicted by 
the society: 
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LR: I have knowledge that people will say when you take insulin, 
that means your blood sugar is not under controlÉ Because people 
keep on saying [that] insulin is for people who have no control.  
 
LT: Older generation, they think insulin is [a] very dangerous 
thing! For them, it [means that] you are in critical stage already. 
 
SA: InsulinÉ they think it is very serious.  
 
 
Lee et al. (2012) documented that negative influences from family members 
has resulted in a barrier toward insulin initiation faced by Malaysian healthcare 
providers. Some participants in my study also reported that the comments from 
their friends and family have contributed to their negative perception of insulin 
treatment, which has magnified the negative attitudes and feelings of personal 
failure: 
 
SL: Yeah, some friends they know [that I am on insulin], but they 
[are] scared. They said: ÒWhy, your diabetes very high?Ó ÒWhy, 
your kidney got problem?Ó  
 
SR: Usual reaction for those who are not diabetic, they said Òso 
serious your diabetic!Ó  
 
 
Healthcare providers in Malaysia expressed that negative influences towards 
initiating insulin treatment and poor support from family members especially 
from their spouses have created a barrier for healthcare providers to suggest 
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insulin treatment to patients (Lee et al. 2012). One participant ZZ, who thought 
that insulin injection is for emergency use, his wife was Ônot very happyÕ when 
she learned that he needed insulin treatment. Her gestures implied that ZZ has 
failed to control his health and her lack of support has created the sense of guilt 
and personal failure for him, which resulted his reluctance to accept insulin 
treatment: 
 
ZZ: I thought it was very weird, [I thought insulin is] for very 
severe case that you have to go emergency. I didnÕt know that even 
for normal [patient] you can also use [insulin]É My wife was not 
very happy. She thought that I was notÉ it shows that you are not 
controlling to diabetes.  
 
Lack of knowledge and education about insulin injections have resulted in 
misconceptions about insulin treatment among Malaysian patients and the 
general public. The misconceptions about insulin injections in that they are 
reserved for severe cases or for emergency treatment has been reported by 
studies conducted in Malaysia and also overseas (Peyrot et al. 2005; Nur 
Azmiah et al. 2011; Abu Hassan et al. 2013; Hassali et al. 2013). These 
misconceptions are reflected in poor knowledge regarding diabetes and insulin 
in the general public in Malaysia, which not only resulted psychological 
insulin resistant in T2DM patients but also the negative altitude from the 
general public. The negative altitude and lack of support from family members 
and friends might contribute to the reluctance of initiation insulin treatment 
because of the stronger sense of personal failure. Therefore, healthcare 
providers must be equipped with effective counselling skills and prepared to 
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provide adequate information to ensure the delivery of diabetic education is 
effective, yet simplified and individualised to the patientsÕ needs. Early 
education at the point of diagnosis regarding the progressive nature of diabetes 
and function of insulin could mentally prepare T2DM patients and alleviate 
their misconceptions.  
 
Raising public awareness of T2DM and the role of insulin is vital to allay the 
negative attitude towards insulin treatment. Support from family members, 
relatives and friends plays an important role in encouraging insulin acceptance 
among T2DM patients. Lack of public awareness of insulin injection also 
resulted social stigma, which will be discussed in CHAPTER 7. 
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5.3 Past Experiences with Injection  
 
During the interviews, some participants reported that they have little 
knowledge about insulin devices especially the participants who did not have 
prior exposure to insulin injection. When insulin treatment was suggested, 
these participants would associate insulin injection with the needles and 
syringes used in media such as movies, or associated them with their bad 
experience in the past, such as from venepuncture or vaccinations (Tan et al. 
2011; Korytkowski 2002). Malaysian children are scheduled for immunisation 
at the age of 6 and later again at age of 15 (Ministry of Health Malaysia 2014). 
As a result, some participants expressed the fear of injection and their first 
impression of insulin injection would be ÔpainfulÕ, required long needles and 
might leave a scar: 
 
ZZ:  I think the most common misconception about people taking 
insulin is that of course it involves the injection part.  
 
LT: The main thing is people scared of needle, the feeling. When 
you are in standard 6 you will have a jab, BCG (vaccination). That 
bloody needle is damn painful. That is the main thing that makes 
people scared. They said Òjab? oh shit long needle!Ó 
 
The wrong perception of long, big needles involved with insulin injection has 
generated a high prevalence of needle phobia for many T2DM patients. Many 
patients with diabetes are initially apprehensive regarding self-injecting, about 
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one per cent of patients suffer from a phobia for injecting and about 5 per cent 
of patients experience emotional distress and feelings of disgust related to the 
self- injecting of insulin (Snoek 2001). Tan et al (2011) suggested that the 
needle phobia might be due to anxiety and not actual needle phobia. Healthcare 
providers should dissociate the bad experiences of previous injection 
encounters in order to address this psychological barrier. In addition, the route 
of administering of insulin should be discussed, patients should be informed 
the different between venepuncture and intra-muscular injection which often 
experience during immunisation, with that of subcutaneous insulin injection. 
The development of modern insulin pen devices also provides diabetes patients 
with an easy-to-use, convenient, and accurate method of insulin delivery 
(Griffin & Hieronymus 2002; Spollett 2008; Bohannon 1999). It provides less 
traumatic methods of insulin delivery, which reduce the complexity of insulin 
dosing and minimising pain associated during injection. The availability of 
finer, shorter needles could alleviate the pain of injections (Korytkowski 
2002).  
 
The association of insulin injections to past experiences with injections has 
contributed to the psychological insulin resistance. It also highlighted that most 
patients have a poor knowledge and awareness of modern insulin pen devices, 
thus some participants worried that they were not able to handle injecting 
insulin. This psychological barrier toward insulin injection is discussed in the 
next section. 
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5.4 Worry that They Cannot Handle Using Insulin 
Injection 
 
During the interviews, some participants reported that they have little 
knowledge about insulin devices especially the participants who did not have 
prior exposure to insulin injection. When insulin treatment was suggested, 
these participants would associate insulin injection with needles and syringes 
used in media such as movies. In movies, injection usually used in emergency 
or critical scenarios and often portrayed with big syringes and long needles. As 
a result, some participants associated insulin injection with critical stage of the 
diseases. ZZ explained in the interview that he learned about insulin injection 
from movies, and it was used in movies to treat patients at critical stage: 
 
ZZ: I get that information of course from movies and every time 
you see people who are really serious [with] diabetes issues that 
they use insulin. That is I think just based on what was in the 
media. 
 
Lack of knowledge and awareness of modern insulin pen devices has 
contributed towards the barriers to initiate insulin treatment. Many participants 
in this study reported that before they started insulin treatment, they had little 
knowledge of what the insulin injection looks like or of the techniques used to 
administer insulin.  SA used the metaphor of Ôgoing into a dark roomÕ to 
reflect his experiences of first starting to use insulin injection: 
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SA: And when you have not use insulin before, it wasÉ  you donÕt 
know you are going into a dark room. You donÕt know what is 
going to happen. 
 
 
The influences of the media also resulted in some participants thinking that 
injections required comprehensive training and that they were only able to be 
administered by healthcare providers because of what they have seen in the 
media: injections often given by doctor or highly trained healthcare providers. 
Patients with T2DM often considered initiating insulin treatment as a complex 
and complicated task and this caused the reluctance and delay in insulin 
treatment (Lee et al. 2012). Patients were also concerned that insulin treatment 
might add to the burden and stress that they already experience from managing 
diabetes on a daily basis, and therefore they do not feel confident that they can 
handle the day-to-day demands of insulin injections (Brod et al. 2009; 
Polonsky et al. 2005). Participants from the interviews reported that they were 
very concerned initially because they had no knowledge of insulin injections 
and they thought that injections required highly skilled techniques and it is a 
complicated task. Therefore they were worried that they would not be 
confident in handling this complex task of injecting: 
 
LV: I scared you know. I donÕt know how to [handle it]É  
 
S: Initially I [was] worried on how to handle the injection but then 
slowly you become more of an expert.  
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Many participants reported that their initial thoughts about insulin injections 
were associated with long needles, vials and syringes. Furthermore they 
thought that it is a complex and invasive task requiring training on 
withdrawing insulin from vials or bottle and skilful injecting technique. PG 
expressed his initial hesitation with insulin injection because he had not been 
shown the modern insulin pen devices. He visualised insulin injecting uses big 
needles and therefore worried how he could handle injecting himself: 
 
PG: Before I started insulin, I canÕt even imagine what the needle 
look like. There is no education to show that actually it is just a 
very small needle only, not a very big needle. You know, people 
[might] think ÒWah the bloody big needle, donÕt know how to jabÓ. 
Initially I think [like that too]É People donÕt know what they are 
getting into. 
 
 
SA: I was quite hesitant. Because, because the needle is too long 
and have to withdraw insulin from the É  Vial and all those things.  
 
A few participants explained that their impression of insulin injections were 
associated with the older, traditional insulin injections that involved needles, 
glass vials and plastic syringes. This can be attributed to the fact that there is a 
lack of educational campaigns or channels for promoting the modern insulin 
pen devices.  A few participants reported that the traditional insulin injections 
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had a negative role which discouraging T2DM patients in accepting insulin 
treatment because of its complicated procedure and invasive: 
 
MM: But with these new devices, only recent year I know about it. 
Before was, the bottle, the syringe, withdraw from the bottle, my 
god! [That was] 10 years ago! 
 
TC: No, but maybe the earlier form of insulin injection probably 
gave people a wrong idea. Those days we had this syringe and 
vials and all that.  
 
Diabetes patients have a high prevalence of psychological insulin resistance 
(PIR); patients often worry about technical concerns, fear that injections will 
be painful, fear of inflicting self-harm, fear of self-injecting or dislike of daily 
injections (Mollema et al. 2001; Zambanini et al. 1999; Brod et al. 
2009)(Hassali et al. 2013). During the interviews, participants were asked 
about their first reaction to insulin treatment, a few participants expressed their 
initial fear was due to having to self-inject insulin. This could also attribute to 
the lack of knowledge of modern insulin pen devices and the ease of using the 
pen devices.  
 
MZ: People are scared. I was scared initially also [because] I have 
to jab myself. 
 
LV: They explained but you know it is the first time we have to use 
it ourselves.  
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Psychological insulin resistance such as fear of self-injecting should be 
addressed and discussed when initiating patients on insulin. Breaking the 
barriers and understanding the needs and concerns of individual patients could 
facilitate healthcare providers to assist patients to overcome psychological 
barriers to insulin treatment.  Early education focusing on diabetes disease and 
its progressive nature would have mentally prepared T2DM patients into 
accepting insulin treatment later in the disease course. T2DM patients should 
be made aware the availability of modern insulin pen devices and the function 
of insulin, which would allay the image of long needles associated with insulin 
injection. Many participants praised the new design of modern insulin pen 
devices; it not only alleviated the needle phobia but also make the injecting 
process simple: 
 
SA: No phobia, I think long before gone. The needle it is so fine, so 
thin, thatÕs convenient. I think people are ok. Formal needle used 
to be that long, that they need the vial, and then depends on the 
angle, you could draw more, draw less. How you [handle it]É 
 
E: Not so hard. Easier now with the new pen, the new pen is 
simple. Simple, after you use and then you throw away. 
 
S: But once you started on the pen, the pen make it easier for you. 
Because once it has been used, you don't have to refrigerate itÉ 
Now this is, this is very easy, you set the dial, you cannot go wrong, 
unless you donÕt know how to read one two three four. Just set the 
dialÉ 
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There is an increase in the range of modern insulin delivery systems, which 
have revolutionised insulin self-care. New modern insulin pen devices provide 
diabetes patient with an easy-to-use, convenient, and accurate method of 
insulin delivery (Griffin & Hieronymus 2002; Spollett 2008; Bohannon 1999).   
There are two types of insulin pens available in Malaysia: prefilled and 
reusable. Prefilled insulin pens are prescribed and dispensed to the patients 
from the majority of Malaysian public hospitals. The availability of the modern 
insulin pen devices should ease the patientsÕ concerns about handling insulin 
injection. It should be made aware during the early diabetes education together 
with knowledge on the progressive nature of T2DM. Education and hands-on 
practise with a placebo should alleviate their fear and anxiety (Griffin & 
Hieronymus 2002; Spollett 2008; Bohannon 1999). However, the information 
should be simplified and individualised. Patients might be overwhelmed by the 
instructions and were not confident to handle injections.  
 
 134 
5.5 Chapter Summary 
One of the aims of this study is to explore patientsÕ perspectives of insulin 
treatment. In this chapter, I have highlighted the negative perspectives of 
insulin treatment faced by the participants. These negative perspectives such as 
sense of personal failure, fear of self-injection, influence from past bad 
experience with injection, have resulted in psychological insulin resistance 
(PIR) and act as barriers toward insulin treatment (see Figure 6 Barriers to 
initiate insulin treatment). The lack of knowledge and awareness of modern 
insulin pen devices has further hindered the acceptance of insulin treatment 
among T2DM patients; this is further discussed in section 8.1 Practice 
Implications.  Patients would associate the needles used in insulin injections 
with the long needles portrayed in movies or from their past experiences, thus 
some patients had initial doubts and worries that they were not capable of 
handling insulin injecting without medical assistance.  They perceived that 
injecting insulin was a complicated procedure, which required intensive 
technical training and precision. 
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Figure 6 Barriers to initiate insulin treatment 
 
Figure 6 above summarised the factors lead to PIR among T2DM patients, and 
the suggestions that could potentially alleviate these barriers.  
 
PIR should be addressed at the early stage of T2DM by trained healthcare 
providers through education focusing on the nature of T2DM and also the role 
of insulin. Early, simplified and tailored diabetes education should make 
T2DM patients more aware of their health condition and the function of insulin 
and better prepare them mentally for insulin treatment. Emphasis should be 
placed on practical and emotional support in order to help patients to accept 
insulin and become more self-efficient to use insulin injection. On the other 
hand, educational campaigns to raise the public awareness of T2DM and 
promote the availability of modern insulin pen devices could alleviate the 
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negative perception of insulin treatment; subsequently ease the patients to be 
more acceptable about injecting, and also encourage the society to be more 
open minded towards insulin treatment. 
 
PatientsÕ perception of insulin treatment might change over the time, their 
reluctance to accept insulin treatment is also dynamic, therefore they might be 
more willing to accept insulin treatment (Tan et al. 2011). Healthcare providers 
should follow up with patients who were once reluctant to initiate insulin 
treatment. As patientsÕ perceptions of insulin treatment might change, in the 
next chapter I will be discussing how patients cope with the introduction of 
insulin injection into their T2DM management. 
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CHAPTER 6  
COPING WITH INSULIN TREATMENT 
 
6.1 Introduction 
This qualitative study aimed to examine the insight of Type 2 diabetes patients, 
and explored their lived-experience of using insulin treatment as part of their 
diabetes management. One of the aims is to explore how patientsÕ attitudes 
toward insulin treatment changed with their experience. In this chapter, I will 
be discussing how the participants coped with the introduction of insulin 
injection into their diabetes management. 
 
From the data analysis, a few prominent themes have emerged which either 
encourage participants to adhere to their insulin treatment or posed as an 
obstacle for insulin compliance. One prominent theme suggested participants 
often make lifestyle adjustment to adapt insulin injection into their existing 
diabetes management routine, despite a few participants feeling that they have 
been forced into accepting insulin treatment. Many participants expressed the 
restrictions and inconveniences to their daily life as a result of the initiation of 
insulin treatment.  
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6.2 Restriction of Lifestyle 
One of the strong themes from the interviews is that insulin injections 
restricted their lifestyle. Many participants complained that insulin treatment 
causes many inconveniences to their day-to-day activities, and also restricted 
them from travelling. Lifestyle restrictions have been reported in many studies 
as a barrier to initiate insulin treatment and has a negative impact on their 
social life (Abu Hassan et al. 2013; Karter et al. 2010; Brod et al. 2009; Morris 
et al. 2005). Patients perceived that insulin injections would Ôtake overÕ and 
Ôcontrol their livesÕ (Morris et al. 2005; Polonsky & Jackson 2004). In my 
study, AM affirmed that insulin treatment had a great impact on his life and he 
feels as if the insulin injection is taking control of his life. He expressed that he 
is deliberately not bringing his insulin injection with him when going out of his 
home however he was very concerned about the effect of food on his blood 
sugar levels. To avoid the dilemma, he had to give up his social life and was 
staying at home more often and he expressed that he felt like it was a big 
commitment to manage T2DM: 
 
AM: Until now [if] I want to go somewhere, I donÕt bring it. But we 
will be concern of what not to eat. But our body, blood sugar is 
high, we cannot control. That is why, I am doing less now, I go out 
less, just stay at homeÉ Less travelling, less. Before I can go, 
travel anywhere. Now all has reduced. Now just stay at home 
alone. Nothing much happening, our activity also reduced, I donÕt 
go socialising tooÉ We have to commitÉ to the disease.  
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One of the common inconveniences faced by participants while using insulin 
treatment is to carry and taking care of insulin injections while travelling. As 
expressed by AM that he had to give up his social life and commit to the 
diseases, many participants reported that they travel less because of using 
insulin injections. They felt that to carry insulin injections while travelling is 
an extra responsibility: 
 
LM: I am finding it difficult, because I travel a bit of here and 
there... Sometime I forget to pack my injection, especially for the 
lunchtime dose.  
 
S: I was not very keen. Because insulin you got to carry your 
insulin here and there. 
 
AM: I feel like the injection had restricted my activities, meaning 
that I cannot go anywhere freely, like holidays or outstation or 
even to Haji. Felt like we cannot do that anymore. If taking pills is 
much easier, before we take lunch or dinner, we just take the pills.  
 
MJ: A bit uncomfortable with it because you want to travel. For 
example [if] you want to go on holiday, you got to carry the pen 
along and put it in a briefcase and carry that. If you forgot, you 
cannot use the insulin. But for tablet itÕs easy.  
 
Travelling is one vital factors affecting non-adherence to insulin treatment as 
reported by Peyrot et al (2012). 43.6% of physicians and 16.2% of participants 
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agreed that travelling is the second most common reasons for insulin omission. 
One of the reasons why they felt that insulin injections restricted their 
travelling was because they had to pack all the necessary medical equipment 
such as extra needles, alcohol wipes, glucometers and others accessories. As 
commented by AM and MJ, they were comparing insulin injection with taking 
oral tablets. They were concerned that there are too many accessories that they 
had to remember to pack with their insulin injection despite the use of modern 
insulin pen devices. They expressed that they had to remember to pack Ôthis 
and thatÕ and bring along Ôall theseÕ with their insulin injection when they were 
planning to travel:  
 
CH: Sometime [when] you [are] travelling, you [have to] bring 
along your jab, your insulin and this and that; got a lot of 
problems. You take tablet, [it is] easier to carry, convenient. 
 
HT: Because I thought is very inconvenient, you have to inject and 
you have to bring your pen along all these, carry all these. 
 
AZ: Basically, because I have been travelling a lot for work. But it 
is ok. Because they know, I will show them the syringe and they 
said that is ok. But you canÕt carry too many needles. CanÕt carry 
too many, maybe can carry like two. Because I think, [it is] for 
security reason.  
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The other factors that restricted participantsÕ travelling plans were the 
changing of their dietary patterns especially when they traveled to a foreign 
country. As explained by LT, besides having to bring the accessories with 
insulin injection, he was concerned with the food and insulin dosage: 
 
LT: So beside that, insulin is kind of a trouble if you travelÉ 
because you go to different places, you eat different things.  
 
 
As a result of these restrictions, some participants felt that their lives have been 
ÔcontrolledÕ by insulin injection, they felt that they are ÔdependentÕ on insulin, 
giving the sense of insulin treatment taking over their life. T2DM patients who 
are on insulin treatment are often concerned about the inconveniences and 
complexities associated with insulin treatment especially those using short-
acting human regular insulin (Meece 2006). Patients have to know exactly 
what they will be eating and the timing of their meals as well. Similar to LTÕs 
experiences of travelling to foreign countries and eating different foods, MZ 
explained how her insulin injections affected her life especially when she 
needs to dine out or when having to attend social functions: 
 
MZ: Insulin we have to take it before food. If you go out for dinner 
and lunch, that makes it inconvenience, you have to jab before you 
eatÉ Because you have to jab before you eat. Sometimes, you jab 
at home; you think that you are on time for your food [when you 
go] outside. [But] only when you go out, you have all this function 
[and] it is difficult. 
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As illustrated in MZÕs case, insulin injections have caused an unnecessary 
restriction on her social lifestyle. And this restriction of her social lifestyle 
leads to non-adherence of insulin treatment. Funnell (2007) reported that other 
lifestyle concerns are related to timing, difficulty in travelling, and loss of 
spontaneity and flexibility. As reported by YF in the interview, he felt that the 
inconvenience cause by insulin treatment was not related to having to bring the 
insulin pen devices, but the loss of spontaneity and flexibility:  
 
   
YF: No, it is not because it is inconvenient to bring the insulin. It is 
because when I want to eat, I will eat. But you need to inject half 
an hour before you eat, I canÕt do that when I am with my clients. It 
is impossible to inject in front of your clients. 
 
 
Use of modern insulin pen devices has addresses many of the barriers to 
insulin treatment and offers substantial improvements in convenience, 
freedom, and flexibility; therefore improves patientsÕ satisfaction and 
adherence for all insulin-using diabetes patients (Spollett 2008; Bohannon 
1999; Meece 2008). Although many participants were concerned about the 
restriction of their lifestyle with the introduction of insulin injection, a few 
participants were delighted with the new modern design of the insulin pen 
devices. Participants acclaimed that the modern insulin pen devices provided 
by the hospital PH is discreet and easy to carry around, the insulin injection in 
pen design could easily fit in pockets and handbags: 
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SR: But then carrying a pen is not an issue; it is in a pen form.  You 
know the pen they are providing here, normally you can just put it 
in pocket, for the ladies just put it in their handbags.  
 
KK: Travelling wise, no problem. Because it is all in a pen form, in 
a pen form it is easy to carry around.  
 
MM: If I go travelling or what, no problem, I just bring one pen 
only. 
 
The availability of modern insulin pen devices has greatly improved the 
convenience, freedom, and flexibility as compared to the traditional insulin in 
vials. Quantitative research involved 1156 participants had reported that 
switching from administration of insulin therapy by vial/syringe to a prefilled 
insulin analogue pen device was associated with improved medication 
adherence, fewer claims for hypoglycaemic events, reduced emergency 
department and physician visits, and also lower annual treatment costs (Lee et 
al. 2006). T2DM patients should be made aware of modern insulin pen devices 
preferably at the initial counselling stage of T2DM to better prepared them 
mentally and also offering them an additional treatment option. During 
discussion on insulin treatment, it is important to consider that the addition of 
insulin injection might lead to lifestyle changes for some patients. The 
objective is to minimise a dramatic lifestyle change among T2DM patients, 
poor patientsÕ satisfaction with their treatment often lead to poor adherence, 
and therefore sub-optimal diabetes control.  
 144 
6.3 Timing of Injection 
For T2DM patients who are nave to insulin treatment, introduction of a basal 
insulin analogue is an excellent strategy when compared to complex regimens 
requiring multiple injections (Neumiller et al. 2009). Basal insulin analogue is 
a long acting, once- daily insulin injection that provides even more freedom 
and convenience and often favoured by patients. In my study, participants felt 
ÔblessedÕ when initiated with basal insulin injection, and most of them 
expressed that it was easy to manage and did not cause any inconvenience to 
their daily lifestyle: 
 
AH: My insulin, used to be three times a day. So now it has 
changed to once a day at nighttime, easier to manage.  
 
CH: So blessed that I only use it initial at nighttime, so I donÕt feel 
so much [of a] problem.  
 
NA: I donÕt feel inconvenient because I only jab at night only. I 
donÕt have the experience of jabbing in the daytime. I donÕt know 
how insulin in the day will affect me; maybe there will some 
restriction to the activities. Maybe have to stop some activities 
because of using insulin. Because I only take it at night, so no 
problem.  
 
 
For participants who required multiple injections in a day, they reported that 
insulin treatment resulted in many disruptions to their daily routines.  As a 
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consequence, participants frequently skip or manipulate the timing of their 
injection especially the afternoon dosage as it tend to interfere most with their 
daily activities:  
 
SL: Sometime I [will] missÉ sometimes [when] I go outside, If I go 
out, I [will] miss the afternoon one. 
 
LM: Sometime I forget to pack my injection, especially for the 
lunchtime dose.  
 
KK: But then insulin I only take it in the morning and eveningÉ 
Afternoon dosage I seldom take. 
 
YF: I inject every morning and night, and one in the 
afternoonÉthen the afternoon is with the timing of the meal too, 
something when I want to start eating but I have no time to inject. 
So I usually just inject once and I tend to skip my afternoon dose.  
 
 
In my study, many participants admitted that they had intentionally skipped 
their lunchtime insulin injection because of the timing of the injection. It is one 
of the biggest factors for non-adherence to insulin treatment. T2DM often 
requires significant lifestyle changes and multiple medications to manage 
blood glucose level and prevent complications. Adherence to prescribed 
therapies is a critical factor in the management of T2DM. Taking insulin 
injection at the prescribed time and frequency are identified as most common 
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difficulties by both patients and physicians (Peyrot et al. 2012). A review paper 
reported that a significant proportion of T2DM patients exhibit poor adherence 
that will contribute to less than optimal glycaemic control (Bailey & Kodack 
2011). Timing of medication is an important factor for poor adherence to the 
management of T2DM. The timing of the dose appears to be highly 
manipulated by participants, and most of them indicated that they took their 
medications daily but not at the exact recommended time (Al-Qazaz et al. 
2011).   
 
Awareness of insulin analogues with improved pharmacokinetic profiles is 
useful in clinical practice especially for T2DM patients who are nave and 
reluctant to insulin treatment because of the potential disturbance on their daily 
activities. Suggesting a basal insulin analogue initially for T2DM management 
is an excellent strategy to overcome the fear of Ôinsulin injection taking over 
their lifeÕ. Basal insulin analogue such as insulin glargine is a long acting, 
once- daily insulin injection which patient usually injects during nighttime at 
home, it provides freedom and convenience and causing minimum disruption 
to patientÕs daily activity.  
 
Healthcare providers in the diabetes field have a key role in promoting patient 
adherence with insulin treatment. T2DM patients often need more than 
emotional support but also practical information to increase their confidence in 
self-managing their T2DM (Stotland 2006). Healthcare providers should take 
initiative to ask about concerns relating to insulin dosing and take into account 
of individual patientsÕ needs and tailored the insulin treatment to fit into 
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patientsÕ lifestyle. Good communication between healthcare provider and 
patients to develop trust could overcome many barriers the T2DM patients 
might have relating to insulin therapy. 
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6.4 Getting Into a Routine 
During the interviews, participants were asked to express their fears or 
concerns about initiation of insulin treatment, at the same time they were asked 
about their solutions to overcome these fears and barriers. The literature 
revealed that resistance to initiate insulin or comply with insulin treatment over 
time may be affected by patientsÕ fear of restrictions required by insulin use 
and hence lifestyle adaptations (Brod et al. 2009). From the data analysis, 
participants had tried adjusting their lifestyle and adapted into using insulin 
injection. Although instructions and counselling were provided, some 
participants were still faced with a great challenge when they first tried to self-
inject insulin. However, with more time and increased experience, they were 
able to master the techniques and adapt into a routine of injecting insulin: 
 
MM: Before that, doctor asked [me] to use, I just followed the 
instruction. Only later I got to know more on how to control [diet 
and] how to adjust [dosage]. Because I am using it for many years, 
I know the dose well. After you eat, you know the [insulin] dose. 
 
YLC: They did teach me how, but during the first few times I really 
do not know how... Then later on, you realise which part of your 
body you should inject. Those part which the fats in it, those part 
without the fat will feel pain. 
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T2DM is a complex, progressive disease that can impact substantially on 
patientsÕ lifestyle and patients often require multiple medications to lower 
blood glucose, reduce cardiovascular risk and address comorbidities (Bailey & 
Kodack 2011). Together with other healthcare providers, pharmacists play a 
crucial role in helping T2DM patients ease into using insulin treatment (Drab 
2009). Pharmacists often have access to counsel T2DM patients on the timing 
of their medication. Participants in my study had mentioned that they could get 
into insulin routine fairy quickly if they knew how to arrange their timetable. 
Pharmacists could use this opportunity to work with these patients to organise 
the timing of their insulin injection in relation to other concurrent medication, 
and fit with their timing of meals and daily activities. As explained by MY, he 
had great difficulty when he first started using insulin injections in particular 
the timing of his insulin injections. However, he was able to get into routine 
after two weeks time. Another participant ZZ also reported the similar 
experience, which he was able to get used to the whole injection process in a 
few days.  
 
MY: At first you find it very difficult, because you [have to] know 
your timing you need to go for insulin. So after these two weeks, 
you know already, before lunch you have to take insulin, dinner 
you have to take insulin... Routine already. Before I felt very 
difficult, I had to see the timetable. Now automatically you know 
already.  
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ZZ: I mean just [take] a few days you have to get used to the whole 
process. But now I can do it in less than 1 minute. So it is not really 
an issueÉ It is faster and it is easier and it is just a matter of 
getting used to and really not an issue. 
 
 
S: Once you get used to it, it became part of a puzzle of your life 
already. So, it's nothing because you know how to plan such as 
how long you are going away, how much insulin you got to bring. 
 
Both practical and emotional support from healthcare providers is crucial to 
ensure patients are able to adapt into using insulin injection quickly. Practical 
skills and techniques of injecting insulin should be carefully demonstrated to 
T2DM patients who are willing to initiate insulin treatment to minimise the 
initial frustration. Without the advice on practicality, patients might find it 
difficult initially in coping with insulin treatment. MR complained that he was 
forced to change his daily routine because of the introduction of insulin 
treatment: 
 
MR: I can imagine a problem. Because during work and 
before sleeping I have to use insulin. So I was forced to 
arrange my timetable.  
 
 
MR expressed that he could predict the problem of the timing of insulin 
injection when he was prescribed insulin treatment. Healthcare providers 
should help T2DM patients to identify potential conflict and working with 
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patients to discuss the barriers of using insulin injection, and allow them to 
integrate insulin treatment into their daily life with minimal disruption. 
 
During the interviews, participants were asked about their fear of needles and 
self-injecting. I was interested to learn how they overcome the fear of needle or 
fear of self-injecting; participants reported the fear would slowly diminished 
after trying out the injection. They explained that the fear of needles was a 
Ôtemporary psychologicalÕ factor, after injecting a few times, they would be 
more comfortable with injecting and subsequently just getting used to insulin 
injection: 
 
ZM: Yes, I was scared. The needle! I have to inject myself with the 
needle right? Needle must bring pain! It looked painful, but after a 
while I get used to it. 
 
INTERVIEWER: You donÕt have fear of needle? 
MM: No, I get used to it. I am used to it. Yes at that time, at that 
time the needle is this long. Now even better, you are used to it, 
thatÕs all.  
 
 
YHK: Time, after sometime you will get used to it. Initially I was so 
scared to do the injection myself; instead my wife helped me to 
inject the insulin. She used to inject them on my limbs which I canÕt 
turn my head and not seeing it. But then after I get used it and I 
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can inject it myself. After you get used to it, I just inject the insulin 
when it is time! 
 
INTERVIEWER: Fear about injection, do you have that fear now? 
MJ: No, I am used to it, two years already. The needle [fear] is 
temporary that is psychological, temporary psychological fearÉ 
After I used to that and then I am ok. 
 
 
 
PG: Just take the first step and try, after you try a few times, you 
find its ok.  
 
From the interviews, participants expressed that they just Ôget used to itÕ. For 
T2DM patients who are willing to initiate insulin treatment, Funnell (2007) 
suggested they could start of by dry injection; patients might want to try 
poking themselves with an insulin needle subcutaneously without actually 
injecting insulin. Healthcare providers could give a demonstration of dry 
injection to themselves in front of the patient or ask patients to give a dry 
injection to themselves at the time of the initial education. Modern insulin pen 
devices are a great tool, which can allay the fear for patients who are 
concerned about the pain of injections. As agreed by MM, he was scared of the 
Ôlong needleÕ in the old days but was much happier with the modern insulin 
pen device.  Funnell (2007) explained that some T2DM patients are often 
described as Òneedle phobic,Ó but only a few patients actually have true needle 
phobias.   
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Although needle phobia is often presumed to be the single largest, contributor 
to psychological insulin resistance, it might be overstated as true injection 
phobia is rare (Polonsky & Jackson 2004). This is consistent with the findings 
in this study as the participants explained in the interviews that the fear of 
needles was a Ôtemporary psychologicalÕ factor, which could be easily 
overcome by practising and perfecting the insulin injecting techniques. 
Polonsky and Jackon (2004) explained that this Ôtemporary fearÕ often 
represents a broader reluctance to consider insulin therapy, reflecting their 
many negative beliefs about insulin or lack of knowledge about its use. This 
suggested the importance of good trust and respectful relationships between 
healthcare providers and patients. Therefore patient-centred education should 
help to alleviate this fear and help T2DM patients to ease into accepting insulin 
treatment to optimise their T2DM management.  
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6.5 Chapter Summary 
This qualitative study aimed to examine the insight of Type 2 diabetes patients, 
and explored their lived-experience of using insulin treatment as part of their 
diabetes management. It is important to understand how patientsÕ attitudes 
toward insulin treatment changed with their experience. The themes emerged 
from my data analysis indicated that T2DM patients are often faced with 
lifestyle restrictions while on insulin treatment. These restrictions had 
impacted on their social activities and also prohibited them from travelling. 
The factors causing these restrictions were often due to the timing of injection, 
and the inconvenience of bringing all the accessories with insulin injection.  
 
Starting T2DM patients on simple insulin regime is a great strategy to 
overcome the fear that insulin treatment is restrictive. Long acting, once-daily 
insulin such as insulin glargine provides freedom and convenience, therefore 
causing minimal disruption to patientÕs daily activity.  Furthermore, T2DM 
should be made aware the modern design of insulin delivery devices, which is 
discreet and flexible compared to the traditional insulin in vials.  
 
Healthcare providers in the diabetes field have a key role in promoting patient 
adherence with insulin treatment. T2DM patients often need both emotional 
support and practical information to increase their confidence in self-managing 
their T2DM especially when starting on insulin injections. Healthcare 
providers need to identify the potential conflicts which patients might have 
with insulin treatment and address them at the early stage of the insulin 
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treatment. Practical and emotional support are both critical to ease patients 
getting into a routine faster and at the same time minimising the disruption to 
their existing lifestyle. 
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CHAPTER 7  
SOCIAL ACCEPTANCE 
 
7.1 Introduction 
In chapter 7, I have highlighted the negative perspectives of insulin treatment 
faced by the participants, which have resulted in psychological insulin 
resistance (PIR) and act as barriers toward accepting insulin treatment. In 
CHAPTER 6, I have discussed how the participants coped with the 
introduction of insulin injection into their diabetes management. In this 
chapter, I will be discussing the social factors, which influences patientsÕ 
acceptance of insulin treatment.  
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7.2 Embarrassment and Social Stigma 
The most frequently reported negative attitudes by Malaysian T2DM patients 
were personal failure (59.2%) and embarrassment of using injection (55.9%) 
(Nur Azmiah et al. 2011). From the data analysis, one prominent barrier of 
coping with insulin treatment is the embarrassment factor. Participants 
affirmed that it was embarrassing to inject in public due to their psychological 
factors. As a result, often patients would intentionally skip their insulin 
injection. Public embarrassment has been identified as a key factor in insulin 
non-adherence behavior; T2DM patients often believe that they have to hide 
their injections to avoid disturbing other people (Brod et al. 2009; Peyrot et al. 
2012; Korytkowski 2002; Abu Hassan et al. 2013). Many participants reported 
that injecting insulin in public were inconvenient because the curiosity of 
others, therefore they preferred to have more privacy and would try to find a 
room with privacy to inject insulin:  
 
PG: Sometimes if you are in a crowded place itÕs very hard to jab. 
People will come and look at you, what is that you are doing... 
 
WM: I donÕt feel comfortable with thatÉ I just do it in morning 
before I go out of the house. Personally I find it very inconvenient 
to go to a public toilet or a coffee shop toilet to do the injectionÉ 
Why do you have to do it in front of public? So I didnÕt see the need 
to do it in front of the publicÉ So anyway, I do it in the morning 
and nighttime I do it. 
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AM: But with injection you need to have to find a place, to inject. 
Normally take some times; we need to find a private place. We also 
donÕt want to let others people see right? Not comfortable, 
uncomfortableÉ How can [I] take injection anytime, anywhere? 
No privacy. When there are a lot of people, very difficult. Like 
where I work, one room sometime can have up to 8 people. Very 
difficult. When you are there, always scared. Because insulin has a 
set time to inject, very scared that not to get to inject... But 
embarrass.  
 
 
ParticipantsÕ perception of social stigma resulted them to hide when injecting 
insulin. However they often faced with difficulties to find an appropriate 
environment to inject insulin in Malaysia. For example, AM complained that 
there were too many people in the room where he worked, therefore he did not 
feel comfortable to inject insulin there and it was very inconvenient for him 
having to look for a place with privacy to inject insulin. As a result, many 
participants would selecting suboptimal locations to inject themselves while 
away from home, such as in public toilets, and might also cause some patients 
to skip or delay injections and avoid social activities. Thus, patients who have 
such psychological barrier usually would feel that their lifestyle being 
restricted (see section 6.2). In the interview with MZ, she voiced that insulin 
treatment had restriction of her social life. She would have to inject her insulin 
dose before she attends any function, because she did not want to inject it in 
public. Therefore she could not time her insulin injection nor the dose because 
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she would not know what time you would get to eat and what sort of foods 
were served.  
 
 
MZ: I bring, but then you want [me] to jab in public? It is not 
convenient that you have to expose yourself to jabÉ ThatÕs why 
sometimes I donÕt jabÉ itÕs just that you need some privacy. Or 
you can go to the restroom but sometimes the restroom is so far 
away. So inconvenient. So just done with it, let go with it.  
 
 
From the interviews, participants often complained that it was inconvenient to 
use insulin injection. The convenience was not due to the injection itself, but 
because the participants were embarrassed to expose injecting insulin in the 
public: ÒIt is not convenient that you have to expose yourself to jabÓ. One of 
the participants, MM, explained his reason for the embarrassment. He would 
hide in the toilet to inject insulin when he was younger because he felt the 
sense of embarrassment:  
 
MM: Long time ago when I use insulin, I normally go to toilet. But 
now [I inject] directly. 
INTERVIEWER: Why do you go toilet?  
MM: Embarrass. But now old already, so it is OK.  
 
I explored further the reason why MM felt that it was embarrassing for him to 
inject insulin in public when he was younger, but he did not have any problem 
to inject insulin now. His explanation:  
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MM: Embarrass, so young and have to use this, now I am sixty 
plus so doesnÕt matterÉ I didnÕt want to tell anyone. I donÕt want 
them to know that I was still young and have this case. 
 
 
MM explained that the public often think that insulin is indicated for older 
people therefore he felt embarrass and he did not want to inform others that he 
required insulin injection. Patients often have the misconception that insulin is 
a medication for old people (Lee et al. 2012). This misconception has 
contributed to the barriers for Malaysian healthcare providers to initiate insulin 
treatment for T2DM patients. Funnell (2001) reported some patients have 
justifiable concerns about the loss of their jobs if they need to initiate insulin 
treatment. LT, a 36 year old male participant explained that he was concerned 
that diabetes would interfere with his work. On top of that, his parents asked 
him not to tell anyone as well. He expressed that it would be an embarrassment 
to expose your bad health: 
 
LT: Because of work, then you cannot like telling customers like I 
am taking vegetarian, I am diabetic all these things. My parents 
asked me not to tell. For first year I didnÕt tell anyone that I am 
diabetic. Parent asked me not to expose your bad health.  
 
Abu Hassan et al. (2013) reported in a recent study that social and cultural 
factors such as social stigma and embarrassment have contributed to insulin 
non-adherence, resulting in omission or skipping of insulin injection among 
Malaysian patients who are on insulin treatment. PatientsÕ perceptions of social 
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stigma for the self- injection of insulin in public can have a restrictive effect on 
disease-management efforts. Brod et al. (2009) reported that due to patientsÕ 
previous negative experiences, or fear of negative experience, have contributed 
inconvenience and embarrassment related to injections. Therefore leading to a 
lack of motivation among these T2DM patients. One of the negative 
perceptions of self-injecting of insulin in public is the association with 
recreational drug use which I will be discussing in the next section. 
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7.3 Association with Recreational Drugs Abuse 
During the interviews, one prominent barrier for injecting insulin in public 
places is due to the concern that if they inject in public places they would be 
perceived as injecting illegal substances or recreational drugs abuse. 
Participants felt that the Malaysian public is educated about recreational drugs 
abuse. Ultimately when the general public see someone self-injecting, they 
would associate it with recreational drugs abuse.  
 
HT: Another, people thinking maybe you are aÉ maybe they donÕt 
know you are the diabetic depend on injection, so they thought you 
maybe [a] drug addict trying to injectÉ 
 
YF: Of course it is not good, they will look at you and think why 
are you inject something when you eat? Like you are fixing your 
addiction to recreational drug by injecting it.  
 
 
NR: So I stop using it if too many people around. I donÕt know, 
later people will say, ÒWhat are you doing?Ó ÒWhat are you 
injecting?ÓÉ  Still have friends [asking] if I am taking recreation 
drug! 
 
Because of patientsÕ previous negative experiences, or fear of negative 
experience, they would omit or delay their insulin injection. As commented by 
NR, a 30 year old male patient, he would not inject insulin when there were 
people around him because he was concerned that the public would perceive 
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him injecting a recreational drug. He was even questioned by his friends about 
taking recreational drug. NR attributed the publicÕs negative perception to the 
educational material about illegal substances abuse: 
 
 
NR: People will think Òwhat are you jabbingÓ, right? WhatÕs this? 
People are educated about recreational drug, stay away!  
 
 
Education and awareness of recreational drugs has increased the knowledge of 
public about this issue, but at the same time it has created negative experience 
for those T2DM patients who required insulin injection such as participants 
NR. Malaysians are aware that some recreational drugs are injected 
intravenously, but most of Malaysians do not know that insulin injections are 
administered subcutaneously. Participants from this study also illustrated the 
perception that recreational drug abusers would inject via vein and tend to have 
needle holes: 
 
YF: It shouldnÕt be, it is a different kind of injection: one is injected 
into tummy and the other is injected into the vein. Those people are 
uneducated on this subject. It is different sort of injection; see it 
doesnÕt leave any needle hole on my skin. 
 
 YHK: Just like a drug addict who needs his fix when the time 
arrives. But they inject into vein, I inject into my skin only and the 
needle is very fine. 
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YF had pointed out that although the public members have the awareness of 
recreational drugs abuse, they were not fully informed and therefore would 
associate any self-injection with illegal drugs abuse. Malaysia declared drug 
abuse as a threat to the security of the country on February 19, 1983 (Scorzelli 
1988). As a result of this declaration, Malaysia initiated a massive effort in law 
enforcement, preventive education and rehabilitation. A government 
initiative,ÒAnti-DadahÓ task force was set up to combat the growth of 
recreational drugs abuse. (Dadah means dangerous drug in Bahasa Malaysia). 
Anti-Dadah task force focuses on preventative education and campaigns. The 
images used in the campaigns often involved portrays syringes and needles and 
sometimes with the image of the self-injecting action (refer to Figure 7 and 
Figure 8) 
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Figure 7 Anti-Dadah campaign (Ministry of Health Malaysia) 
 
Picture adapted from Ministry of Health Malaysia 
Figure 8 Poster used in school to raise awareness of recreational drug abuse 
 
Picture adapted from http://www.picstopin.com/231/lukisan-poster-dadah-ajilbabcom-
portal/http:%7C%7Cmuslimsocialservicesagency*org%7Cwp-content%7Cthemes%7Cposter-
lukisan-anti-dadah-i19*JPG/ 
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Self-injection, needles and syringes attributed a strong negative connotation 
associate with recreational drugs abuse. Given that injection is the only 
common route of administration for insulin treatment, it is not surprising that 
social stigma plays a key role in psychological insulin resistance. Reluctance to 
self-inject in public places are associated with the fear of being stigmatised, 
being looked upon by others an ÔaddictÕ (Snoek 2001; Brod et al. 2009; Morris 
et al. 2005).  
 
Some T2DM patients have the perception that to inject insulin made them feel 
like a drug addict and losingÕ normalityÕ, people with diabetes want to live as 
ÔnormalÕ a life as possible in a social context (Morris et al. 2005). LM felt that 
the Malaysian public had strong stigma associated with T2DM and insulin 
injection. She commented that people and even her friends made remark about 
her T2DM and the need of using insulin injection, which she was very concern 
about and she wanted to be ÔnormalÕ and not ÔoddÕ: 
 
LM  I [told] my friends I am an insulin dependent , but everybody 
look at me [weird]É Social stigma. They think you are very odd. 
Even my old people call me Ò The sweet person comingÓ. We have 
a phobia, people think you are an insulin dependent, they think, 
something you are outÉI mean the [Malaysians]É ÒOh she is an 
insulin dependentÓ. They give that kind of remarks you know? 
Especially those who are not aware of this. 
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LMÕs comment suggested that there is a need of raising public awareness of 
T2DM and insulin treatment to alleviate the social stigma. One prominent 
theme from participantsÕ interviews is the need to raising public awareness of 
T2DM and insulin injection, which is discussed in the next section. 
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7.4 Raising Public Awareness 
Lack of awareness and education about insulin injections have resulted in 
misconceptions about insulin treatment among Malaysian patients with 
diabetes and the general public. These misconceptions have not only resulted 
in psychological insulin resistance among T2DM patients but also the negative 
attitude from the general public. Misconceptions such as insulin treatment are 
indicated for severe cases and signified personal failure; insulin injections are 
only for old people have illustrated a significant lack of knowledge of diabetes 
and role of insulin among T2DM patients. Other social stigma such as the 
association of insulin injection with recreational drugs abuse and the 
embarrassment to self-inject insulin in public highlighted the need to raise 
public awareness of insulin injection. Many participants in this study suggested 
there should be more awareness of insulin treatment for the public and de-
stigmatise the public misconception about injection. LM was being called 
names by her relatives and she felt being discriminated because of her T2DM 
and that she had to use insulin injection. Another 58 year old participant, BK 
sounded frustrated because how the public perceived her as sick person and 
she would like to be treated as ÔnormalÕ. They explicitly stated that there 
should be more awareness about T2DM and insulin treatment to the public:  
 
LM: But everybody look at me [weird]É Social stigma. They think 
you are very oddÉ they should have awareness for the people.  
 
 169 
BK: ItÕs true that we have diabetes but the public shouldnÕt 
perceived us as sick people, we are not physically sick everyday 
and you canÕt tell who has diabetes and who need insulin. Insulin 
works well for me and I do not think that I am sick just because I 
inject insulin.  
 
Due to the lack of knowledge and awareness of insulin injection in the general 
public, and the influence of media about recreational drug abuse, people are 
curious about the injection and the resultant the unwanted social stigma. PG 
felt that Malaysian society is not very educated on the subject of insulin and 
that people would comment about their injection and think that they were 
taking a recreational drug: 
 
PG: Most people just donÕt know what you are doing, just too 
much on TV you know. People taking drugs and all this, people 
actually think you are jabbing yourself with donÕt know what. Once 
they know it is insulin, they couldnÕt be botheredÉ Need to be 
more open, people also need to think more openly. 
 
 
PG suggested that there should be more awareness of insulin injection so that 
people are educated about it and they could be more supportive toward T2DM 
patients using insulin in public places. Increased public awareness might ease 
T2DM patients to be more comfortable about self-injecting, and also 
encourage other people to be more open minded towards insulin treatment 
(Chai et al. 2013b). Public education also needs to be focused on knowledge of 
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T2DM, not only the preventative measures but also the role of insulin 
treatment and in particular dealing with hypoglycaemic events.  SR voiced the 
opinion that there should be an information card such as medical bracelets to 
be carried by T2DM patients who use insulin injection.  
 
SR: They should know what medication or what are the things that 
you have, so that they are more aware. So if I am having hypo and 
any of my friend is nearby or there then they know what to do... If 
they have [something] that they can carry around saying that you 
are a diabetic patient that really helps. It is a kind of signal or a 
piece of info saying that you are a diabetic patient, if you have 
anything just to let the public that you are a diabetic patient. Only 
for fast action thatÕs really helpful.  
 
Medical-identification products are available via Diabetes Malaysia (PDM) but 
it was not greatly promoted and Malaysian public and even patients are not 
aware of the products (Diabetes Malaysia 2007). Medical-identification 
products can save time in an emergency event. They contain important medical 
information that is crucial for diagnostic purposes such as during a 
hypoglycaemic event. SRÕs statement also suggested that the awareness of 
hypoglycaemic event among the general public is very low. In fact, another 
participant, LT, also voiced the opinion that diabetes awareness is not Ôout 
thereÕ. Agreed by LT that information on T2DM and insulin treatment were 
not greatly promoted unlike cancer and cardiovascular diseases: 
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LT: All because of lack of awareness... The only awareness is only 
[seen] in hospitals. So it is not out there. Is not out there, it is not. 
Heart attack is out there, cancer is out thereÉ But you can put 
your advertisement on midnightÉ but this is an awareness needed. 
 
From the interview with LT, his comments suggested that there were much 
publicity on medication, healthy lifestyle, cancer and cardiovascular diseases, 
but not much information on T2DM and how to cope living with T2DM. LT 
mentioned, ÒPeople who really want to spend money on medication but donÕt 
want to spend money on awarenessÓ, he was referring to Malaysians in general 
who needed to be more educated on healthy lifestyle to prevent T2DM. 
Because the lack of awareness, they would suffer more when diagnosed with 
T2DM (hit the jackpot):  
 
LT: People who really want to spend money on medication but 
donÕt want to spend money on awarenessÉ All because of lack of 
awareness, when they needed it, when they hit the jackpot that time 
only they suffer... Actually they do, Malaysian government they 
only tell you [about] healthy lifestyle.  
 
LT used the analogy of Ôhitting the jackpotÕ to describe the reaction of T2DM 
patients when they were diagnosed; he felt that it was like wining a lottery, an 
unexpected but unfortunate event due to the lack of awareness. He suggested 
that the public should spend more effort to prevent T2DM rather than spending 
money on treatment (quick fix). This comment highlighted that in general, the 
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Malaysian public does not have the adequate knowledge about diabetes and 
insulin treatment.  
 
It is important to incorporate insulin treatment in educational campaign to 
create an awareness of the importance of insulin injection for T2DM patients. 
This would aim at improving the health literacy of the general public, in 
particular to de-mystify and de-stigmatise self-injecting of insulin in public. 
Raising public awareness of T2DM and the role of insulin is vital to allay the 
negative attitude towards insulin treatment. Awareness can be promoted via 
local television or social media, such as having a character in a drama or video 
clip playing T2DM patient who required insulin injection. It would help the 
audience understand the difference between recreational drugs and insulin 
injection, and also the importance of insulin treatment to some T2DM patients. 
Ultimately, patientsÕ understanding of and adherence to appropriate diabetes 
self-management practices would only able to be translated into practice if the 
perception of social stigma is alleviated (Brod et al. 2009).  
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7.5 Chapter Summary  
Social stigma and embarrassment are the key factors related to psychological 
insulin resistance. The association of insulin injection and recreational drug 
abuse has resulted in fear to use insulin injection in public, thus causing poor 
adherence. The availability of modern insulin pen devices has enabled patients 
to inject more discretely. Understand patientsÕ lifestyle and needs, and starting 
patients with basal insulin or longer acting insulin analogues regimens can also 
eliminate this barrier for some patients. 
 
Raising public awareness via television and social media should help to de-
mystify and de-stigmatise self-injecting of insulin in public. Alleviation of 
social stigma should facilitate T2DM patients to adhere to insulin treatment 
and improve self-management. At the same time, public education campaigns 
should include information on hypoglycaemic events, which might experience 
by T2DM patients on insulin treatment. There is a need to promote medical-
identification products to T2DM and the general public, such identification can 
save time in an emergency as medical identifications provide emergency 
personnel with important information that allows them to act quickly. 
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CHAPTER 8  
CONCLUSION 
  
8.1 Practice Implications  
The findings of this study have provided valuable insights that further our 
understanding of the complexities of initiating insulin treatment among T2DM 
patients in Malaysia and how they perceive insulin treatment. This section 
draws on the findings of this study and presents the implications for healthcare 
providers working in the field. 
 
This study raises several issues that are of importance to T2DM patients in 
Malaysia. The findings of this study suggest that there is a lack of awareness of 
modern insulin pen devices. Many patients associate insulin injections with 
past experiences with injections such as vaccinations, which is a complicated 
procedure and involves drawing medicine from glass vials via needles and 
administered either via intramuscular or intravascular (Tan et al. 2011; 
Korytkowski 2002). As a result, patients perceive that injecting insulin is a 
complicated procedure, which required intensive technical training and 
precision. Additionally, patients would relate injection to syringe and needles 
and fear of needles and perception of pain (see Figure 9 Consequences of lack 
of awareness of modern insulin pen devices).  
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Figure 9 Consequences of lack of awareness of modern insulin pen devices 
 
 
The development of insulin pen devices has greatly reduced these negative 
perceptions. Ease of learning how to use a modern insulin pen is a crucial 
factor for encouraging early acceptance of insulin treatment (Spollett 2008). 
The availability of modern insulin pen devices is particularly useful for 
insulin-naive patients, elderly patients, and those patients with visual or 
manual dexterity disabilities. Modern insulin pen devices are not only easy to 
handle, easy to use, but also can improve dosing accuracy compared with 
conventional needles and syringes (Meece 2008). The pen-shaped design of 
insulin injection also provides more flexibility and convenience to patients; 
their compact size allows ease to carry around and discreet insulin 
administration. 
 
Thus, many barriers of using insulin injections could be addressed at the early 
stage of T2DM by making patients aware the availability of modern insulin 
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pen devices. It would be particularly beneficial for those patients who have not 
seen insulin pen devices before; healthcare providers could demonstrate the 
injecting procedure and let the patients experience handling the pen devices. 
During counselling, emphasis should be placed on both practical and 
emotional support in order to help patients to accept insulin treatment and 
become more self-efficient to use insulin injection.  
 
To alleviate the negative perceptions of insulin injection by Malaysian society, 
educational campaigns directed to the public are needed to raise awareness of 
diabetes and the important role of insulin treatment; subsequently to ease the 
patients with Type 1 and Type 2 diabetes mellitus to be more acceptable about 
self-injecting in public. These campaigns should encourage society to be more 
open minded towards insulin treatment and address the current social stigma 
toward self-injecting insulin in public. 
 
Awareness of T2DM and role of insulin injections should be promoted to a 
wider community not limited to only healthcare facilities. The Malaysian 
Health Promotion Board, MySihat (Sihat means Health in Bahasa Malaysia), 
was established in 2006 to support non-profitable organisation and community 
empowerment (Kaur et al. 2011). MOHM and MySihat could evolve to take on 
a bigger role in enhancing diabetes awareness in Malaysia. This could be 
promoted at many levels, including schools, work places, and community 
events across the country.  It should also be promoted in the media to a wider 
range of audience via local television or social media, such as having an acting 
character in a drama or video clip portraying T2DM patient who is using 
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insulin injections. It would help the audience understand the difference 
between recreational drugs and insulin injection, and also the importance of 
insulin treatment to some T2DM patients. The perception of social stigma need 
to be addressed so patientsÕ understanding of and adherence to insulin 
treatment only able to be translated into practice. 
 
Early diabetes education should make T2DM patients more aware of the 
progressive nature of T2DM and the function of insulin, this would better 
prepare them mentally for insulin treatment in the future especially to allay the 
negative perception of personal failure. This suggestion to have early 
discussion about insulin treatment corresponded to the suggestion by Hassali et 
al. (2013).  
 
Healthcare providers across different disciplines such as doctors, pharmacists, 
and diabetes nurses should have a systematic program in place for early 
diabetes education to enhance the patientÕs knowledge and awareness. 
Healthcare providers should provide adequate but simplified practical support 
together with emotional support when suggesting insulin treatment. PatientsÕ 
concerns relating to insulin dosing need to be addressed early on and 
healthcare providers also need to take into account of individual patientsÕ 
needs and tailor the insulin treatment to fit into patientsÕ lifestyles.  
 
Starting T2DM patients on a simple insulin regime such as once-daily injection 
with insulin glargine is a good strategy to overcome the fear and worry that 
insulin treatment is restrictive and complicated to handle. Simpler insulin 
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regimes provide more freedom and convenience, therefore causing minimal 
disruption to a patientÕs daily activity and therefore would ease the transition 
from oral anti-diabetic medication to insulin treatment. Practical and emotional 
support are both important to help patients getting into routine and minimising 
the disruption to their lifestyle. 
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8.2 Reflexivity: Practical Application in the Study 
Reflexivity means sensitivity to the ways in which the researcher and the 
research process have shaped the collected data, taking account of the 
researcherÕs own personal experiences, theoretical biases, recognising the role 
of values and a priori assumptions in shaping any research account (Murphy et 
al. 1998; Mays & Pope 2000)  
 
Theoretical considerations about reflexivity for qualitative research have been 
discussed in section 2.3. In this study, I have employed an interpretative 
phenomenological analysis (IPA) approach, in which I had to try to understand 
patientsÕ lived-experience and how they made sense of their experiences. I 
tried to explore personal experience through an interpretative process. 
(Biggerstaff & Thompson 2008). IPA also considers that one cannot get close 
to the participantÕs personal world directly or completely, it is a two-stage 
interpretation process, hence a double hermeneutic (Smith & Osborn 2008). 
This hermeneutics interpretative process must also depend on the researcherÕs 
own conceptions, which are required to understand the participantÕs world 
through another level of interpretative activity.  
 
I have attempted to present the participantsÕ perspectives as truthfully and 
honestly as I can in this thesis. I recognise that this thesis is the product of the 
interaction between the participants and myself and is socially contingent. The 
data were constructed and interpreted by the patients and interpreted by myself 
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and are affected by a variety of factors such as age, sex, social class, and 
professional status (Mays & Pope 2000). 
 
During the first few interviews with participants, I introduced myself as a 
pharmacist and subsequently I had noticed that my role hindered me from 
building a good rapport with the participants (see section 2.4.8). There were a 
few occasions in the interviews where participants asked me health-related 
questions. Participants were asking my opinion on insulin injection, which I 
did not want the participants perceiving my role as a pharmacist. This could 
lead to interviewee giving response he or she thinks a health professional 
wants and therefore data collected would not be as truthful as it should be 
(Britten 1995). Questions asked by MZ and YLC below were targeted to a 
healthcare professional, which I did not feel comfortable giving my opinion:  
 
 
MZ: I think I want to stop [using insulin]. Can you be off insulin? 
 
YLC: Different companies? Or different stage of patients using 
different needle? The needle and the insulin itself? Because the 
insulin I use is different and my brother used different. 
 
 
In the subsequent interviews which I had finely-tuned my interview skills; I 
introduced myself as a PhD research student instead of mentioning my 
pharmacist role. However my pharmacist background has given me an 
advantage especially in terminology and clinical knowledge. There were 
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numerous occasions in the interviews where participants referred to a medical 
procedure such as angioplasty, or a name of a medicine. This might have been 
a problem if the interviewer did not have a clinical or hospital background; it 
might be an obstacle of the flow of conversation because patients expected the 
interviewer to resonate with the contents of their conversations.   
 
However, my pharmacist background also posed a limitation in this study. As 
much as I tried to suspend my clinical knowledge, there was occasion when I 
finished participantsÕ sentences especially when they were referring to a 
medical terminology and they had difficulty with the terminologies. These 
interruptions might divert the participants from explaining more in-depth about 
a particular situation and how they dealt with it.  
 
Besides my pharmacist background, being Malaysian and understand the local 
slang give me an advantage as well during interviews. The majority of the 
interviews were conducted in English, but there were many occasions when the 
participants would use local slang and mixed languages which is the feature of 
how Malaysians talk. A few occasion the participants used Tamil language in 
the interviews but I was no able relate to. The majority of participants would 
use a few Bahasa Malaysia terms or expressions in the interviews such as  
ÒterukÓ, ÒaiyahÓ. Overall it did not hinder the flow of conversation because the 
participants expected me to know what they meant. I was not very fluent with 
Bahasa Malaysia during some of the interviews, which the participants were 
not able to understand English. I found that I could not build a good rapport as 
well as those interviews conversed in English language. There was more 
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degree of interpretation necessary in order to justifiably articulate the 
participantsÕ perspective. My understanding of the content was an 
interpretation of my understanding at the time rather than necessarily what they 
actually meant. Having that in mind, future research will be required to explore 
patientsÕ perspectives of insulin in different cultural groups by interviewers 
who can speak the same language to obtain rich data and also avoid the context 
Ôlost in translationÕ. 
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8.3 Limitations 
All research studies have limitations and these should be taken into account 
when interpreting the findings. This study was designed to be undertaken in 
one public hospital in the government administrative town in Malaysia. 
Therefore the transferability of the findings to other settings will be 
challenging. Murphy et al. (1998) stated that generalisations of the rationalistic 
variety are not possible because phenomena are intimately tied to the times and 
contexts in which they are found. The theories developed from this study at PH 
might not be able to be applied to patients who sought treatment from a rural 
hospital; the findings might, however provide explanatory theory for the 
experiences of other patients who are in comparable situations from similar 
background.  
 
Recognition needs to be given to the differences in experiences, which can be 
attributed to cultural background. Whilst some experiences were common 
across these participants there were certainly experiences that were unique to 
participants from different ethnic groups. This limitation of the current study 
has opened up a potential area that could be addressed by future research (see 
section 8.4 Future Research).  
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8.4 Future Research 
This study has highlighted future research that could help to further detail 
patientsÕ perceptions of insulin treatment in different cultural groups and in 
rural areas as well, where patientsÕ beliefs about insulin use may be different. 
Prevalence of T2DM are seen among Malay, Chinese and Indian, the three 
major ethnic groups in Malaysia (refer Figure 1), therefore future research is 
required to better understand and observe the differences in perceptions 
between ethnicity groups. This would help to determine which approaches and 
strategies would facilitate insulin acceptance and help improve the 
psychological care of diabetes patients within particular ethnicity groups.  
 
PatientsÕ perceived barriers to initiate insulin treatment and their perceptions 
have attracted many researchers in Malaysia (Abu Hassan et al. 2013; Lee et 
al. 2012; Lee et al. 2013; Nur Azmiah et al. 2011). There are many findings 
reported from patientsÕ perspectives and also from healthcare providers (Abu 
Hassan et al. 2013; Chai et al. 2013a; Lee et al. 2012), these findings could be 
used to design quantitative research to further enhance and established the 
phenomenon of psychological insulin resistance. 
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8.5 Concluding Remarks 
 
To study the phenomenon of diseases without books is to sail an 
uncharted sea, while to study books without patients is not to go to 
sea at all     (William Osler) 
 
There is an increasing global trend for countries to invest in understanding 
patientsÕ health experiences (Ziebland et al. 2013). This study aim has 
generated Malaysian T2DM patientsÕ accounts of their experiences with 
insulin treatment as part of their glycaemic control. In this thesis, I have 
presented an insight of T2DM patients and their experiences of managing their 
glycaemic control with insulin treatment in the Ôreal worldÕ. It allows us to 
understand what was important to a lay person as a diabetic patient in 
Malaysia, in particular the barriers perceived by a lay person regarding insulin 
treatment, and also the facilitators or motivators to adherence to the treatment.  
 
This study used qualitative methods in order to provide an explorative 
investigation of the lived-experiences of the participants. I have employed 
qualitative methods in order to preserve the complexities of human behaviour, 
this research method enabled me to focus on the meanings, experiences, and 
views of people, such as why do patients worry about using insulin treatment 
and how do patients adapt to insulin treatment in their daily activities. This 
approach is particularly useful in unveiling patientsÕ lived-experiences because 
the relevant variables associated with an outcome are not apparent. I have 
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employed face-to-face, semi-structured interviews with participants to obtain 
answers to the aims and objectives of this study. Face-to-face interviews 
provided a rich description of how ÔrealÕ T2DM patients experienced their 
diabetes in everyday life and how they contextualised their experiences.  
 
One of the findings about patientsÕ reactions to initiation of insulin is that their 
response is greatly influenced by their prior exposure and encounters with 
insulin injections. Patients with prior knowledge of insulin injections, such as 
close friends and relatives who are on insulin, react more calmly to the 
suggestion of insulin treatment. This could be due to the fact that the majority 
of Malaysians often live in a close-knit society, with patientsÕ experiential 
learning and observing of others managing T2DM with insulin injection, this 
group of patients are therefore more aware of the efficacy of insulin treatment. 
They also exhibit motivation to achieve a better control of T2DM and to 
prevent its complications. Another facilitator to initiate insulin treatment is 
believing that insulin is effective to warrant a better quality of life. ÔThinking 
of the futureÕ encourages patients to accept insulin treatment because they want 
a better quality of life and not to depend or burden their family members. 
 
On the other hand, patients with poor knowledge or no prior exposure to 
insulin injection are often reluctant to accept insulin treatment. This could also 
be attributed to the lack of awareness of the modern insulin pen devices and 
the influences of past experience with injection. The portrayals of syringes and 
needles in media and the government initiatives against recreational drug abuse 
also play an important role at influencing T2DM patientsÕ perceptions of 
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insulin and contributed to the well-documented psychological insulin 
resistance (PIR). They often perceived that injecting insulin was a complicated 
procedure involving needles, syringes and vials, and required intensive 
technical training and precision. As a result, some T2DM patients have a great 
difficulty to accept insulin treatment because they often worry that they are not 
capable of handling insulin injecting without medical assistance.   
 
Psychological insulin resistance such as personal failure and embarrassment 
are reported by many other studies, which ultimately contributed to the initial 
fear of accepting insulin treatment, and also affecting the adherence of insulin 
injection (Polonsky et al. 2005; Nur Azmiah et al. 2011; Brod et al. 2009; Abu 
Hassan et al. 2013). The misconceptions that T2DM progressed uni-
dimensionally and about the need to initiate insulin indicating a personal 
failure have shown the lack of knowledge of T2DM and the role of insulin 
treatment. A sense of personal failure and embarrassment regarding injecting 
insulin in public also resulted in poor adherence to insulin treatment. 
Typically, T2DM patients with such psychological insulin resistance could 
rather skip or delay their insulin injection during the daytime or when they are 
out and about. They preferred to inject insulin away from public and often hide 
in a toilet or in their car while injecting. Or they would inject the dose at home 
before going out or skip the dose entirely. Because of the sense of 
embarrassment and the lack of social acceptance of self-injecting insulin in 
public, patients often feel that their insulin injection has restricted their 
freedom, and taking control of their life. These factors have resulted in poor 
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acceptance of insulin injection and resulted in many T2DM patients not 
achieved good glycaemic control even though they are on insulin treatment.  
 
The extent of psychological insulin resistance is magnified if the patients need 
to inject insulin more than once daily, especially if they required an afternoon 
dose of insulin. Patients were often reluctant to self-inject insulin in public 
because the fear of social stigma. In general, the Malaysian public is not well 
educated on the subject of insulin treatment. Often people would associate any 
self-injection to recreational drug abuse. As a result, many participants felt 
uncomfortable to self-inject insulin in the public places. On top of the social 
phobia, patients often find it hard to cope with a midday injection because the 
uncertainty of what food to eat and the timing of injection. Some patients 
might feel that they are being force into changing their lifestyle because of 
insulin injection, thus the perception of lifestyle restriction. Some patients 
adapted into the routine quicker than others, often because they were started on 
basal insulin and with adequate trainings on the injecting technique and 
counselling.  
 
Effective counselling and early education facilitate the acceptance of insulin 
treatment, especially the metaphors used to describe the mode of action of 
insulin. Many Malaysians believe that western medicine could potentially be 
ÔdepositedÕ in the body after consumption, and therefore would cause 
undesired side effects such as organ damage. In comparison, insulin injections 
would be injected directly into the bloodstream to exert its effect. Patients 
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believed that insulin injection would just replace their own dysfunction insulin 
and it should be more ÔnaturalÕ compared to oral anti-diabetic medication.  
 
Therefore, it is crucial for healthcare providers in Malaysia to be aware of the 
health literacy and cultural considerations among the patients. It is hoped that 
these would be integrated into the health delivery system in Malaysia to 
empower patients, improve patientsÕ self-efficacy and thus improve care and 
health outcomes. 
 
The experiences of T2DM patients using insulin treatment have provided novel 
insights into patientsÕ perception of diabetes management. The findings from 
this research offer the potential for healthcare providers and other organisation 
working in the diabetes field to improve patient care and adherence to diabetes 
medication, therefore prevent diabetes complication and subsequently reduce 
cost as a result from the better health outcomes. 
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Appendix 1: Patient Information Sheet 
 
 
3DWLHQWV¶([SHULHQFHRI,QVXOLQ7KHUDS\IRU7\SH'LDEHWHV0DQDJHPHQW 
Pengalaman Pesakit dalam Terapi Insulin untuk Pengurusan Diabetes Jenis 2 
 
!
About the Study: You are invited to take part in a study which is exploring your 
experience of using insulin therapy.  
Perihal Kajian: Anda dijemput untuk menyertai dalam satu kajian yang berkaitan dengan 
pengalaman anda dalam penggunaan terapi insulin. 
 
 
Purpose of the Study: Currently, very little research has explored this issue in 
Malaysia.  We would like to better understand some of the barriers and potential 
solutions so that we are able to improve any future service development in this area. 
Tujuan Kajian: Pada masa kini, penyelidikan di Malaysia yang berkaitan isu ini 
amat terhad. Kami ingin mendalami dan memahami segala rintangan serta merumuskan suatu 
penyelesaian yang berpotensi supaya kita dapat menimbal balik tentang kemajuan dalam 
perkhidmatan berkaitan bidang ini pada masa hadapan. 
 
 
Participation: Participating in this study is voluntary and will involve being interviewed 
by a researcher, which will take around 1 hour. The interview will be tape recorded and 
later transcribed and you may be quoted anonymously (no name mentioned) in 
publications, e.g. reports and published papers. Even if you agree to being taped, you 
may choose to have the recorder turned off at any time and withdraw from the interview 
without any negative outcome or prejudice.   
Penyertaan: Penyertaan dalam kajian ini adalah secara sukarela dan peserta akan ditemuramah 
oleh seorang penyelidik, yang akan mengambil masa kira-kira 1 jam. Temuramah ini 
akan dirakamkan  dan kemudian disalin dan anda mungkin dipetik tanpa nama (nama 
tidak disebut) di dalam penerbitan, contohnya  laporan dan kertas yang diterbitkan. Malah jika 
anda bersetuju untuk dirakam, anda berhak untuk meminta perakam itu dimatikan pada bila-
bila masa dan menarik diri daripada temuramah itu tanpa apa-apa hasil yang negatif serta 
prejudis. 
!
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!
!
Confidentiality: If you choose to participate in this study, the research processes will 
provide confidentiality for you. If the information you provided is reported or published 
this will be done anonymously. All attempts will be made to protect the identity of 
interviewees, and places or persons mentioned in the interviews, although for some 
individuals who are representing professional or other organisations, it might be possible 
for someone who knows them to identify them as a source. Transcriptions will be kept 
for six years for future reference for the purposes of publication of reports or peer 
reviewed publications and will be stored in a locked filing cabinet separate from consent 
forms. After this time period it will be professionally destroyed.    
Kerahsiaan: Jika anda memilih untuk menyertai dalam kajian ini, proses penyelidikan akan 
menyimpan segala maklumat secara rahsia. Jika maklumat yang anda berikan dilaporkan atau 
diterbitkan,  ia akan dilakukan tanpa nama. Segala usaha akan dibuat untuk melindungi identiti 
bagi orang yang ditemubual dan tempat atau seseorang yang disebut dalam temu bual 
itu, walaupun bagi sesetengah individu yang mewakili profesional atau organisasi yang lain-
lain, ia mungkin mustahil bagi seseorang yang mengetahui mereka untuk mengenal 
pasti mereka sebagai sumber. Transkripsi akan disimpan selama enam tahun untuk rujukan 
masa depan bagi tujuan penyiaran laporan atau penerbitan kaji-semula dan akan disimpan di 
dalam almari berlaci yang dikunci berasingan daripada borang keizinan. Selepas tempoh 
masa ini, ia akan dismunahkan secara profesional. 
!
Results: The information that you provide will be used to help us plan future research and 
service provision in this area.  You will also be able to request a summary of the research.  
Keputusan: Maklumat yang anda berikan akan digunakan untuk membantu kami merancang 
penyelidikan masa depan dan peruntukan perkhidmatan dalam bidang ini. Anda juga boleh 
memohon untuk mendapatkan rumusan penyelidikan. 
!
Further information: If any further information is required by the participant, he/she is 
free to contact the researcher, Jim Chai, via email: khyx1jch@nottingham.edu.my or local 
supervisor, Mr. KT Wong via email: Kok-Thong.Wong@nottingham.edu.my. 
Maklumat Lanjut: Jika ada apa-apa maklumat lanjut yang diperlukan oleh para peserta, sila 
hubungi penyelidik, Jim Chai,melalui e-mel:  khyx1jch@nottingham.edu.my atau penyelia 
tempatan, Encik KT Wong, e-mel: Kok-Thong.Wong@nottingham.edu.my. 
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Appendix 2: Research Consent Form
!
!
 
3DWLHQWV¶([SHULHQFHRI,QVXOLQ7KHUDS\IRU7\SH'LDEHWHV0DQDJHPHQW 
Pengalaman Pesakit Insulin Terapi untuk Diabetes Pengurusan  
! ! ! ! ! !
1. I confirm that I have read and understand the information sheet dated 5/8/2011 
for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
Saya mengesahkan bahawa saya telah membaca dan memahami lembaran maklumat 
yang bertarikh 5/8/2011 untuk kajian di atas. Saya akan berpeluang 
untuk mempertimbangkan maklumat,bertanya soalan dan mendapatkan jawapan yang 
memuaskan. 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my legal rights being affected. 
Saya faham bahawa penyertaan saya adalah secara sukarela dan saya bebas untuk 
menarik diri pada bila-bila masa, tanpa memberi apa-apa sebab, tanpa menjejaskan hak 
undang-undang saya. 
3. I understand that relevant data collected during the study, may be looked at by 
responsible individuals from The University of Nottingham.  I give permission for 
these individuals to have access to this data. 
Saya faham bahawa data yang berkaitan adalah dikumpulkan semasa kajiaan, boleh 
dilihat oleh individu yang bertanggungjawab dari University of Nottingham. Saya 
memberikan kebenaran untuk individu-individu ini mendapatkan maklumat 
daripada data ini. 
4. I give my consent for the audio-taping of interview as described in the information 
sheet. 
Saya memberi persetujuan saya bahawa  temuramah boleh dirakamkan seperti yang 
diterangkan di dalam lembaran maklumat. 
5. I give my consent for anonymised direct quotes to be used in reports and 
publications. 
Saya memberikan persetujuan saya bagi pemetikan langsung tanpa nama yang akan 
digunakan dalam laporan dan penerbitan. 
6. I agree to take part in the above study.    
Saya bersetuju untuk menyertai dalam kajian di atas. 
 
________________________ ________________ ____________________ 
Name of Participant   Date   Signature 
 
_________________________ ________________ ____________________ 
Researcher    Date   Signature 
 
Patient¶s Copy 
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Appendix 3: Interview Topic Guide 
 
What is the experience of being diagnosed with diabetes? 
¥ When did you find out having diabetes?  
¥ How that happened? 
¥ Anyone in our family with diabetes? 
¥ Do you remember what medications were prescribed? 
¥ Anything thing in your daily changes after you found 
out about diabetes? 
 
What is the experience of using insulin to control diabetes? 
¥ When was insulin introduced? 
¥ Why did the doctor start you on insulin? 
¥ How did you react when insulin was mentioned as part 
of your treatment plan? 
¥ How much do you know about insulin back then? 
¥ How did you find it using insulin injection initially? 
 
 
What influences these experiences? 
¥ When the doctor started you on insulin, was your family 
around? 
¥ How did you tell them about the news? 
¥ What was their reaction? 
¥ How about people you work with, do they know? 
¥ How about your friends, what do they think about 
insulin? 
 
 
How do patientsÕ perspectives of insulin treatment change 
overtime? 
¥ How do you adapted to insulin treatment?  
¥ What changes do you have to make after using insulin 
injection? 
¥  If someone who has reluctant to use insulin, how would 
you advise them? 
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Appendix 5: Demographic Data 
The aim of the study was to conduct semi-structured qualitative interviews 
with a sample of T2DM patients who are using insulin treatment as part of 
their diabetes control to explore their experience of using insulin treatment. 
More than 100 patients were approached but only forty-two patients agreed to 
be interviewed. Patients with Type 1 Diabetes Mellitus or gestational diabetes 
were excluded from the study. Patients who had emergency insulin treatment 
were also excluded. In total thirty-seven T2DM patients who were currently 
using insulin treatment were interviewed.  
 
Demographic data of the participated patients are summarised in Table 6. More 
than Thirty-seven T2DM patients were interviewed; all of the patients were 
Malaysian. The average years of diagnosing with T2DM is 13.6 years and the 
average HbA1c is 8.88%. The mean HbA1c reported by the Malaysia Diabetes 
Clinical Audit (2011) was 8.2% (Abdul Rahman 2012) 
 
There were 24 male and 13 female patients who participated in the study. 17 
patients were Malay, nine patients were Chinese, eight patients were Indian; 
followed by two mixed races patients and one patient was from Iban 
(indigenous tribe from Sarawak state of East Malaysia) background (refer to 
Table 5 and Figure 10). 
 
The National Health and Morbidity Survey 2011 reported the Indians had the 
highest prevalence of T2DM at 24.9%, followed by the Malays at 16.9% and 
Chinese at 13.8% (Kaur et al. 2011). There were more Malay patients recruited 
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than Indians despite the prevalence of diabetes is highest among Indians, this is 
because the Malays was the predominant ethnic group in Peninsular Malaysia 
which constituted 63.1% (Department of Statistics Malaysia 2011). 
 
Table 5 Summary of patientsÕ particulars 
  
 
 
Figure 10 Ethnicity of participated patients 
 
 
 
Total Participants 37
Race
Iban 1
Chinese 9
Malay 17
Indian 8
Mixed 2
Average years of T2DM 13.57
Average HbA1c 8.88%
Average number of Insulin 1.4
Average number of OAM 4.1
Iban, 1 
Chinese, 9 
Malay, 17 
Indian, 8 
Mixed, 2 
Iban 
Chinese 
Malay 
Indian 
Mixed 
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Table 6 Demographic data of participated patients 
 
 
AH 53 Male Malay Malay 2 6 14.6 1 3
AM 68 Male Malay Malay 2 11 6.7 1 5
AZ 50 Female Malay English 3 10 8.2 2 5
BK 58 Female Indian Malay 2 21 13.9 1 5
CH 50 Male Chinese English 2 17 7.2 1 6
E 59 Female Malay English 2 8 7.6 1 3
ET 55 Male Iban English 2 27 9.1 1 3
HH 51 Male Malay Malay 2 8 8.9 1 6
HT 59 Male Chinese English 3 26 8.1 1 5
KK 58 Male Chinese English 2 10 6.5 1 5
LM 61 Female Indian English 1 15 8.4 2 1
LR 50 Female Indian English 1 20 8.6 2 2
LT 36 Male Chinese English 1 25 7.7 1 3
LV 35 Female Indian English 3 2 12.7 1 4
MJ 60 Male Malay English 3 7 7.7 1 6
MM 52 Male Malay English 2 19 8 1 4
MR 38 Male Malay English 4 6 8 2 4
MY 51 Male Malay English 2 2 6.30 2 2
No. of 
OAM
HbA1c 
(%)
No. of 
InsulinPatient Age Gender Race
No. of Co 
morbidity
Length of 
T2DM (Year)
Language Used 
in Interview 
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MZ 60 Female Malay English 2 22 9.3 2 4
NA 44 Female Malay English 1 3 9.3 1 2
NR 30 Male Malay Malay 3 3 8.4 1 4
PG 52 Male Mixed English 1 11 9 1 3
RK 61 Male Indian English 6 4 8.7 2 5
S 65 Female Malay English 4 17 7.6 1 6
SA 60 Male Indian English 2 32 7.9 2 5
SL 50 Female Indian English 1 5 10.6 2 5
SR 46 Male Indian English 2 16 7.6 2 6
TC 69 Male Mixed English 3 13 6.9 1 5
WM 50 Female Chinese English 2 25 7.7 2 3
YF 52 Male Chinese English 2 12 11.4 2 3
YHK 52 Male Chinese English 3 21 13.3 2 7
YLC 56 Female Chinese English 5 15 6.7 1 4
YP 66 Male Chinese English 2 18 7.3 1 5
ZA 46 Female Malay English 1 13 9.1 1 3
ZM 56 Male Malay Malay 1 10 11.1 2 6
ZT 42 Male Malay Malay 1 17 7.5 2 2
ZZ 40 Male Malay English 3 5 11.1 1 3
No. of 
OAM
HbA1c 
(%)
No. of 
InsulinPatient Age Gender Race
No. of Co 
morbidity
Length of 
T2DM (Year)
Language Used 
in Interview 
